MikeLigalig.com

EnSoftek partners with Pfeifer & Associates, provider of substance abuse services in Oregon, to deploy its state-of-the-art DrCloudEHR solution.

BEAVERTON, ORE. (PRWEB) NOVEMBER 17, 2020
EnSoftek, a leading provider of electronic health record (EHR) systems, today announced that Pfeifer & Associates has selected the DrCloudEHR solution to replace its current EHR system in order to improve efficiency in their delivery of services, enable virtual technologies to connect with its consumers and meet state reporting requirements.
"Pfeifer & Associates is excited to move from our two system EHR, which in the past has been described as "clunky' by our staff and auditors," said Sally Pfeifer, Executive Director, Pfeifer & Associates.
Pfeifer & Associates offers professional treatment and housing to adults struggling with substance use disorder (SUD) issues in Redmond, Bend and La Pine, Oregon. The company will use many of DrCloudEHR's features, including TeleHealth, Patient Portal, and the COVID-19 screening tools.
DrCloudEHR is designed to support the healthcare system's growing focus on data exchange, coordination of care, and elimination of information gaps that could adversely affect positive health outcomes.
"We welcome Pfeifer & Associates as a partner and look forward to delivering our Meaningful Use certified DrCloudEHR with connectivity and interoperability with state reporting, labs and other complimentary technologies." said Adam Feldman, Senior Vice President Business Development.
About DrCloudEHR and EnSoftek, Inc.
Currently in use in 26 states throughout the country, DrCloudEHR from EnSoftek is a Stage 3 Meaningful Use-certified, cloud-based electronic health records (EHR) system designed for behavioral health and human services organizations. DrCloudEHR offers "anytime, anywhere access" to enable delivery of superior services, improved patient care and health outcomes, and better overall patient satisfaction. EnSoftek provides diversified enterprise IT solutions to both public and private sector enterprises.
About Pfeifer and Associates
Pfeifer and Associates has been in service since 1998, staffed by fully certified and credentialed alcohol and drug specialists, recovery mentors, and housing specialists to provide a personalized treatment experience for people who are having substance abuse issues and DUII problems. Pfeifer's vision is, "a community that immediately helps all individuals who are seeking freedom from substance abuse issues". Pfeifer focuses on working with individuals in a one-on-one setting, ensuring that they are comfortable, and treat every individual with dignity and respect.
Follow us on Twitter, LinkedIn, and Facebook.
http://www.drcloudehr.com; http://www.ensoftek.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Thirty-five U.S. Dermatology Partners dermatologists from across Texas to receive the prestigious peer-nominated Texas Monthly Super Doctor and Rising Star awards

DALLAS (PRWEB) NOVEMBER 17, 2020
U.S. Dermatology Partners is proud to announce 35 U.S. Dermatology Partners doctors are being recognized by their peers in Texas Monthly Magazine. Of those, 24 are being recognized as Super Doctors in the December 2020 issue of Texas Monthly. Nine will be recognized as members of the Super Doctors Hall of Fame and five of the nine have been voted by peers since the inception of the award. Hall of Fame members are those who have been selected for 10 or more years. As one of the medical field's most prestigious titles, only 5% of the state's physicians receive this designation.
An additional eleven U.S. Dermatology Partners doctors were recognized as Rising Stars in the July 2020 issue of Texas Monthly. Doctors recognized as Rising Stars meet the same criteria as Super Doctors and have been actively practicing for 10 years or less. Only 2.5% of all active physicians are selected to the Rising Star list.
Each year, Texas Monthly asks doctors across the state to nominate colleagues (excluding themselves) who they would trust for their own medical care. The Super Doctors research team then investigates independently. Candidates are evaluated based on peer recognition, professional achievement, and disciplinary history. Candidates are also rated on their involvement in scientific publications, medical research, participation in lectures, and other professional activities. The highest-ranking nominated physicians are asked to serve on a selection panel of peers, which helps to determine the final list of Super Doctors.
U.S. Dermatology Partners began in 2013 and has grown to one of the largest single-specialty dermatology practices in the country. The group is focused on attracting and retaining the top physicians in the field of dermatology and also includes fellowship-trained Mohs Surgeons and dermatopathologists. The Texas Super Doctors is a unique award, designed to benefit educated consumers seeking exceptional care. Physicians from U.S. Dermatology Partners have been named as recipients of this prestigious award for six consecutive years with a growing number of U.S Dermatology Partners physicians receiving the award each year. U.S. Dermatology Partners can be found in over 50 locations throughout the state of Texas. To find a dermatologist near you go to http://www.usdermatologypartners.com.
"We are proud to have so many of our physicians honored by their peers for their professional excellence and achievements. Their inclusion in this prestigious award is a tribute to their dedication to our organization's purpose of delivering ethical and exceptional patient care experiences," said Paul Singh, CEO
The physicians being honored represent cities throughout the state of Texas including Dallas, Fort Worth, Plano, Sherman, Grapevine, Austin, Georgetown, Cedar Park, Carrollton, Houston, San Antonio, and Tyler.
The complete list is published in the December 2020 issue of Texas Monthly.
U.S. Dermatology Partners Super Doctors Legacy Hall of Fame 2020
Recognized for Dermatology
Lawrence L. Anderson, M.D., Tyler – 16 years
Aaron Joseph, M.D., Pasadena – 15 years
Howard A. Rubin, M.D., Dallas – 16 years
Hans M. Sander, M.D., Austin – 16 years
Dale G. Schaefer, M.D., Austin – 17 years
U.S. Dermatology Partners Super Doctors Hall of Fame 2020
Recognized for Dermatology
Elizabeth Basler, M.D., Houston
Mark Koone, M.D., Sherman
Mark A. Price, M.D., Houston
Danny R. Thomas, M.D., Fort Worth
U.S. Dermatology Partners Super Doctors 2019
Recognized for Dermatology
Alma Criseida Berlingeri-Ramos, M.D., Tyler
Roopal Bhatt, M.D., Austin
Jessica Dorsey, M.D., Cedar Park
Cindy Greenberg, M.D., Houston
Aubrey Chad Hartmann, M.D., Cedar Park
Jordan Ilse, M.D., Belton
John LeVasseur, MD San Antonio
Monica Madray, M.D., Georgetown
Amy A. McClung, M.D., Austin
Shanna Burris Meads, M.D., Tyler
Clint Moss, M.D., Sherman
Bryan Selkin, M.D., Plano
Howard Steinman, M.D. Carrollton, Plano, Grapevine
Breck Thrash, M.D., Dallas
Bryan L. Townsend, M.D., Austin
U.S. Dermatology Partners Rising Stars 2020
Recognized for Dermatology
Caitlin Farmer, M.D., Flower Mound, Plano
Jennifer Holman, M.D., Tyler
Weilan Johnson, M.D., Georgetown
Laura Lester, M.D., Cedar Park
Bobbak Mansouri, M.D., Tyler
Michaela Overturf, M.D., Nacogdoches
Trisha Patel, M.D., Dallas
Valerie Truong, M.D., Dallas, Plano
Daniel Walker, MD, Grapevine
Calvin Williams, M.D., Keller
John "Jay" Wofford, MD, Dallas, Plano
About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners patients not only have access to general medical, surgical, and cosmetic skin treatment through its coordinated care network, but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Oral Care R&D powerhouse miBrite announced the launch of its new tooth whitening product: miBrite ClearPaste. Developed by the world's top oral care product researcher and formulator, Dr. Martin Giniger, Ph.D., DMD, miBrite ClearPaste is the latest advancement in tooth whitening technology.

BOCA RATON, FLA. (PRWEB) NOVEMBER 17, 2020
miBrite, the brand that sparks confidence and smiles, is proud and excited to announce miBrite ClearPaste. Being the latest paradigm-shifting oral care technology developed by R&D powerhouse Smash Labs, LLC., miBrite ClearPaste instantly whitens teeth without the use of peroxide or bleach. Instead, miBrite ClearPaste uses the advanced color theory used by Hollywood makeup artists for decades.
The mechanism miBrite ClearPaste utilizes to whiten teeth involves specific deep purple pigments. The particular shade of purple used in ClearPaste makes teeth whiter because it is the opposite of the yellow color typically found on stained teeth. When you brush your teeth with miBrite ClearPaste, the advanced bioadhesive hydrogel disperses and coats your teeth - making them appear to be whiter (or less yellow).
What's most exciting about miBrite ClearPaste is that this technology enables an entirely new demographic to whiten their teeth safely - those who have restorations such as crowns, veneers, or implants. Until now, the only whitening option for people with artificial teeth was to remove and replace their restoration. Replacing existing dental work is a very invasive and expensive solution for people who want to quickly and safely whiten their teeth.
Having worked on teeth whitening products since the late 1990's, Dr. Martin Giniger, Ph.D., DMD, Chief Scientist at Smash Labs, made it his mission to develop a teeth whitening product that was safe and effective on crowns and veneers. "It is commonly known that teeth whitening products that contain hydrogen peroxide or carbamide peroxide are not recommended for composites, crowns, or veneers. Peroxides only work to whiten organic stains on natural teeth and do not change the colors of restorations," says Dr. Giniger, "and our R&D team thought if we can't change the color of the restoration, then why don't we remove the yellow color wavelength of light that is reflected off the teeth? This is exactly what miBrite ClearPaste does." 
miBrite ClearPaste will become the go-to teeth whitening product that the world has been searching for as it checks all the boxes of a tooth whitening product that is so desperately needed. Sold in beautiful, airless pump packaging that dispenses the correct amount, miBrite ClearPaste can safely be used in the morning to assure day long white teeth with no tooth sensitivity. 
For more information, visit miBrite's website: http://www.mibrite.com 
About Smash Labs, LLC and miBrite
Smash Labs, LLC is a multi-faceted oral care product innovation international firm based in Boca Raton, Florida, and Amsterdam, The Netherlands. Dr. Martin Giniger, Ph.D., DMD heads the company as Smash Lab's Chief Scientist and works together with Oral Care R&D formulator Matt Spaid. Smash Labs works closely with companies worldwide and helps them formulate the products of their dreams. For more information, visit http://www.smash-labs.com and http://www.mibrite.com 
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The nonprofit donates a total of $16,959 in grant money to 17 medical institutions to support NICU families and patients

CHICAGO (PRWEB) NOVEMBER 17, 2020
Little Giraffe Foundation, a registered 501(c)(3) organization dedicated to funding neonatal research and supporting families and premature babies in the NICU, announced today the 17 recipients of the foundation's 2020 NICU Support Grants.
"This year has been especially difficult for the families we serve, caring for their loved ones in the NICU on top of a global pandemic. That's why the Little Giraffe Foundation board of directors is pleased to fund 17 NICU support grants to help parents and families," said Amanda Santoro, co-founder and president of the Little Giraffe Foundation. "Every single one of these grant recipients put a lot of thought and care into how they are going to help support their respective NICU, and we look forward to seeing these programs and projects come to fruition."
This year's Little Giraffe Foundation's NICU Support Grant recipients are as follows:

Abington Health Foundation, Abington, Pennsylvania — to receive $1,000 to help families acquire the items they need to have a safe transition from the NICU to home.

Akron Children's Hospital, Akron, Ohio — to receive two grants of $1,000. One to fund parking, travel passes, food cards. And one to purchase memory making items for families who have experienced the loss of a baby while in the NICU.

Catawba Medical Foundation, Hickory, North Carolina — to receive $1,000 toward one large neoBLUE blanket LED Phototherapy System.

Norton Children's Hospital Foundation, Louisville, Kentucky — to receive $1,000 for gas gift cards for parents traveling over 50 miles one way to visit their baby in the NICU.

Edward Hospital, Naperville, Illinois — to receive two $1,000 grants. The first for the 'Beads of Courage Program,' which provides NICU patients and families with a strand of beads to help tell their story of courage during their NICU stay. The second to give families voice recorders, used during their NICU stay.

AMITA Health Saint Joseph Hospital, Chicago, Illinois — to receive $1,000 for HALO SleepSacks and Joey Bands for NICU admissions of less than 32 weeks gestation.

Lourdes Foundation, Inc., Lafayette, Louisiana — to receive $1,000 for Lullaby Sound Spas and portable Sound Machines for families to take home.

Franciscan Health Foundation, Indianapolis, Indiana — to receive $1,000 for the purchase of gas cards for families visiting their babies in the NICU.

Texas Tech University Health Sciences Center, El Paso, Texas — to receive $1,000 for meal cards for breastfeeding mothers.

Nationwide Children's Hospital Foundation, Columbus, Ohio — to receive $1,000 for Compact Swings for babies at The Ohio State University Wexner Medical Center and Mount Carmel St. Ann's Hospital.

North Colorado Medical Center, Greeley, Colorado — to receive $999 to provide graduation celebrations for NICU families.

Franciscan Health Foundation, Crown Point, Indiana — to receive $1,000 for insulated cooler bags for breastfeeding NICU mothers.

Northeast Georgia Medical Center, Gainesville, Georgia — to receive $1,000 for gas cards, meal tickets, grocery gift cards and hygiene items for NICU families.

Franciscan Health Foundation, Olympia Fields, Illinois — to receive $960 toward Pack 'n Plays for NICU/SCN infants.

The Tiny Miracles Foundation, Darien, Connecticut — to receive $1,000 for the stocking of food in family rooms and providing in-hospital meals for parents during the holiday season.

"The mission of The Little Giraffe Foundation has always been to fund neonatal research and support the patients and parents of the NICU. We see this mission in every one of these institutions and the work they are doing for their NICU communities," said Mike Santoro, co-founder of the Little Giraffe Foundation. "We are proud to offer these 17 support grants so that they can continue funding valuable programs that help children and families in need. The entire Little Giraffe Foundation community would like to thank our monetary donors and volunteers that make this funding possible. With the current climate being stressful for many families, we look forward to providing even greater support to programs like these in 2021 and beyond."
To learn more about the Little Giraffe Foundation and its efforts to aid in NICU patient and family support, as well as neonatal medical research, please visit: http://www.littlegiraffefoundation.org/ and follow the organization's news on Facebook at: https://www.facebook.com/LittleGiraffeFoundation.
About the Little Giraffe Foundation:
The Little Giraffe Foundation is a national 501(c)(3) non-profit based in Chicago, dedicated to supporting parents and patients of the neonatal intensive care unit (NICU). Since 2011, the foundation has delivered more than 19,000 holiday gift bags and funded over $320,000 in neonatal medical research and NICU support grants



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Plastic Surgeon and Breast Reconstruction Specialist Dr. Constance Chen Offers Practical Tips about Breast Pain.

NEW YORK (PRWEB) NOVEMBER 17, 2020
Most women suffer some form of breast pain at some point in their lives. It may be mild or severe, constant or intermittent. It may be in the form of soreness, sharp burning pangs, or tightness. "Breast pain, or mastalgia, is usually straightforward to diagnose and treat," says plastic surgeon and breast specialist Dr. Constance M. Chen. "While it is seldom a sign of something serious, pain that doesn't go away after one or two menstrual cycles or that persists in women after menopause should be evaluated by a doctor."
Most breast pain is cyclical – linked to hormonal fluctuation associated with the reproductive cycle. Women describe cyclical breast pain as the breasts feeling heavy, tender, swollen, and achy. It is caused by increases in estrogen and progesterone that occur before the menstrual period and cause the breasts to swell. Cyclical breast pain generally affects both breasts, intensifies in the week or two leading up to the menstrual period, then recedes. It most often affects women during their childbearing years and as they are approaching menopause. Breast tenderness can be eased with over-the-counter pain relievers and by reducing salt, fats, and caffeine in the diet. Birth control pills – or switching to a different formulation – can also help.
Dr. Chen notes: "The breasts may remain tender during the first trimester of pregnancy in response to increased hormone levels and that continuing breast soreness often accompanies a missed menstrual period as an early sign of pregnancy."
Fibrocystic breast disease, also triggered by hormones, is characterized by dense, lumpy breast tissue that may become painful in response to the monthly cycle. The lumps are fluid-filled cysts and can be clearly differentiated from more dangerous lumps composed of a solid mass of cells that may signify a benign or malignant tumor. Cysts may resolve on their own but any lump in the breast must be evaluated by a doctor via mammogram, ultrasound, or aspiration – drawing fluid from the cyst.
Non-cyclical breast pain -- unrelated to reproductive hormones – most often occurs in one breast and in a localized area though the pain may spread throughout the breast. There are several causes:
Mastitis is most common in breast-feeding women (lactation mastitis) but can occur at any time. It is characterized by inflammation of the breast tissue that causes swelling, redness, pain, and warmth and sometimes fever and chills. During lactation, mastitis is usually caused by a blocked milk duct or by bacteria entering the breast through an opening in the skin or a cracked nipple. It is generally treated with antibiotics.
Injury to the breast can be from a previous surgery, from an accident, or from sports. There may be a sharp pain at the time of the trauma followed by tenderness for days or weeks. A doctor should be seen if pain doesn't subside or if there is redness and warmth, which could indicate the presence of infection, if there is severe swelling, or if there is a bruise that doesn't go away.
Support issues are most often experienced by women with large, heavy breasts but poor support can cause the ligaments to stretch and cause pain in breasts of any size, particularly after exercise. Pain may also affect the neck, back, and shoulders. A properly fitted, supportive bra should be worn at all times and a sports bra when exercising.
Medications can cause breast pain as a side effect. Hormonal therapies used in infertility treatment, birth control pills, and hormonal replacement after menopause can cause breast tenderness. Some psychiatric medications and those used for coronary disease can also have this effect.
"Many women worry that breast pain might be a sign of breast cancer," says Dr. Chen. "While this is unusual, it's not impossible. Inflammatory breast cancer, which accounts for 1%-5% of breast cancers does cause pain as well as redness, swelling, and thickened or dimpled skin. The important thing for women to know is that while most breast pain isn't dangerous, any condition that doesn't resolve over the course of the menstrual cycle or a week or two should be evaluated by a doctor. In the vast majority of cases, treatment will be rapid and effective."
Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

HHAeXchange to provide EVV aggregation to ensure 21st Century Cures Act compliance

NEW YORK (PRWEB) NOVEMBER 17, 2020
HHAeXchange, a leading provider of homecare management solutions for payers, providers, and state Medicaid agencies, announced today that it has been selected by the West Virginia Bureau of Medical Services as its state aggregator for Electronic Visit Verification (EVV). The contract was awarded to HHAeXchange on October 21, 2020.
As West Virginia's aggregator, HHAeXchange will provide comprehensive oversight and management of the State's EVV data in compliance with the 21st Century Cures Act. Signed into law in 2016, the 21st Century Cures Act was designed to decrease fraud, waste, and abuse, and to help bring new innovations and medical advances faster to Medicaid participants who need them. Under the Cures Act, all Medicaid personal care services and home health care services must be electronically verified.
HHAeXchange's aggregator platform supports West Virginia's Open EVV Model by consolidating all visit data regardless of the EVV system being used, reducing administrative burden, and delivering powerful data visualization and analytics dashboards to enable the State to manage provider compliance and ensure participants are receiving the right care at the right time.
The platform dynamically connects the West Virginia Medicaid Program to the vast network of homecare providers, improving the efficiency of the homecare ecosystem and the Medicaid program, and helping to ensure Medicaid members are receiving care. West Virginia providers will be able to submit confirmed visits and bill directly to the State through the free HHAeXchange Portal.
"Our mission here at HHAeXchange has always been twofold: to help provide better outcomes for participants, and to simplify the homecare management process along the way," said Greg Strobel, CEO of HHAeXchange. "As West Virginia's EVV partner, we're looking forward to offering the State and its providers and direct care workers EVV tools that will not only allow them to ensure full compliance with the federal mandate, but also make their lives easier and help them deliver a higher quality of care for all participants."
Earlier this year, HHAeXchange was also chosen by the State of New Jersey to aggregate Medicaid beneficiary visit data on its behalf. As an industry-leading provider of homecare management solutions, HHAeXchange has helped numerous states and MCOs manage billions of dollars in Medicaid claims while achieving a new level of oversight, transparency, and efficiency that hasn't previously existed in the marketplace.
In the coming weeks, HHAeXchange and West Virginia will engage program stakeholders to educate them on next steps and ensure they receive all information necessary to support a successful implementation in Q1 2021.
About HHAeXchange
Founded in 2008, HHAeXchange is the leading technology platform for homecare and self-direction program management. Developed specifically for the Medicaid patient population, the HHAeXchange platform connects state agencies, managed care payers, providers, and caregivers through its intuitive web-based platform, enabling unparalleled communication, transparency, efficiency, and compliance. For more information, visit hhaexchange.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Collaboration Offers a Best-In-Class Spa Experience to Gordon and Grant Hot Tubs and Spas Owners.

SANTA BARBARA, CALIF. AND BOULDER, COLO. (PRWEB) NOVEMBER 17, 2020
Gordon and Grant and Clear Comfort have collaborated to deliver the best, healthiest and easiest spa experience. The new collaboration brings Gordon and Grant's high-end wooden and acrylic hot tubs together with the leading AOP water treatment. Gordon and Grant's Clear Comfort offering is available immediately.
"Clear Comfort is the top sanitation system we proudly recommend thanks to it's powerful Advanced Oxidation Process that is not only healthy for our customers but for their hot tubs as well," says Joe Bolger, General Manager at Gordon and Grant. "Crisp, clean and crystal-clear water that enhances the soaking experience and protects customers is a win-win for us."
Customers of Gordon and Grant's high-end wooden and acrylic hot tubs both receive unbeatable advantages with the addition of Clear Comfort. As an authorized dealer of Jacuzzi, Sundance and Marquis hot tub brands, Gordon and Grant understands high-quality and offering Clear Comfort guarantees a healthy, fresh and clean spa water experience with drinking water chlorine levels or less. Additionally, Clear Comfort's AOP allows customers to extend the longevity of their high-end wooden spas avoiding damage or corrosion to spa surfaces.
"We are proud to collaborate with a company that shares the same focus on the needs of customers as well as our mutual environmental commitment," said Steve Berens, CEO of Clear Comfort. "Gordon and Grant's effort to give back to environmental groups directly matches our ideals to provide water that is healthy for the spa owners as well as the environment."
Clear Comfort's AOP system provides Gordon and Grant's luxury acrylic and wooden spa offerings with non-corrosive, sustainable and healthy water with minimal chlorine and other chemicals. Bringing together Clear Comfort and Gordon and Grant, hot tub customers are assured high-quality and lasting enjoyment.
To take advantage of this collaboration today, please visit clearcomfort.com/gordon-and-grant
About Clear Comfort
Clear Comfort manufactures and sells pool and spa water disinfection systems to enhance recreational water treatment. Clear Comfort's patented hydroxyl-based advanced oxidation (AOP) technology provides the best swimming experience available with proven, effective and non-toxic treatment. With headquarters and manufacturing based in Colorado, Clear Comfort customers receive a sustainable, "Made in the USA" product. Clear Comfort is a proud Impact Driven company delivering healthy, ethical and sustainable solutions to the market. For more information about Clear Comfort, please visit http://clearcomfort.com.
About Gordon and Grant Hot Tubs and Spas:
As Santa Barbara's exclusive authorized dealer of luxury spas Jacuzzi, Sundance, and Marquis, Gordon and Grant's premium acrylic spas continue to be the most popular choice for backyard hot tubbing. In addition, their custom wood hot tubs are crafted and manufactured at their downtown location. Gordon and Grant are committed to providing Santa Barbara and surrounding areas with the highest quality spas, hot tubs, equipment, and service, carrying on the hot water tradition Gordon and Grant started in the 70's. For more information about Gordon and Grant, please visit http://www.gordonandgrant.com




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Customer communications management (CCM) platform DataOceans today announced that Joseph Smith, formerly of Blue Cross Blue Shield, has joined its Advisory Board.

ATLANTA (PRWEB) NOVEMBER 17, 2020
DataOceans LLC, (https://www.dataoceans.com) a leading customer communications management (CCM) platform, today announced that Joseph Smith has joined its Advisory Board.
Mr. Smith had held leadership positions in the healthcare insurance industry, including Blue Cross Blue Shield (BCBS) organizations in the Midwest, Northeast and Southwest. He recently retired from his role as Senior Vice President and CIO at Arkansas Blue Cross and Blue Shield.
Speaking of the new affiliation, DataOceans' founder and CEO Larry Buckley commented, "Joe brings to us decades of leadership in healthcare IT governance and strategy. His deep understanding of these areas will be a valuable contribution that will help us continue to deliver innovative customer communications for our clients in the healthcare industry."
Throughout his career Mr. Smith has served in numerous healthcare leadership roles, on several occasions representing BCBS in formal testimony to Committees of Congress. In 2011 he was selected to receive Information & Technology Magazine's "Elite 8" Award. He has also been awarded a patent for the business strategy and supporting computer system to support the healthcare industry's migration to ICD 10 coding nomenclature.
Mr. Smith has founded four major user groups for shared systems investments, and currently serves as an advisor to firms and committees in the technology and healthcare sectors. He is the founder of several healthcare-related companies: Shareware LLC, a shared capabilities company; Shared Health Plan Systems LLC, which enables multiple health plans to administer their health products on a single shared operations platform; and HITvision, which specializes in Healthcare IT arbitration.
According to Smith, "The health insurance industry is in need of new solutions to leverage growing volumes of EHR data to improve efficiencies and patient outcomes. I'm very pleased to join DataOceans' advisory board to help them continue to deliver the next generation of communications to their clients."
About DataOceans. DataOceans delivers a fully integrated and comprehensive CCM platform built for communications and revenue lifecycle management, where business rules can be applied to deliver agile and consistent communications, including billing statements, compliance notifications, and marketing promotions, across distribution channels that include print, online, mobile, interactive PDF and mobile alerts. DataOceans enables clients to transform how they engage with customers, innovate how they do business, and simplify their technology landscape. For more information, visit https://www.dataoceans.com or follow us on LinkedIn at https://www.linkedin.com/company/dataoceans/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Technology leader Odoro supports over 600 providers and their patients at SLUCare with fast and safe, digital check-in for appointments across their locations including their new state-of-the-art outpatient medical building, the Center for Specialized Medicine.

NEW YORK (PRWEB) NOVEMBER 17, 2020
Odoro, a leader in digital patient access solutions, today announced the results of the adoption of their digital registration platform by SLUCare Physician Group, the academic medical practice of Saint Louis University School of Medicine. The implementation of the Odoro registration platform was introduced as part of SLUCare's efforts to expand digital patient access. In the near future, the platform will also include the ability to search for providers and schedule appointments online.
The SLUCare practice recognized the value of the stress-free, quick, paperless experience for patients provided by the Odoro solution even before the pandemic started. The platform helped the practice adapt to the "new normal" once the pandemic began, as patient digital registration became essential in accommodating social distancing and complemented the process of virtual visits.
SLUCare patients quickly adopted the new technology, which is used by providers in internal and family medicine, ophthalmology, OBGYN, orthopedics, hematology, dermatology, sports medicine and cosmetic medicine. Just ten days after going live, nearly 90% of patients used Odoro to sign in for their visits, on their laptops, tablets or cell phones. Today, over 70% of patients complete their entire pre-visit process digitally, avoiding face-to-face interactions before seeing a doctor.
The benefits to SLUCare patients and physicians for physical visits include reduced waiting times and increased safety for patients and staff. For tele-health visits with no physical front desk, Odoro's online platform becomes essential in streamlining the practice's financial and compliance processes.
"We are excited to provide our patients with a safe, efficient, paperless registration as part of our new modern patient experience," said Matt Zimmie, M.D., MSHI, SLUCare assistant vice president and chief medical information officer. "The high adoption rates speak for themselves. The solution was well received by our practice staff as well as our patient community."
The new workflow is simple: prior to an appointment, whether in office or virtual, patients are reminded to register online. COVID-19 pre-screening, insurance data, payment processing and consent forms are all completed digitally, ensuring a contactless experience. Data is automatically updated on SLUCare's practice management system, minimizing documentation for staff. When arriving at the clinic, patients use onsite kiosks or their personal devices to check-in and complete any remaining requirements or payment.
"We are proud to support SLUCare's vision of providing a state-of-the-art patient experience by digitizing their patient access. Our hand-in-hand collaboration with Glenda Jackson, Director Revenue Cycle Technology, and her professional team, was a model of successful implementation. We celebrate their tireless efforts to support their medical teams during these challenging times, making this vision a reality," said Dikla Ranen, Co-founder and COO of Odoro "SLUCare today represents where all practices will need to be in the near future, as all physicians will require what I call a 'virtual front desk.' Practices need effective ways to collect payments and get consent forms for virtual visits. When patients step into the office, it will then be a continuance of that same safe, quick and seamless experience."
SLUCare and Odoro were introduced through the St. Louis-based organization, GlobalSTL, an initiative of BioSTL that recruits high-growth companies from around the world to enrich and grow St. Louis's innovation economy.
About Odoro, A Clearwave Company
Odoro transforms the patient experience for health systems and practices, with an integrated platform of digital solutions for online scheduling, self-registration and personalized patient communications. Odoro's technology and advanced algorithms efficiently and accurately match patients, providers and locations, addressing provider and health system needs. With adoption rates of up to 90%, Odoro streamlines workflows, reduces inefficiencies and generates high levels of satisfaction and loyalty among patients.
To learn more, please visit: http://www.odoro.com
About SLUCare
SLUCare Physician Group is the academic medical practice of Saint Louis University School of Medicine, with more than 600 health care providers and 1,200 staff members in hospitals and medical offices throughout the St. Louis region. SLUCare physicians are among the most highly trained in their fields - more than 50 specialties in all - and are national and international experts, renowned for research and innovations in medicine. For more information, please visit http://slucare.edu/
About Clearwave
Clearwave is a premier digital check-in and eligibility-verification solution provider for the healthcare industry. Since 2004, the company has helped its customers improve the patient experience via a comprehensive technology solution that combines Clearwave's patient self check-in solutions and eligibility-verification engine to improve insurance verification workflows, increase revenue collections and improve data access. Clearwave is headquartered in Atlanta, Georgia. For more information, visit http://www.clearwaveinc.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

App focuses on deep healing and the power of community to help women overcome the hardships of 2020

LOS ANGELES (PRWEB) NOVEMBER 17, 2020
Huma Rising announced that its app for women's healing and empowerment is now available on the iOS App Store. The app was created by women, for women who want to release self-limitation, unworthiness, and unhealthy emotional patterns.
"COVID and the year 2020 have brought us a unique opportunity to face ourselves," said founder and CEO Marina Harmon. "For many of us, old traumas and unprocessed pain have come up to be addressed. We've seen the return of things like anxiety, eating disorders, and addictive behaviors as the persistent stress of this year has reactivated many of our deeper issues. With this immense need for healing, we felt it was the right time to share Huma Rising with the world."
Huma Rising is not just another meditation app. It includes powerful talks, community gatherings, and deep-healing experiences designed to help women understand and transform their emotional lives. These methods help women create freedom from self-sabotage, limiting beliefs, and debilitating emotions, allowing them to feel their innate worthiness. With practices that slow the brain waves to reach the subconscious mind, the source of our emotional programming, Huma Rising helps women create new thought patterns, empowering beliefs, and healthy ways of being.
Huma Rising's primary meditation practice, Yoga Nidra, is used by the U.S. Department of Defense to heal veterans with PTSD. The practice is unique in that it surfaces unresolved emotions and thought patterns in a way that doesn't activate the stress response. Instead, by soothing the nervous system, it allows for the resolution of these emotional experiences and subsequent rewiring of the brain. Yoga Nidra is shown to help release negative beliefs, reduce emotional reactivity, and significantly decrease anxiety, depression, and stress.
"This time is a turning point," Harmon said. "We can either avoid our emotional needs, or we can allow this experience to transform us. This app is for the women who want to wake up, who want to be free, and who are ready to release old, limiting beliefs that keep us playing small."
About Huma Rising
Huma Rising is an app, virtual studio, and community designed to help women heal, step into their worth, and learn to deeply trust themselves. With practices designed by a team of powerful, embodied women, Huma Rising is on a mission to help all women embrace themselves as they are. The company was founded by Marina Harmon, who left the corporate world in 2018 to record and edit hundreds of hours of meditations, teach herself mobile app development, and build the Huma Rising app. Huma Rising is headquartered in Los Angeles. Visit humarising.com or follow @huma.rising on Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

What does one need to know about drug and device advertising and promotion? Here are the must-dos to avoid violations. Register today.

FALLS CHURCH, VA. (PRWEB) NOVEMBER 18, 2020
Advertising and Promotion Compliance:
Latest Developments and Keys to Successful Compliance with FDA Regulations and Guidance
An FDAnews Webinar
Wednesday, Dec. 2, 2020, 11:00 a.m.-12:30 p.m. EST
https://www.fdanews.com/adpromocompliance
Promotional activities can be magnets for warning letters or untitled letters.
How can one successfully comply with the FDA's complex advertising and promotion guidelines?
Join Covington & Burling LLP's Stefanie A. Doebler, a Partner, and Christopher Hanson, Special Counsel, for an introduction to advertising and promotion principles, including requirements for promotion (incorporating claims substantiation, fair balance and off-label promotion) and key differences between drug and device promotion.
They will use case studies from recent enforcements to explain the most important risk areas, including:

Key statutory definitions used in the Federal Food, Drug and Cosmetic Act (FD&C Act), such as misbranded, labeling and false and misleading

The primary requirements for advertising and promotion set forth in the FD&C Act and implementing regulations

The FDA's recent guidance on promotion consistent with the approved labeling described in its 2019 guidance, "Medical Product Communications That Are Consistent With the FDA-Required Labeling"

The scope of the prohibition on preapproval promotion, 21 CFR 312.7, 812.7

The difference between promotion and disease awareness communications, described in FDA's draft guidance, "'Help-Seeking' and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms"

What one doesn't know about drug and device advertising and promotion will hurt you. Arm oneself against violations with this webinar.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details:
Advertising and Promotion Compliance:
Latest Developments and Keys to Successful Compliance with FDA Regulations and Guidance
An FDAnews Webinar
Wednesday, Dec. 2, 2020, 11:00 a.m.-12:30 p.m. EST
https://www.fdanews.com/adpromocompliance
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/adpromocompliance
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Protective face masks have infiltrated apparel and makeup trends and, in the spirit of the season, holiday shopping lists.

PORT WASHINGTON, N.Y. (PRWEB) NOVEMBER 17, 2020
Protective face masks have become part of the new norm throughout the U.S. Along the way, they have infiltrated apparel and makeup trends and, in the spirit of the season, holiday shopping lists. In fact, 31% of holiday shoppers plan to give masks as stocking stuffers or gifts this year, according to The NPD Group's Annual Holiday Study.
In terms of how and where consumers are shopping for these masks, NPD's Checkout data shows that e-commerce dominates dollar sales, but as stores reopened and more retailers entered the market with reusable options, e-commerce began to lose share. Warehouse clubs, specialty retailers, and mass merchants have been the primary gainers in this shift – providing consumers with more shopping and product assortment options for the holiday season.*
Impact on Beauty and Fashion
Covering the nose and lips, protective face masks place greater emphasis on the wearer's eyes. Consequently, dollar sales of lip makeup declined faster than all other makeup products year-to-date through September versus last year. Compared to lip and face, eye makeup has seen the softest sales declines and gained market share. Under the mask, setting sprays, which may help consumers solve the problem of keeping makeup in place, grew by an average of 9% month-over-month.**
"While protective face masks focus attention on the eyes, we still want to keep the rest of our face looking good for when the mask comes off – not to mention keeping the mask itself free of smudges," said Larissa Jensen, NPD's beauty industry advisor. "Masks have created a shift in our beauty behavior, and elevated the categories that address the consumer's new set of needs."
Fashion that solves problems is what has won with consumers over the last few years. Jeans with stretch, leggings with pockets, activewear with moisture-wicking properties, and the reemergence of belt bags are some examples of innovation that has piqued consumer interest. Now faced with the challenge of carrying a protective face mask and keeping it clean, consumers have reason to seek another set of options.
"Beyond the protective face masks themselves, which have become the new fashion accessory in their own right, the fashion industry once again has an opportunity to employ innovation to address consumer needs that complement this latest addition to our wardrobe," added Maria Rugolo, NPD's apparel industry analyst. "If masks continue to be a more permanent part of society, at least for the near future, we expect to see continued innovation in how we carry these items. There could be a greater need for pockets, especially for men and a potential opportunity for cargo shorts and pants to come back into style. While no one knows how long masks will be part of consumers' everyday lives, helping them navigate these times as easily as possible will go a long way."
*Source: The NPD Group/ Checkout, May-September 2020
**Source: The NPD Group/ U.S. Prestige Beauty Total Measured Market, January-September 2020
###
About The NPD Group, Inc.
NPD offers data, industry expertise, and prescriptive analytics to help our clients grow their businesses in a changing world. Over 2,000 companies worldwide rely on us to help them measure, predict, and improve performance across all channels, including brick-and-mortar, e-commerce, and B2B. We have services in 19 countries worldwide, with operations spanning the Americas, Europe, and APAC. Practice areas include apparel, appliances, automotive, beauty, books, B2B technology, consumer technology, e-commerce, fashion accessories, food consumption, foodservice, footwear, home, juvenile products, media entertainment, mobile, office supplies, retail, sports, toys, and video games. For more information, visit npd.com. Follow us on Twitter: @npdgroup.
NPD's Checkout service offers robust data for tracking and improving performance across all channels plus buyer analytics to help businesses keep current customers and win new ones. Over 130,000 consumers, the largest omnichannel panel focused on general merchandise and foodservice, provide us with receipt-based information on their in-store and e-commerce purchases. With comprehensive data from the same consumers over time, Checkout illuminates trends in behavior including migration to shopping online by category and consumer demographics. Buyer analytics deliver insight into most valuable customers, brand loyalty, brand leakage / lift, brand launches, and more.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Makers Nutrition has donated over $30,000-worth of a chocolate-flavored immune health-supporting powder to LeSEA Global Feed the Hungry.

HAUPPAUGE, N.Y. (PRWEB) NOVEMBER 17, 2020
2020 sure has been a year of confusion, contention, and concern. Be it directly or indirectly, everyone around the world has, in some way, been affected by COVID-19. And while we cannot predict the future, nor can we change the past, we can indeed play our part in the larger picture.
That is why Makers Nutrition has donated over $30,000-worth of a chocolate-flavored immune health-supporting powder to LeSEA Global Feed the Hungry. Ranging from inflammatory response to bone and joint health, as well as energy production, metabolism, and mitochondrial health, this immune formula is filled with supportive nutrients that can help boost the health of those who need it most.
"Donating flavorful premium-grade powder is one thing we can do to make a difference through this wonderful organization that reaches so far for so many in need," said Director of Multimedia Marketing Rosemary Tambini. "We are thrilled to be able to give as much as we have this year to Feed the Hungry and encourage all who are able to follow suit."
This is Makers Nutrition's third consecutive year donating to Feed the Hungry. It is one of many charities the company has participated in during the COVID crisis and the holiday season. The Makers team wishes everyone a healthy holiday and a Happy New Year, especially to individuals whose lives have been significantly altered by the pandemic and malnutrition.
About LeSea Global Feed the Hungry
LeSea Global Feed the Hungry is a non-profit, evangelical Christian humanitarian organization, founded in 1987 by Dr. Lester Sumrall, to respond to God's challenge, "That my church in the third world does not die of hunger before I return." It is an organization focused on fighting hunger due to poverty, war, famine, and natural disasters. Feed the Hungry is dedicated to feeding the poor and hungry around the world, empowering the church worldwide. Feed the Hungry has delivered more than $200 million of food and supplies to hungry, hurting people in 94 nations around the globe. This organization also responds with emergency food and relief during disasters like the Japan tsunami, Haiti earthquake, Oklahoma tornadoes, Hurricane Sandy, and Syrian crisis.
About Makers Nutrition
Makers Nutrition, an Inc. 5000 Fastest-Growing Company in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With this acquisition, BluePearl will offer in-home end-of-life care to pet owners in northern California, and telehealth support services nationwide.

TAMPA, FLA. (PRWEB) NOVEMBER 17, 2020
BluePearl Specialty and Emergency Pet Hospital today announced it has acquired PetHospice, a California-based end-of-life services company focused on telehealth and education as well as in-home care for pets, their owners, and veterinarians. The company name will transition to BluePearl Pet Hospice. Through this acquisition, BluePearl—a leading provider of specialty and emergency veterinary care with more 95 practices across the U.S.—will offer in-home hospice, palliative care, and euthanasia for pets in San Francisco, Marin, Napa, and Sonoma California counties.
In addition to in-home end-of-life services for pets, BluePearl Pet Hospice offers nationwide telehealth services, professional grief counseling, free online education, and community support. As a tertiary care provider of essential veterinary services, treating more than one million critically ill and injured pets each year, BluePearl aims to expand its scope of veterinary services to provide a more complete system of care to veterinarians, owners, and their pets as end of life nears.
"This marks a huge shift for the end-of-life landscape in veterinary medicine, and for us at PetHospice. In addition to launching the first hospice and palliative care service integrated within a specialty hospital setting, we were also the first to launch a nationwide telehealth platform dedicated to quality of life and end-of-life support," stated Shea Cox, Founder and CEO of PetHospice. "By joining the BluePearl family, our team will be better positioned to fulfill our mission of making every pet's end-of-life journey as meaningful as the life they've lived, and we will lead the expansion of these vital services nationwide. My hope for the future is that we'll continue to broaden the scope of end-of-life services and provide integrative care to families across the U.S."
BluePearl plans to expand in-home end-of-life services to markets nationwide. Through BluePearl Pet Hospice, support for pets is available from the moment a terminal diagnosis is made or a decline in quality of life is seen, and it continues beyond pet loss to include pet owner grief support. Each BluePearl Pet Hospice client is assigned a dedicated hospice doctor, nurse, care coordinator, and pet loss specialist who assists in navigating the complex end-of-life process.
"Now more than ever, the human-animal bond plays an integral part in pet owners' lives. Understanding this, BluePearl Pet Hospice focuses not only on end-of-life services for the pet, but also on the human component of care," remarked Darryl Shaw, CEO and Co-founder of BluePearl. "Along with our mission to provide remarkable care to pets, our hospitals seek to improve pets' quality of life as end of life nears—whether this mean days, months, or years. With BluePearl Pet Hospice support throughout the end-of-life process, pet owners can spend less time worrying and more time enjoying the time that remains."
With immediate plans to expand, BluePearl Pet Hospice is actively seeking compassionate veterinary professionals to join its team, which includes veterinarians and veterinary technicians. Learn more about BluePearl Pet Hospice career possibilities here.
About BluePearl Specialty and Emergency Pet Hospital
Founded in 1996, BluePearl is one of the largest specialty and emergency veterinary practices in the U.S. today. BluePearl has more than 95 hospitals in 27 states that together employ 5,900+ Associates, including 1,160+ veterinarians, 1,650+ veterinary technicians, and 3,000+ other professionals. Each year, our compassionate teams provide high-quality care for over one million pets and their families. BluePearl clinicians also participate in clinical studies to discover new treatments and procedures that improve pet health. As part of the Mars Veterinary Health family of brands, BluePearl is committed to its purpose—A BETTER WORLD FOR PETS—because pets make a better world for us. Learn more at https://bluepearlvet.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Munique Maia is pleased to announce the launch of a brand-new website for her plastic surgery clinic. The user-friendly website showcases Dr. Maia's elite qualifications and services she offers in plastic and reconstructive surgery and non-invasive cosmetic treatments.

TYSONS, VA. (PRWEB) NOVEMBER 17, 2020
Munique Maia, MD, of Maia Plastic Surgery is a leading, board-certified plastic surgeon in the Washington, DC, area. She is well-known for her expertise and ability to achieve incredible, natural-looking results for her patients. Maia Plastic Surgery's new website is easy to navigate and features an appealing design that is tailored to the needs of both her current and potential patients. The innovative website, http://www.maiaplasticsurgery.com, provides high-resolution photos and informative content that accurately reflects Dr. Maia's unique knowledge and talent. It was designed to keep patients fully educated on the treatment options available to them at Maia Plastic Surgery.
Dr. Munique Maia has an exceptional reputation for her artistic eye and outstanding skills as a plastic surgeon and welcomes men and women who want to explore enhancing their appearance. Dr. Maia is recognized for her excellence in mammaplasty or breast cosmetic surgery. She is also highly respected for her knowledge and artistic talent in various types of facial cosmetic surgical and non-surgical procedures. In addition, Dr. Maia offers a full spectrum of body transformations at her clinic, including tummy tucks, body lifts and liposuction procedures. The Maia Plastic Surgery team also utilizes the latest cosmetic procedures to help patients look their best at any age, from facial fillers, medical-grade skincare and cosmetic injections to other med spa treatments.
"I am thrilled to share our new website. It is a great resource to help patients stay informed and involved in the services and procedures we provide at Maia Plastic Surgery," says Dr. Munique Maia, founder of Maia Plastic Surgery.
More About Dr. Munique Maia:
Dr. Maia is a board-certified Harvard fellowship-trained plastic surgeon. She specializes in cosmetic surgery and non-invasive treatments of the face, breast and body. Dr. Maia started her surgical training at the world-renowned Cleveland Clinic Foundation. She trained in aesthetic surgery at the prestigious Manhattan Eye Ear and Throat Hospital (MEETH) in NYC, the most prestigious training program in the country and is internationally recognized in the field of cosmetic surgery. Dr. Maia then completed advanced training in aesthetic surgery at Beth Israel Deaconess/Harvard Medical School in Boston. Dr. Maia has devoted her time to research and is dedicated to advancing the field of plastic surgery. She has presented her research worldwide, receiving numerous awards and is the author of over 50 original articles, abstracts and book chapters on plastic surgery.
Maia Plastic Surgery serves patients from two locations, 8100 Boone Boulevard, Suite 730 in Tysons Corner and 5530 Wisconsin Ave, # 1208 in Chevy Chase, MD. If you would like more information about Maia Plastic Surgery, please visit the brand-new website at http://www.maiaplasticsurgery.com or call 703-574-4500.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SARASOTA, FLA. (PRWEB) NOVEMBER 17, 2020
AltMed Florida, one of the fastest growing medical cannabis companies in Florida, continues its statewide expansion with a three-day opening, starting Friday Nov.20, 2020 at 10am for its newest MÜV Medical Cannabis Dispensary.
Location: 2612 Santa Barbara Blvd. on the southwest corner of Santa Barbara and Veterans Pkwy.
"The residents of Lee County love the quality of therapeutics and the level of customer care they receive at our dispensaries," said John Tipton, AltMed Florida CEO. "This newest addition will compliment what's already happening at our nearby locations in Fort Myers and Bonita Springs."
"Given the exceptional patient demand and our continuous growth in southwest Florida, the Cape Coral location is a natural addition to our MÜV Dispensary portfolio as we serve patients statewide," said Mike Smullen, AltMed Enterprises Chairman, Co-Founder and CEO.
Described as a 'Waterfront Wonderland', Cape Coral ranked first in Florida in WalletHub's 2019 'The Happiest Cities in America'; a perfect match for the iconic MÜV smiling logo.
During the opening, staggered over three-days (Nov.20-Nov.22) for crowd mitigation, all licensed Florida medical cannabis patients will receive a one-time use only, one per patient, 25 percent off their entire first purchase. Patients can begin ordering for express pickup on Thursday Nov.19 at muvfl.com where they will see real-time live inventory including specific strains and potencies of products.
Deemed an essential service during the pandemic, AltMed Florida has been able to expand its workforce to over 700 employees with additional teams coming onboard at each of its 16 new dispensaries this year. With higher demand for products from 27 total dispensaries, AltMed has also generated additional construction employment and staffing with the expansion of its 220,000-square-foot cultivation facility in Apollo Beach.
The newest state-of-the-art MÜV dispensary will offer an extensive selection of award-winning products including flower, pre-rolls, a wide range of vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its tinctures, 72-hour transdermal patches and transdermal gels. MÜV also has one of the widest selections of concentrates for patients' needing macro-dosing options.
Like AltMed Florida's 26 other locations (Apollo Beach, Bradenton, Bonita Springs, Clearwater, Deerfield Beach, Fort Myers, Gainesville, Jacksonville/San Marco, Jacksonville Beach, Lady Lake, Lakeland, Longwood/Orlando, Lutz, North Port, downtown Orlando, Ormond Beach, Pensacola, Port St. Lucie, Sebastian, Sarasota, St. Petersburg, Shalimar, Tallahassee, Tampa, Wellington and West Palm Beach) MÜV Dispensaries are designed to provide a premium experience – think Apple Store, with a modern design and expert staff that undergoes extensive training.
The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders - only products that license holders make themselves can be sold in their dispensaries.
For more information about the new ADA-compliant MÜV Medical Cannabis Dispensary in Cape Coral, including hours and available MÜV products, visit muvfl.com.
AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 220,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida's cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV Medical Cannabis Dispensaries stand out.
About MÜV - The MÜV brand of medical cannabis infused products launched in Arizona in 2016 and quickly gained international attention and recognition. MÜV Dispensaries by AltMed Florida was formed a year later through the partnership of AltMed Enterprises and Plants of Ruskin, a multi-generational Florida agricultural leader. Through continual research and development, MÜV has received multiple patents for its award-winning MÜV Products line that provides quality, consistent and reliable medical cannabis products to patients at all 28 locations (one in Arizona muv-az.com, 27 in Florida muvfl.com, and more added each month). Patients are encouraged to place reservations online at muvfl.com for in-store pickup, order for delivery, or visit any one of the 27 MÜV Dispensaries for alternative medical cannabis medicine you can trust.
About Plants of Ruskin, LLC - d.b.a. AltMed Florida, LLC - With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.
About AltMed Enterprises - Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
Forward-Looking Statements -
To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as "may," "should," "estimates," "predicts," "continues," "believes," "anticipates," "plans," "expects," "intends," "potential," "strategy" and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

BLUE BELL, PA. (PRWEB) NOVEMBER 17, 2020
Griswold Home Care of Winston-Salem proudly announces it has achieved accreditation through the Accreditation Commission for Health Care (ACHC) for Private Duty services.
Accreditation is a process through which healthcare organizations demonstrate compliance with national standards. Accreditation by ACHC reflects an organization's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.
ACHC is a nonprofit organization that has stood as a symbol of quality and excellence since 1986. ACHC is ISO 9001:2015 certified and has Centers for Medicare & Medicaid Services (CMS) deeming authority for Home Health, Hospice and DMEPOS.
"Over the last seven years our agency has received exceptional reviews from clients as a provider of choice and from staff as an employer of choice," said Norman Potter, Griswold Home Care of Winston-Salem Director. "Looking towards the future, we knew we were good candidates for independent verification of our strong and growing operation. Verification provides true evidence of our excellence in the delivery of exceptional home care services to prospective clients, referral partners and employees."
Potter explained further, "We chose ACHC as our accrediting organization because of their rigorous standards. We truly believe that we are a better agency on all fronts as we strived for and met all ACHC standards."
For more information, please visit https://www.griswoldhomecare.com/winston-salem/ or contact Norman Potter at norman.potter@griswoldhomecare.com or call 336.462.8472
About Griswold Home Care
With 200 locations in 30 states, Griswold Home Care is one of the country's top home care companies, delivering compassionate care 24/7 to its clients. Its purpose is to give people the help they need to live in the place they love. Through this purpose, Griswold Home Care helps adults maintain quality of life despite advanced age or onset of illness through services including companion care, home services, personal care, and respite care. Founded by the late Jean Griswold in 1982, the company has maintained its founder's profound sense of empathy for older and disabled adults and those living with chronic conditions. For more information, visit http://www.griswoldhomecare.com or call 215.402.0200.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

The brand is expanding the revolutionary power of its hero probiotic ingredient, AOB, with the reformulation of the entire line and introduction of two new restorative skin care kits to reveal healthier skin, just as nature intended.

CAMBRIDGE, MASS. (PRWEB) NOVEMBER 17, 2020
Mother Dirt, pioneers of probiotic skincare, is the first skin wellness system that uses the restorative power of live, active probiotics to restore the skin's microbiome.
Mother Dirt is proud to announce the reformulation of it's entire line to now include the transformative power of their Active Probiotic System featuring AOB, Ammonia Oxidizing Bacteria. AOB is the key ingredient in Mother Dirt's hero product, AO+ Restorative Mist and one that has garnered a massive fan following throughout the years.
"We have received countless emails, DMs, reviews and social posts asking for more probiotic formulas and we are thrilled to finally be able to deliver on our customer's requests across the entire product line," said Senior VP of Product & Marketing, Karin Piscitelli.
With the new reformulations Mother Dirt also announces two new skincare kits to the Mother Dirt family.
Introducing The PeaceKeeper and The Difference, Mother Dirt's Active Probiotic System Starter and Acne Treatment Kits that keep the peace and restore skin's ecosystem, bringing harmony and balance.
"We at Mother Dirt believe that your skin is fundamentally amazing," said Piscitelli. "What we have found is that it is actually traditional skincare that has adversely affected the skin's natural microbiome and stripped it of the powerful bacteria that keeps the peace and allows it to thrive. This presents itself in the form of dryness, oiliness, breakouts, and everything in between. Our latest kits are scientifically based to restore the complex ecosystem of your skin. Just like nature intended."
The PeaceKeeper features a terrific trio of products that repair the damage caused by traditional skincare and rebalance the skin biome. When used together, the powerful probiotic extracts in the Probiotic Foaming Cleanser and Probiotic Moisturizing Serum prime skin so the live and active AO+ Restorative Mist can nourish and restore. Priced at $99 at launch through the holidays; regular price: $119.
The 3-step PeaceKeeper includes:
Step 1 - Probiotic Foaming Cleanser: Containing a powerful probiotic blend, this foam cleanser removes impurities while refreshing and nourishing the skin without stripping or over-drying.
Step 2 - Probiotic Moisturizing Serum: This lightweight, dermatologically-approved serum contains a powerful and safe-for-skin probiotic blend that locks in moisture and restores balance, leaving a radiantly nourished complexion.
Step 3 - AO+ Restorative Mist: The only live and active topical probiotic of its kind, this patented mist is formulated with more than 3+ billion CFUs in every bottle. It interacts with elements naturally found in sweat to biologically balance the microbiome. This is the hero of the Active Probiotic System.
The cleanser and non-comedogenic moisturizing serum act as primers and enhance the results of the AO+ Restorative Mist, giving the biome a probiotic boost. When used together, this is where the real magic happens.
The Difference works as a complete clinically-tested system to treat acne by repairing the damage caused by traditional skincare to rebalance the biome and clarify skin. When used together, the powerful probiotic extracts in the Probiotic Foaming Cleanser and the new Daily Acne Treatment Lotion prime the skin so the live and active AO+ Restorative Mist can fully nourish and restore. Priced at $99 at launch through the holidays; regular price: $129.
In addition, Mother Dirt is unveiling a new Probiotic Hydrating Conditioner to complement their newly reformulated Probiotic Hydrating Hair Wash. Together this pair is designed to reveal hair that looks shinier, fuller, and feels softer and stronger.
Mother Dirt is on a mission to restore the skin microbiome, activating the transformative power of probiotics to repair the imbalance caused by traditional skincare and reveal biologically-balanced and vibrant skin. Their live and active patented topical AO+ Restorative Mist is the hero of their line and the first and only product formulated with their secret ingredient, Ammonia-Oxidizing Bacteria (AOB). Mother Dirt has been featured in The New York Times, Elle, Women's Health, Allure, and more. Follow them on Instagram @motherdirt.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Sharon Kleyne Teaches Spit Virus Carrier Education with Dr. Jill Maron on Sharon Kleyne Talk Radio. FDA Approved Nature's Tears EyeMist FDA Approved Trade Secret pH-Balanced Water Sponsors Power of Water Water Life Science Sharon Kleyne VoiceAmerica.

GRANTS PASS, ORE. (PRWEB) NOVEMBER 17, 2020
Air Date: 9 November 2020
Guest: Dr. Jill Maron is a Professor of Pediatrics and Vice Chair of Pediatric Research at Tufts Children's Hospital, Boston, MA. Maron also serves as Executive Director of the Mother Infant Research Institute at Tufts Medical Center, a multi-disciplinary research enterprise conducting basic, translational and clinical science to advance maternal and newborn care.
https://www.voiceamerica.com/episode/126816/encore-the-power-of-neonatal-saliva
*
Sharon Kleyne, founder of Bio Logic Aqua Research Water Life Science, is a world leader in recognizing that the COVID-19 pandemic sheds a bright light on diagnostics. Scientists, researchers and physicians are scrambling like never before to decode and diagnose the virus in its rapidly-changing varieties and an unlikely path, neonatal saliva diagnostics, has emerged as an exciting, effective virus-busting tool.
Kleyne, leading the way in waking up the world to the significance of saliva (spit), welcomes Dr. Jill Maron, Executive Director of the Mother Infant Research Institute at Tufts Medical Center, a multi-disciplinary research enterprise conducting basic, translational and clinical science to advance maternal and newborn care where she cares for and studies premature and sick babies.
Maron tells Kleyne, host of the internationally syndicated The Power of Water & Your Health sponsored by FDA approved Nature's Tears EyeMist, natural pH balanced water technology for acid mantle immunity strength and protection, on VoiceAmerica World Talk Radio & Apple iTunes, "I fell in love with caring for babies," says Maron. "One of the things I struggled with as a baby doctor was communicating with my patients because they can't tell us how they're feeling, telling us what hurts. It drove me into research to discover how I could give these babies a voice and help guide my path. Inspired me to focus over the last fifteen years on saliva, or spit, to discover platforms for diagnosis.
Our goal when we go into the neonatal intensive care units," Maron continues, "is to look at these babies as individuals and personalize the care we give them."
Spit has also been a research focus for Kleyne, who educates international audiences about the way spit carries Coronavirus. Kleyne urges Maron's input and Maron references two ongoing research studies, NIH sponsored trials aimed at integrating a salivary infectious screening platform (Salivary Profiling in Infants Treated for Suspected Sepsis-SPITSS) and an oral feeding readiness platform (Neonatal Oral-feeding Readiness in Salivary High-throughput diagnostics- NOuRISH).
The premature babies Maron cares cannot produce much saliva, or spit. "In my patients, we get literally one drop of saliva," Maron tells Kleyne, "and from there we're able to interrogate that saliva for a broad range of developmental signals, inflammatory signals; it's also a rich source of microbes. We can detect harmful organisms that could lead to infection. Saliva is providing us a window into the body, filtering blood....how the saliva changes week by week by week in these prematurely born babies. One of the powers of Saliva for me is that I can monitor how they're developing and growing. I don't have to stick them for blood."
Kleyne speculates that studying saliva will help us better understand nutrition and addiction. Maron agrees. "How do we understand babies who struggle to eat? How do we better take care of them as their speech emerges? In partnership with Dr. Emily Zimmerman at Northeastern University, we've been able to follow babies looking at salivary biomarkers that we believe are shared between the ability to eat and ultimately the ability for our speech to emerge." Maron stresses early recognition for early intervention.
Kleyne suspects that babies can be addicted to food and Maron believes that preferences for taste and smell can be indeed be passed on from parent to child. The Hypothalamus in the brain houses food sensors and drug receptors. Maron comments on babies born to mothers addicted to drugs. "As we wean them off of drugs," says Maron, "we observe that the baby's addiction is transferred on to food. One of the more significant findings in saliva of babies relates to the studies of gut/brain access. Saliva is integral to our stomach, telling our brain when it's time to eat and when it's time to stop. Premature babies don't know when to eat and how to eat. They're functioning as if they're still in the womb."
Neo natal saliva research is opening doors and windows to a vast landscape of cures and treatments.
*
If you care about immunity protection for the organ of the eyes, listen to these programs.
They feature wisdom, knowledge, new technology and health tips for better living every week on the internationally syndicated The Power of Water & Your Health sponsored by Nature's Tears EyeMist, naturally pH balanced water technology for acid mantle protection on VoiceAmerica World Talk Radio & Apple iTunes with Program Director Rose Hong of Global Dragon TV with Sharon Kleyne.
LISTEN to the internationally syndicated The Power of Water & Your Health sponsored by Nature's Tears EyeMist, FDA approved, naturally pH balanced water technology for acid mantle protection, on VoiceAmerica World Talk Radio & Apple iTunes. This program features Dr. Jill Maron, Professor of Pediatrics and Vice Chair of Pediatric Research at Tufts Children's Hospital, Boston, MA.
Follow this link: https://www.voiceamerica.com/episode/126816/encore-the-power-of-neonatal-saliva
Some recent Sharon Kleyne talk radio programs feature:
Dr. David T.W. Wong, DMD, DMSC https://www.voiceamerica.com/episode/125933/saliva-diagnostics
Nancy Yonally Coleman & James Derick https://www.voiceamerica.com/episode/125837/be-safe-strategies-for-you-and-your-families-to-go-back-to-school-and-work-safely-during-covid
Dr. David Clarke https://www.voiceamerica.com/episode/125671/hidden-stresses-and-your-health
If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution technology Nature's Tears EyeMist, sponsor of Sharon Kleyne's talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In-person delegates at last week's conference praised the smaller, innovative event with cutting-edge safety measures while virtual attendees lauded the energy that comes with tuning into a real event with interactive sessions allowing their voices to be heard

MIAMI (PRWEB) NOVEMBER 17, 2020
The Global Wellness Summit (GWS), the annual gathering of international leaders in the multitrillion-dollar global wellness economy, has received rave reviews for its first-ever hybrid event, which promises to be a new model for conferences. Notable as one of the first US meetings to take place both in person and virtually, the hybrid "Safe Summit" was held at The Breakers Palm Beach from November 8–11, and attracted 100+ in-person delegates and 500+ highly engaged virtual attendees.
"We knew the only way to host a Summit this year was to create a new model for how a conference can be convened. Safety was paramount, but it in no way impeded social connection or the Summit's robust agenda—where we were able to mix both in-person and virtual keynotes, panels and brainstorming sessions," said Nancy Davis, chief creative officer and executive director of the GWS. "Ultimately, I believe this was one of the most important Summits in our 14-year history."
The Summit's main stage presentations are also available "on-demand" so delegates and virtual attendees can view them at a later date. Individuals can still register to be part of the Virtual Access Package, which allows access to the videos, as well as the Global Wellness Institute's landmark report, "Defining the Mental Wellness Economy," the first research to size and analyze the multi-sector mental wellness market.
The 2020 GWS: a successful case study of how to "reset" meetings in the age of distancing
Like so many conferences in the age of COVID-19, the Summit faced serious challenges: How to convene an in-person event that provided human connection and networking but was as safe as possible–while providing a virtual platform that was less sterile than a placeless "all-Zoom" experience. The solution was a unique hybrid conference, where virtual attendees experienced the dynamism of attending an actual event, as conference producers enabled conversations between in-person delegates and virtual attendees.
"We feel privileged and gratified to have had this second opportunity to be the location of the Global Wellness Summit and to collaborate with their team in staging a successful and safe conference," said Paul Leone, chief executive officer of The Breakers Palm Beach. "This forum allows us to share inspirational thinking and powerful ideas, accelerating our own momentum to continue our mission of being a purpose-driven organization that is committed to the wellbeing of our team, guests and community."
The in-person Summit—balancing safety and connection
Every aspect of the conference was designed to create a safe, hygienic way for people to meet, which meant new collaborations with leading health and technology leaders. Richard Carmona, MD, the 17th Surgeon General of the US, served as medical advisor. Delegates experienced a host of cutting-edge technologies to keep them safe: from mandatory COVID-19 testing at check-in provided by Premier Family Health of Palm Beach (all delegates tested negative) to lighting pioneer Healthē deploying their Far-UVC and UVC light technologies in myriad ways to continuously fight airborne and surface-level potential coronaviruses in indoor conference spaces. Delos contributed air purification units for indoor conference and event spaces. All delegates were physically distanced with creative seating arrangements at least six feet apart. (Thanks to Lynne and Victor Brick's donation of Planet Fitness equipment, delegates could choose a recumbent bike instead of a ballroom chair.) Two podiums were placed at extreme opposites of the stage so speakers could alternate while the podiums were sanitized after each use. All presenters wore masks on stage as well. Fun, however, remained on the agenda, including a "Mask-erade" party featuring socially distanced disco dancing.
Many delegates have written, expressing gratitude for both the safety and human connection. Nikki Miller, director of Kohler Waters Spas, noted, "I've just returned home from the most incredible, safe and intimate Summit. This was my first time attending, and I would be lying if I said I didn't have concerns about attending due to COVID. But the GWS went above and beyond to keep us safe yet connected emotionally and physically—exactly what we all needed. I met some of the most inspiring wellness leaders that I know will be life-long connections. Thank you for bringing this global group together with confidence, intention and purpose."
Making a virtual experience come alive
The Summit is a profoundly global organization, each year attracting delegates from 50 nations, and with travel restrictions in place, virtual access was critical. Having attendees tune into the energy of a real conference in a real place, while working to inject as much interactivity as possible between in-person and virtual attendees, overcame the sterility that can happen with an all-Zoom event. Virtual attendees report that they "felt they were there in the room with delegates and speakers and experienced that magical GWS energy" from wherever they logged in.
Prerecorded content meant remote keynotes and panels had no technical glitches, and speakers were then Zoomed into for live Q&As, giving both in-person and online delegates access to the same real-time, interactive discussions. The flexibility of a virtual platform also allowed for surprise "Zoom-ins" with wellness leaders including Arianna Huffington; Bob Roth, CEO of the David Lynch Foundation; Golden Door founder Deborah Szekely; and Six Senses CEO Neil Jacobs. Seamlessly moving between in-person and virtual attendees was the goal: For instance, a "hybrid" lunch hosted for Global Wellness Institute Ambassadors connected both in-person and global virtual attendees.
The leading conference on the business of wellness
Committed to ensuring that the Summit delivered on the business connections that are the hallmark of every Summit (and result in real deals), the GWS created a unique "reverse pitch" presentation, where top investors had two minutes each to tell the in-person and virtual attendees what they are looking for in terms of wellness investments. All attendees were then invited to send their business plans to appropriate investors.
In addition, in-person delegates spent afternoons in breakout sessions collaborating on how to "reset the world with wellness" (the conference theme) and debating the future of diverse wellness markets. To give virtual attendees an analogous experience, Anna Bjurstam, wellness pioneer, Six Senses, and GWS board member, hosted twice-daily, interactive sessions over Zoom, allowing virtual attendees from Singapore to San Francisco to participate in the brainstorming in their own time zones.
Numerous delegates reported that the lower cost ($500) for virtual access meant they were able to attend for the first time.
About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. The 14th Summit took place at The Breakers Palm Beach, FL, from November 8–11, 2020. The 2021 GWS will be held in Tel Aviv, Israel, November 15–18.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

John Mizerany brings twenty years experience to the new role.

GREENWICH, CONN. AND SAN ANTONIO (PRWEB) NOVEMBER 17, 2020
Great Point Partners portfolio company, Little Spurs Pediatric Urgent Care, a provider of pediatric urgent care services with 13 locations across Texas, announced the appointment of John Mizerany as Chief Executive Officer. Mr. Mizerany brings nearly 20 years of relevant health care services experience to this new role having previously held positions at CareNow DFW (CEO), Alliance Spine & Pain Centers (COO), and Fresenius Medical Care North America (Group Vice President). While CEO of CareNow DFW, Mr. Mizerany had full responsibility for its urgent care locations in North Texas as well as the management of a 50+ physician family practice group. Under his leadership, CareNow DFW experienced 33% revenue growth and 41% EBITDA growth.
"We welcome John's experience and leadership to Little Spurs," said Rohan Saikia, Managing Director at Great Point Partners. "John's background, focus on high quality care, and vision make him well-equipped to continue the Company's history of clinical excellence and growth. We are excited to have someone with his ability and record of accomplishments join and lead the Company."
"I am excited to join Little Spurs as CEO where we will continue to focus on high quality pediatric patient care and increasing access for additional communities," said Mr. Mizerany.
"Given my prior experience, I personally know the value proposition and potential of pediatric urgent care services, and I look forward to delivering an enhanced experience to the existing and future communities we serve."
About Great Point Partners
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $1.9 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III, which has $307 million of committed capital. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III) and public equity funds (BMVF, approximately $1.4 billion). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 200 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, pharmaceutical infrastructure, alternate site care, medical device and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.
Reach Great Point at 203-971-3300 or http://www.gppfunds.com.
About Little Spurs
We created Little Spurs Pediatric Urgent Care because we realize that most patients waiting in the Emergency Room for treatment are not there for life threatening emergencies, yet still need care that is not available in most pediatric offices. We have assembled a skilled staff of pediatric emergency room experienced, board certified pediatricians, and experienced advanced practice practitioners who are highly qualified to take care of your child's minor emergencies. Our Vision: To become the premier pediatric urgent care provider in Texas; offering care for all children in our communities. Our Mission: To provide excellent medical care to all pediatric patients; strive for high quality customer service, and become a destination workplace for medical professionals. Our Values: Compassion, Respect, Teamwork, Dedication, Communication and Quality Care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Quality Rehab Management Chooses Forcura as Referral Management Solution

JACKSONVILLE, FLA. (PRWEB) NOVEMBER 17, 2020
Forcura, a healthcare technology company that enables safer patient care transitions along the care continuum, announces its formal launch into the rehabilitation therapy sector and will offer its full suite of workflow, care coordination and analytics solutions to contracted and private practice therapy providers. Providers will benefit from administrative cost savings, reduced held claims and the ability to make data-driven decisions. The move is the first of several new market introductions the technology company plans in the next year, and aligns with its vision to become the standard communications platform for the post-acute healthcare industry.
Since its launch in 2012, Forcura has primarily served the home health and hospice markets, and currently partners with 460 clients who provide care for approximately 550,000 patients every month. Client communications are powered by Forcura's HIPAA-secure, cloud-based platform that streamlines patient care transitions, enabling clients to onboard new patients rapidly, improve cash flows by efficiently routing medical records for signature to referring providers, and optimize operations with real-time performance analytics. With similar business processes and needs, the rehabilitative therapy market will benefit equally from Forcura.
Quality Rehab Management-The Continuum (QRM-C), a community-based rehabilitation management company that enables post-acute providers to extend their outpatient therapy services into the home setting, has recently selected Forcura as it's referral management technology partner. QRM-C has licensed and implemented the full suite of Forcura products. Meredith Mull, executive vice president of population health management at QRM-C, expressed that "Forcura has made our goals of improved timeliness and efficient staffing processes achievable. We now have a more cohesive, digital referral management process that enables us to get in front of the patient faster." Mull concluded, "Forcura is an essential part of what helps us keep clients satisfied."
Craig Mandeville, founder and CEO of Forcura, shared his enthusiasm on empowering better patient care across additional post-acute sectors. "The opportunity to decrease the risks associated with patient care transitions, remove barriers that hinder care delivery, and simplify collaboration between and among providers - these goals motivate our team every single day." Mandeville continues, "QRM-C is an outstanding model of how the healthcare industry is evolving to support improved outcomes and an even better patient care experience. We are so proud to partner with them."
Forcura is exploring additional post-acute lines of business and partnerships to expand its footprint, and has plans to launch more products and services in 2021.
About QRM-C
QRM-C, a post-acute private practice management company, headquartered in Dallas, TX, assists SNFs, home health agencies, and assisted living communities with providing community-based outpatient services. Their model consists of a full suite of private practice management and billing services that affords these providers the ability to follow their patients beyond their doors. Through a mixture of downstream partnership contracts and outpatient rehabilitation and remote patient monitoring in the home, the QRM-C model allows providers of senior care to keep their patient throughout the continuum of managed care in the home. QRM-C's parent company, also headquartered in TX, also provides a full suite of management and value-added services to SNFs and home health agencies by converting their programs in-house and providing all operational, clinical, and financial management of their programs. QRM and QRM-C are in over 300 client locations in 18 states.
About Forcura
Forcura, a leading healthcare technology company headquartered in Jacksonville, Florida, facilitates continuity of care via technology, analytics and a deep commitment to enabling better patient care. The Forcura suite of tools is powered by Forcura Connect, a proprietary framework for standardizing interoperability and integration among post-acute health care organizations, physicians, electronic health records (EHRs) and other supporting technology vendors. Through our technology and analytics solutions, we are a step closer every day to elevating the opportunities of post-acute care. The company has received awards for Fastest Growing Company for the fifth consecutive year, Best UI/UX Design in SaaS, and Best Places to Work by Inc. Magazine. For more information visit http://www.forcura.com, call 800-378-0596 or follow Forcura on LinkedIn.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

World-class solutions for decapping, automated Cartesian handling, or fluid dispensing are now available.

ISLANDIA, N.Y. (PRWEB) NOVEMBER 17, 2020
Festo announces it now offers diagnostic and testing device manufacturers a one-stop-shop for world-class vial sorting, decapping, kinematic sample-handling, and fluid dispensing solutions. This critical mass of life sciences automation products from Festo will enable device manufacturers to bring products designated for pandemic-related diagnostics and testing to market faster and with lower engineering overhead.
"The pandemic has created an urgent need to ramp up development and production of high-speed diagnostic and testing equipment," said Craig Correia, Director of Life Science, Festo North America. "Festo is not only expanding its range of product and system solutions, but also is allocating resources in terms of custom engineering and assembly."
Festo medical device components are designed and manufactured in an ISO 13485 quality environment, which makes validation easier and reduces time-to-market for lab device manufacturers. The company's global logistics infrastructure ensures rapid delivery and replacement of core products, and its global technical support team minimizes downtime.
Grippers, kinematic systems and components, liquid dispensing modules, and sensors
The versatile EHMD compact rotary gripper caps and decaps sample vials, loads centrifuges, and grips, rotates, and places microwell plates. An optional module with Z compensation automatically adjusts to cap thread pitch, which increases throughout by eliminating the need for head-adapter changeover. Combined with a EXCM planar surface gantry handling system and a camera, the EHMD gripper supports quality inspection, barcode reading, and label printing.
The EHPS family of parallel electric grippers and extensive range of pneumatic grippers provide additional solutions for handling trays, vial, and plates. For additional kinematic solutions beyond the EXCM gantry, Festo offers the EGSC/ELGC modular linear actuators, the ERMO rotary actuator, and the new EHML space savings telescoping slide.
The EXCM gantry, which is ordered as either a drop-in assembly or quick-to-assemble kit, can be integrated with a VTOE eight-liquid valve manifold. The VTOE features a 9 mm pitch channel for filling an entire row of microwell plates simultaneously. A single new VAEM solenoid valve controller operates all eight channels of the VTOE. VAEM rapid and precise control can decrease coefficient of variation (CV) from 3% to less than .5%. Having a single compact controller reduces component count and space requirements.
The new VYKA dosing valve from Festo is a media separated solenoid valve that precisely dispenses fluids and controls flow in manifold duct plates for continuous flow applications. The VYKA is suitable for EXCM gantry system mounting.
For bar code reading and fill level sensing, Festo solutions provide simple setup and configuration. Product solutions in the vision and sensors category include the SBSI vision sensor for object and barcode sensing, the SOEG optoelectronic infrared sensor, the SOOF fork light barrier, and the SOEC color sensor.
For applications where standard-sized desktop kinematic systems are not feasible, Festo's dedicated team designs custom gantries and liquid handling systems. Custom solutions range from simple two axis gantries to full subsystems performing complex tasks.
The Festo Technology Engineering Center (TEC), located just north of Boston, works with individual customers on automated motion and fluid handling solutions. The TEC is the company's first engineering center in the United States devoted to the life sciences, developing new high speed, high accuracy fluid handling products based on pneumatic principles.
For more information on sample handling and liquid dispensing solutions or to provide details of an automation need, please contact Festo at life.sciences.nam@festo.com. Visit Festo at https://www.festo.com.
###
About Festo    
Festo is a leading manufacturer of pneumatic and electromechanical systems, components, and controls for process and industrial automation. For more than 40 years, Festo Corporation has continuously elevated the state of manufacturing with innovations and optimized motion control solutions that deliver higher performing, more profitable automated manufacturing and processing equipment.
Connect with Festo: Facebook, LinkedIn, Twitter and YouTube



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Regal Harvest from Pari Foods is a women-owned brand made by 5th generation rice growers that has been growing rice in the Punjab region also known as "The Land of Five Rivers", to ensure the purest water and soil.

EDISON, N.J. (PRWEB) NOVEMBER 17, 2020
Not all rice is equal. While basmati rice is considered much healthier than white rice, it must be grown and cooked right in order to have the best tasting and healthiest rice possible. Regal Harvest from Pari Foods is a women-owned brand made by 5th generation rice growers that has been growing rice in the Punjab region also known as "The Land of Five Rivers", to ensure the purest water and soil. Longer than any other basmati rice, and aged for two years–which is 4 times longer than others---and cooked to absolute perfection, Pari Foods ensures that their rice has the best flavor and the healthiest rice.
Pari Foods has developed a rich history when it became the world's first branded basmati rice to be exported from India in 1980. Today, Pari Foods produces a wide variety of rice catering to the needs of their clientele, spread across the globe. Their distribution network is global with direct supply to some of the leading brands in the world with direct packaging for renowned international brands. Their secret to becoming one of the leading exporters of rice in India? Supplying rice of highest quality, sourced from the foothill of Himalayas and other rice growing areas in India. They grow their rice in perfect locations for the best soil and water, which allows the starch to be removed in a 2 year aging process. Most rice exports only age their rice for 6 months, and some not at all. This makes their grains softer and nuttier tasting, with a lower glycemic index that makes it suitable for people fighting against diabetes. Since Pari Food's rice are the largest grains available, it's not only better for consumers but more profitable for food service companies.
With the rise in Indian food popularity in the U.S., it has not taken long for Pari Foods brand Regal Harvest, to secure distribution in major supermarkets and the rapidly growing Basmati rice market. Regal Harvest offers naturally aromatic aged rice that has stood the test of time when it comes to quality and taste. Regal Harvest is the age old rice Pari has been providing its customers for many years and is now internationally available to all its clientele.
Along with Organic and Brown rice products, Pari Foods will continue to launch new flavors in 2021, continuing to be the pioneer in the rice industry. Pari Foods is also set to expand its line in 2020 with Parboiled Basmati rice that will compete with the product offerings of Uncle Ben's, Par Excellence and Riceland.
Regal Harvest is currently available at Smart Foodservice, Restaurant Depot, Chef's Warehouse and BJ's Wholesale.
For more information on Pari Foods and its impressive product lines, visit PariFoods.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Provider of Platforms for Patient-Centric Clinical Trials Adds Capability for Remote Participation

PLANO, TEXAS (PRWEB) NOVEMBER 17, 2020
In response to the COVID-19 pandemic, Halo Health Systems has added a televisit feature to its clinical trial software that enables decentralized and hybrid clinical trials. With the addition of the televisit capability, patients are able to connect virtually to their clinical trial sites.
"Our aim is to ensure patient and clinician safety and at the same time allow important clinical research to continue during this difficult time," said Veer Mehta, Founder of Halo Health Systems. He said the Smart Clinical Trials application is currently being used at beta research sites that are addressing multiple therapeutic areas.
Partnering with Halo Health on the project is Reveles, a leading provider of decentralized (in-home) clinical research solutions. R'Kes Starling, CEO and Founder of Reveles Clinical Services, said the project will expand the options for patients who want to participate in clinical research.
"Our goal is expanding the population of people who are able to participate in clinical trials by removing barriers that have long existed, particularly for minorities and underserved communities," Starling said. "In addition to benefitting patients, it will support industry sponsors and clinical researchers who also face challenges related to the pandemic."
The application offers three key capabilities:
1.     Easy-to-access televisits for online video connectivity among research teams and patients.
2.     A "bring-your-own-device" (BYOD) model that makes it easy to participate.
3.     Complete HIPAA privacy and security compliance.
"These capabilities are necessary for ongoing clinical trials as well as for new vaccines and therapies to treat COVID-19," said Mehta. "Televisits are a key feature. They enhance decentralized clinical trials by boosting operational efficiency."
The Smart Clinical Trials platform is compatible with existing mobile devices and allow patients to communicate from any location, reducing the burden of travel costs when commuting in-person to clinical trial sites. Once participants download the application, they can connect to a live video to consult virtually with the research team at the trial site. In addition to compliance with HIPAA, the platform is compliant with 21 CFR Part 11 regulations.
"Our patients are expressing much concern to come to our medical complex during this time of pandemic, so having this tool will be a real asset to keeping in touch with our patients and ensuring their safety. " said Allison Camacho, Director Site Operations of Dallas Diabetes Research Center. "We are excited about what Halo's software has to offer to clinical trials. The ability to conduct telemedicine visits through a secure platform, to reduce the number of times patients will have to drive to our site will be very helpful."
About Halo Health Systems
Halo Health Systems is a patient-centric digital platform that accelerates the clinical trials of pharmaceutical and biotech companies through the use of IoT, AI and mobile technologies. It provides telemedicine, remote patient monitoring, patient engagement and workflow automation to collect high- quality data at reduced costs while increasing patient access and diversity.
For more information on Halo Health System, contact info@halohealth.io.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New group of industry experts will advise on strategic growth, reimbursement strategies

WASHINGTON (PRWEB) NOVEMBER 17, 2020
Babyscripts, the leading virtual care platform for managing obstetrics, today welcomed Krista Drobac; Christina Jenkins, MD; and Fran Soistman, Jr. to the Babyscripts Advisory Board. The new group of advisors will offer guidance on Babyscripts' payer strategy: a unique collaboration for care coordination between Babyscripts, the payer and the provider that seeks to open up new pathways to reimbursement and expand access to digital tools for the Medicaid pregnant population.
With diverse experience in Managed Care Organizations; hands-on knowledge of the investment landscape; clinical, business and policy expertise, the new members of the Advisory Board will play a crucial role in Babyscripts' current work in care management and social risk, directing the company as Babyscripts expands its footprint in Managed Care and enhances its payer offering. The decision to welcome the new group of advisors also marks another layer in Babyscripts' dedication to health equity, diversity and inclusion at the leadership level.
Krista Drobac is a partner at Sirona Strategies and was previously the director of the Health Division at the National Governors Association's Center for Best Practices, and a Senior Advisor at the Center for Medicare & Medicaid Services. In addition to consulting, Krista serves as the Executive Director of the Alliance for Connected Care, an organization dedicated to ensuring that all patients are able to realize the benefits of telehealth and remote monitoring. She also serves as Co-Chair of Aligning for Health, a coalition advancing social determinants of health policy at the federal level.
Prior to her role as strategic advisor to healthcare leaders and entrepreneurs, Dr. Christina Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals (H+H) built to restructure the delivery system and improve population health and value-based payment capabilities for 1M Medicaid and uninsured lives. Dr. Jenkins currently sits as a Board Member of Independence Health Group and is also a Venture Partner for Portfolia's FemTech and Active Aging and Longevity Funds.
Fran Soistman is the Founder, President and CEO of Healthcare Management & Transformation Advisory Services LLC. Prior to its founding, Fran was Executive Vice President at CVS Health and President of Aetna's Government Services Portfolio of Businesses. Mr. Soistman represented Aetna on the Healthcare Leadership Council in Washington DC where he served on the Executive Committee as Treasurer, and on the Health Care Transformation Task Force where he served as the Chair of the Board.
"We've compiled an all-star team of advisors, all leaders in their field, to help us get digital tools into the hands of pregnant moms," said Juan Pablo Segura, President and co-founder of Babyscripts. "We've long been focused on finding new ways to remove barriers to access, and payer reimbursement is a key pathway — especially in the wake of the pandemic, we're seeing a lot of payer interest in using digital tools, and our advisory board is going to help us leverage that interest to improve access and provide more care at zero cost to mothers."
Delivering care to geographically and economically vulnerable populations is a cornerstone of the company's mission. In 2019, Babyscripts created the Joint Deployment model, a partnership model between patient, providers, and payers to use Babyscripts Virtual Maternity Care to improve access for these vulnerable populations, and recently was instrumental in the passage of one of the first ever digital health reimbursement mandates, an addendum to the DC Council's Postpartum Care Expansion Act. The only clinically-validated solution of its kind singularly-focused on obstetrical problems, the solution approaches maternity care through a digital education layer, patient management through remote monitoring, and collaboration between care team and payer to improve member care.
About Babyscripts
Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. We've spent the last six years delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit http://www.babyscripts.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Officials at the San Diego-based healthcare real estate firm say they are now demolishing the adjacent plaza to make way for parking, and that the $19 million pavilion is 74 percent leased

TUCSON, ARIZ., AND SAN DIEGO (PRWEB) NOVEMBER 17, 2020
PMB, one of the nation's leading healthcare real estate owners and developers across the continuum of care, announced major construction and leasing milestones for the new Class A, 55,000-square-foot St. Mary's Medical Pavilion it is developing on the Carondelet St. Mary's Hospital campus in Tucson.
PMB has completed the shell building at 1707 W. St. Mary's Road and has begun demolition of the adjacent, obsolete 37,000-square-foot Century Medical Plaza that the firm acquired in December 2018. PMB will develop 275 surface parking spaces on the cleared area for visitors to the new building.
Mark D. Toothacre, President of PMB, said, "Our team at PMB is thrilled to successfully complete the building shell and to finalize the agreement to demolish the outdated medical plaza next to the pavilion. We are well on our way to advancing the delivery of high-quality, much-needed modern healthcare that will serve nearly 240,000 patients in western Tucson and the surrounding communities."
Mr. Toothacre also announced that the $19 million project on the campus of the 400-bed acute-care hospital is already 74 percent pre-leased by a wide variety of healthcare providers. A major healthcare group will anchor the building with a 23,000-square-foot multispecialty practice. Other tenants will be The Oncology Institute of Hope and Innovation, MHC (Marana Health Clinic), Grossman & Grossman, Sonora Quest Labs and Pima Orthopedics.
Jake Dinnen, PMB Senior Vice President Development, said he is pleased with the amount of pre-leasing for the pavilion.
"A number of high-quality tenants have already reserved space in the pavilion and we are seeing strong interest in the remaining available space," Mr. Dinnen says. "The pavilion provides many benefits to tenants, including customizable suites; market lease rates; an ideal, convenient location; and the opportunity to be an investor/owner in the building."
The architect for the project is Swaim Associates Ltd., and the general contractor is Barker Contracting Inc., which are both headquartered in Tucson. Leasing is being handled by Tucson-based Cushman & Wakefield/Picor, and the property manager will be San Diego-based PMB RES. Capital One - Healthcare Financial Services is providing funding. The pavilion is slated to be completed in January 2021.
A limited amount of space is still available in St. Mary's Medical Pavilion. Interested healthcare providers should contact Richard Kleiner, Cushman & Wakefield/Picor at rkleiner@picor.com or 520-546-2745.
For more information about St. Mary's Medical Pavilion, please visit: https://pmbllc.com/news-release-st-marys-medical-pavilion.
About St. Mary's Hospital
Carondelet St. Mary's Hospital is southern Arizona's longest continuously operating hospital founded in 1880 by the Sisters of St. Joseph of Carondelet. It is one of Tucson's and the greater southern Arizona region's top medical centers. The facility is recognized as a destination hospital for the most modern and minimally-invasive heart and vascular surgery, advanced stroke care, unique and personalized cancer treatment, and emergency care. For more information, please visit http://www.carondelet.org.
About PMB
PMB's mission is to improve healthcare delivery, effect change and positively impact communities. As a healthcare real estate developer focused on the continuum of care, PMB can provide the infrastructure to cure disease, heal families and empower the greatest minds in the industry. Healthcare is in our DNA. Our company is 100 percent focused on healthcare real estate across the continuum of care – from community-centric health and wellness to health-focused seniors housing, outpatient, inpatient and post-acute care. PMB has developed over 100 facilities to date representing approximately 5.5 million square feet. The firm owns and manages 66 medical facilities comprising over 4.2 million square feet. For more information, please visit http://www.pmbllc.com.
# # #



START your own Wordpress site, business or personal website, or online store at www.siteground.com

WPC prepares its community for the 6th World Parkinson Congress in Barcelona, Spain

NEW YORK (PRWEB) NOVEMBER 17, 2020
The World Parkinson Coalition (WPC) is launching its first ever WPC Dual Language webinar program in English and Spanish. This series is designed to help prepare the non-medical and non-research Parkinson's community members to attend and actively participate alongside scientists and clinicians at the 6th World Parkinson Congress in Barcelona, Spain in June 2022.
The WPC hosts the most unique international scientific conference in the Parkinson's space. Every three years at the World Parkinson Congress, the WPC brings together basic scientists, neurologists, general physicians, nurses, rehab specialists, clinicians, as well as people with Parkinson's (PwP) and care partners to learn about Parkinson's, build collaborations, and expand our understanding of a disease that impacts more than 10 million people worldwide, 300,000 of whom live in Spain.
"The World Parkinson Congress is a scientific meeting unlike any other Parkinson's gathering," said Elizabeth Pollard, WPC Executive Director. "It's important that when non-health professionals arrive at the Congress, some of them for the first time at a scientific meeting, that they are educated and prepared for the talks so they can participate fully and walk away with an even greater knowledge than when they arrived."
Parkinson's knows no boundaries, and many people living with PD who speak Spanish find it difficult to find high level educational information about Parkinson's from trusted sources in their native language. This series will include top-notch presenters, covering key topics, in both languages, offering equitable resources.
Presenters in the series are bi-lingual experts in Parkinson's with decades of clinical and research experience. The series will continue to grow in 2021 with additional topics and presenters. Each webinar set will have two 1-hour webinars. The first webinar will be in English, followed by a short break. When the speakers return, the webinar will be presented again in Spanish.
Registration and details can be found at https://www.worldpdcoalition.org/webinarseries
Webinar #1: Lightheadedness and Parkinson's
Date: Wednesday, Dec 2, 2020
Webinar #2: Deep Brain Stimulation - Part 1
Date: Thursday, Dec 10, 2020
Webinar #3: Deep Brain Stimulation – Part 2
Date: Thursday, Jan 21, 2021
Panelists to include:
Horacio Kaufmann, MD, FAAN, Dysautonomia Center at NYU Langone Health
Patricio Millar Vernetti, MD, Dysautonomia Center at NYU Langone Health
Mariella Graziano, BSc, PT
Gonzalo J. Revuelta, DO, Medical University of South Carolina
Adolfo Ramirez-Zamora, MD, University of Florida
Francisco Ponce, MD, Barrow Neurological Institute
Adriana M. Strutt, PhD, ABPP-CN, Baylor College of Medicine
"Being a part of this new virtual bi-lingual Parkinson's series is exciting," said Dr. Horacio Kaufmann, the Axelrod Professor of Neurology at NYU School of Medicine in New York. "It shows the strong commitment of the WPC to reach patients all around the world. I would not be surprised if the next series includes Chinese, and of course Catalan."
Learn more about and register for talks in the series at https://www.worldpdcoalition.org/webcast
This webinar series is being launched with support from Theravance Biopharma, Boston Scientific, and Medtronic.
About the World Parkinson Coalition and WPC 2022
The World Parkinson Coalition Inc. provides an international forum for learning about the latest scientific discoveries, medical practices, caregiver initiatives and advocacy work related to Parkinson's disease. The triennial World Parkinson Congresses provide a space for the global Parkinson's community of researchers, clinicians, health care professionals, people with Parkinson's and their care partners to meet in person, network, and discuss advances in Parkinson's research, improve understanding and promote advocacy worldwide, while influencing future research and care options. The WPC 2022 will attract more than 4,500 delegates.
About Parkinson's Disease
Affecting nearly one million Americans and 10 million people worldwide, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's. There is no cure for Parkinson's and 60,000 new cases are diagnosed each year in the United States alone.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series. Neuropsychiatric Disease and Treatment.

DUBAI, UNITED ARAB EMIRATES (PRWEB) NOVEMBER 17, 2020
Kids Neuro Clinic and Rehab Center, Dubai announces today groundbreaking findings of a new research study on the treatment of Autism Spectrum Disorder (ASD) in younger children. The results, published in the international, peer-reviewed journal, Neuropsychiatric Disease and Treatment, share breakthrough findings in ASD research. For the first time in medical literature, researchers describe a complete resolution of ASD core signs and symptoms using a combination of FDA approved pharmacological medications and standard supportive therapies.
Autism spectrum disorder (ASD) is a lifelong debilitating neurodevelopmental disorder characterized by repetitive and restricted patterns of behavior, difficulties with communication and social interaction.
Worldwide, the prevalence of ASD is increasing at an alarming rate yet understanding causes of ASD still at large remain unclear. It is well documented however, that care and management for ASD patients has a significant socioeconomic impact consistently across the globe.
Due to limitations of published data on costs of ASD patient management locally, a review of published data in the United States of America, where ASD affects one in 59 children, showed societal costs of managing ASD in 2015 were a staggering $268 billion. This figure, which had increased more than six-fold since 2006, is further estimated to rise to $461 billion by 2025 following existing treatment approaches. This data highlights the critical need for progressing knowledge to support ASD treatment and management.
Currently, ASD is considered to be a non-curable disorder. As stated in the National Institute of Neurological Disorders and Stroke (NINDS, USA) fact sheet for ASD, "There is no cure for ASD. Therapies and behavioral interventions are designed to remedy specific symptoms and can improve those symptoms." [1]
However, recent findings published by Dr. Hamza Alsayouf at the Kids Neuro Clinic and Rehab Center in Dubai, provide promising hope. This pivotal study shares data which reveals pharmacological intervention resulted in an absolute and complete resolution of ASD core signs and symptoms in younger children aged four and older. [2]
In this study, 18 children diagnosed with ASD were successfully treated following treatment protocols developed by the Dubai Healthcare City based center, using risperidone and aripiprazole. Both drugs, which are US Food and Drug Administration (FDA) approved, are used for the treatment of challenging behaviors such as irritability, aggression, and self-injury that coexist with ASD in children aged five and above. The findings reported in this study include ten patients (56%) showing unprecedented complete resolution of their core ASD signs and symptoms, while the remaining eight patients (44%) exhibiting significant improvements in their symptoms ranging from 60 to 80%. Furthermore, these improvements were reported stable with no regression observed during the follow-up period.
These breakthrough findings are the result of Dr Hamza Alsayouf's, Director of Kids Neuro Clinic and Rehab Center. dedicated and long-term commitment to advance knowledge on the use of pharmacological intervention in ASD. "We are extremely pleased that our research is being published at an international platform. This is an area of much-needed focus. This study shows for the first time that, against the prevailing opinion, ASD signs and symptoms can indeed be completely resolved," said Dr. Alsayouf. He further added, "While we have many video testimonials for ASD children who have been treated successfully at our center over the years, our aim was to ensure our impressive results are published in reputable scientific literature to substantiate our experience in the treatment of ASD."
This retrospective study expands the evidence-based use of FDA-approved medications that have been available for many years and believed only be effective in managing behavioral issues. "Based on our extensive center experience and applying in-depth scientific evidence, we have demonstrated that use of these medications can help to target the core signs and symptoms of ASD, and not just to treat behavioral issues. We strongly believe that ASD is neuropsychiatric in nature and shares many features with other neuropsychiatric diseases and needs to be approached the same way," said Dr. Alsayouf.
"We have found chronic use of these medications for more than one to two years is key as well as individualizing treatment plans. Finding the optimal combination and tailoring doses of medications for each patient following a personalized approach is crucial and it is imperative to optimize overall patient outcome. As this study shows, when indicated, the use of ADHD medications in addition to antipsychotic medications helped control ADHD symptoms and boost attention which plays a major role in the learning process," added Dr. Alsayouf.
In the study, Dr. Alsayouf provided a treatment algorithm and explained every patient's treatment journey, with the hope to stimulate further controlled clinical research.
This study shows that early tailored pharmacological intervention along with early intervention standard supportive therapies can successfully treat core signs and symptoms in younger ASD patients. It is anticipated that a double-blinded, placebo-controlled study will be performed to validate these findings and further support development of a cure for this chronic and devastating disorder.
As Dr. Alsayouf concluded, "While it may take us decades to uncover the underlying causes of ASD, this should not divert our attention away from treating this debilitating condition from what we know today. We believe our case series will prove to be a big eye-opener."
The study appears in volume 20 of Neuropsychiatric Disease and Treatment.
About Dr. Hamza A Alsayouf, MD
Dr. Alsayouf is an American Board-certified Pediatric Neurologist who completed his training at Nationwide Children's Hospital, Ohio State University, from 2006–2009. He is the founder and owner of the Kids Neuro Clinic and Rehab Center at Dubai Healthcare City, Dubai, UAE.
About the Journal
Neuropsychiatric Disease and Treatment is an international, peer-reviewed and open-access journal, (5-year impact factor, 2.6) reporting on clinical therapeutics and pharmacology research on a range of neuropsychiatric and neurological disorders. Neuropsychiatric Disease and Treatment is the official journal of The International Neuropsychiatric Association (INA).
About the Study Center
Kids Neuro Clinic and Rehab Center is a pediatric neurology clinic and pediatric rehabilitation center located in Dubai Healthcare City. The Center is the first independent pediatric neuroscience facility in Dubai that specializes in child neurology and child rehabilitation.
Kids Neuro Clinic and Rehab Center intends to publish further research in this area and encourages interest from individuals and industry wishing to collaborate in its ASD research program.
Website: https://www.kidsneuroandrehab.com/
For more information, please contact:
Dr. Hamza Alsayouf
Email: Leeamra1000@gmail.com
Tel: 0097145570326
References
NIH National Institute of Neurological Disorders and Stroke. Autism Spectrum Disorder Fact Sheet. September 2015. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Autism-Spectrum-Disorder-Fact-Sheet
Alsayouf HA, Talo H, Biddappa ML, et al. Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series. Neuropsychiatric Disease and Treatment. https://www.dovepress.com/pharmacological-intervention-in-children-with-autism-spectrum-disorder-peer-reviewed-fulltext-article-NDT



START your own Wordpress site, business or personal website, or online store at www.siteground.com

American Treatment Network announced the opening of its innovative integrative treatment program for outpatient addiction treatment and mental health today. Recognizing the current fragmented nature of outpatient addiction services, American Treatment Network, set out to create an evidenced based, best in class treatment program that would appeal to the multiple stakeholders involved in addiction treatment and recovery.

HAVERTOWN, PA. (PRWEB) NOVEMBER 17, 2020
American Treatment Network announced the opening of its innovative integrative treatment program for outpatient addiction treatment and mental health today. Recognizing the current fragmented nature of outpatient addiction services, American Treatment Network, set out to create an evidenced based, best in class treatment program that would appeal to the multiple stakeholders involved in addiction treatment and recovery.
Working with policy makers, payors, physicians, and patients they have created a model that is evidenced based and cost effective to increase access to care. "We started from the ground up and began asking the tough questions about fragmented care in current treatment models" stated Dr. Robert Cerrato. He continued, "Our goal was to develop a program that combines both physical and behavioral health care, care coordination, and with our investment in new technologies, we will deliver on the promise of value-based care". The main goal of any addiction treatment program is to maintain sobriety and prevent relapse and possible death. American Treatment Network has created a unique program that is evidence based and personalized to each patient. Patients can benefit from physical health care services and behavioral health treatments all in one location.
The practice offers medication assisted treatment (MAT), Individual and Group Counseling, Intensive Outpatient (IOP), and Partial Hospitalization (PHP) services with the added benefit of care coordination. "We have created an environment of supportive care and our patients have a team of experienced care givers that are solely focused on their health and successful outcomes. "Our core values of personalized, patient focused care, can be seen in everything we do" mentions SVP of Clinical Services Kelly Clarke. She continues, "We are especially excited about our ability to track and publish our outcomes, we treat our patients in a value-based environment and believe our high touch engagement model with result in higher sobriety success rates and outcomes."
Conveniently located in the heart of Delaware County, with easy access to public transportation, American Treatment Network is contracted as an in-network provider with Medicare, Medicaid, Commercial Insurers, and the Veterans Administration Community Care Program. Current plans call for multiple locations within Pennsylvania, New Jersey, Maryland, and Delaware.
About American Treatment Network:
American Treatment Network is an outpatient substance abuse clinic headquartered in Havertown, Pennsylvania. We are committed to transform the lives impacted by addiction and substance use through comprehensive and personalized healthcare solutions. We strive to minimize the pain of addiction by restoring emotional and physical health, spirituality, hope and renewed relationships.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Delta Air Lines and CMN Hospitals partner for the Child Life Specialist of the Year award to honor Child Life Specialists.

SALT LAKE CITY (PRWEB) NOVEMBER 17, 2020
Children's Miracle Network Hospitals (CMN Hospitals) is pleased to announce that Mattie Dunn is the recipient of the second annual Child Life Specialist of the Year award.
Presented by Delta Air Lines, Dunn was chosen from a select group of child life specialists nominated by Children's Miracle Network Hospitals member hospitals from across the United States in recognition for her outstanding service and commitment to patients.
As an employee of Cincinnati Children's for 30 years and a child life specialist for the past seven years, Dunn empowers children and families as they navigate complicated and emotional journeys with psychiatric, behavioral and developmental disabilities. Because standard medical procedures like blood draws or MRIs can be daunting for a nonverbal or disabled patient, their family and hospital staff, Dunn acts as an advocate to identify and accommodate the individual needs of her patients.
Her creative and personalized approach eases a child's anxiety and fear while delivering first-rate medical and emotional care. Dunn's attendance to her patients, her optimism and tireless work ethic inspired her entire community.
As the winner of the Child Life Specialist of the Year award, Dunn received two round-trip Delta tickets. The airline also made a $15,000 donation to Cincinnati Children's in honor of Dunn.
Delta Air Lines, in partnership with CMN Hospitals, created the Child Life Specialist of the Year award to honor and recognize the hard work and compassion of Child Life Specialists and the critical services they provide for hospitalized children and their families, along with bringing awareness to the need for child life funding at children's hospitals.
Child Life Specialists help normalize the hospital experience and bring joy and comfort to pediatric patients and their families. Many of the funds raised by CMN Hospitals are used to fund Child Life programs and help make up the gap between what government and insurance pay for and the actual cost of caring for kids in our member hospitals.
*video footage filmed prior to the pandemic
About Cincinnati Children's
Cincinnati Children's, a nonprofit academic medical center established in 1883, is one of the oldest and most distinguished pediatric hospitals in the United States. A leading medical research institution and teaching hospital, Cincinnati Children's is consistently ranked as one of America's best children's hospitals by U.S. News & World Report.Learn more at http://www.cincinnatichildrens.org.
About Children's Miracle Network Hospitals
Children's Miracle Network Hospitals raises funds and awareness for 170 member hospitals that provide 32 million treatments each year to kids across the U.S. and Canada. Donations stay local to fund critical treatments and healthcare services, pediatric medical equipment and charitable care. Since 1983, Children's Miracle Network Hospitals has raised more than $7 billion, most of it $1 at a time through the charity's Miracle Balloon icon. Its various fundraising partners and programs support the nonprofit's mission to save and improve the lives of as many children as possible. Find out why children's hospitals need community support, and learn about your member hospital, at CMNHospitals.org and facebook.com/CMNHospitals.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Granger joins Elev8 Cannabis as the company adds new dispensaries in Massachusetts

EUGENE, ORE. (PRWEB) NOVEMBER 18, 2020
Elev8 Cannabis, an emerging adults-medical cannabis company with a dispensary in Eugene, Oregon, Athol, Massachusetts, and two others to open by spring 2021, in Massachusetts, announced today that Naomi Granger was named Elev8 Cannabis chief financial officer. Granger becomes the company's first CFO. Her appointment is effective immediately.
"Naomi brings the perfect balance of expertise and experiences to the role as Elev8 Cannabis continues to expand our multi-state dispensaries and strengthen our focus on providing excellent service and cannabis products for our customers," said Seun Adedeji. "She has been an outstanding leader in the cannabis industry, having co-founded DOPE CFO and after delivering strong financial and operational management throughout her 15-year career working for "Big 4" accounting firms."
After serving as CFO for dozens of cannabis companies and teaching proper cannabis accounting to over 600 accounting firms across the United States, Granger decided to launch Green Leaf CFO to further hone her skills in the ever changing cannabis industry, build stronger strategic partnerships and provide even more value to aspiring cannabis businesses.
"I am thrilled to join Elev8 Cannabis in this chief financial officer role, and I look forward to working closely with Elev8 as it continues growing and its value increases," Granger said. "Seun has built a strong foundation for an enduring cannabis business, and I am poised to help Seun and the company expand on what he's started by creating and implementing financial strategies that benefit the growth of Elev8 Cannabis."
Granger's appointment coincides with the opening of two additional Massachusetts Elev8 Cannabis dispensaries to open in early 2021 in Orange and Williamstown. "Having Naomi on board as we grow further into the state of Massachusetts is extremely important for Elev8 achieving the best in financial advising as well as for overseeing the best choices in order for it to remain profitable," Adedeji said.
About Elev8 Cannabis
Elev8 Cannabis was founded by Seun Adedeji in 2017, to bring a variety of high-quality health and wellness cannabis products to the public. To learn more about Elv8 Cannabis promotions and dispensaries, visit http://www.elev8cannabis.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Like most routine preventative care, dental and eye exams may detect early indicators of potentially dangerous health care issues. This partnership allows us to work directly with employers to improve employees' overall health and well-being.

BOSTON (PRWEB) NOVEMBER 18, 2020
OnSight Eyes announces strategic partnership with Jet Dental to offer employers the convenience of on-site dental and eye care for their employees. Like most routine preventative care, dental and eye exams may detect early indicators of potentially dangerous health care issues. This partnership allows us to work directly with employers to improve employees' overall health and well-being.
"The OnSight Eyes – Jet Dental Partnership gives employers the opportunity to deliver excellent convenience of care options to their employees. By working together we are helping expand access to, and increase engagement with high-quality health care right inside of their office." Said Ben Krysiak, OnSight CEO.
On-site services help drive savings and employee engagement in a number of ways: reduced absenteeism, improved retention and prevention of advanced disease stages. Despite the pandemic, Jet Dental and OnSight Eyes have been able to safely and consistently deliver on-site health care services.
"Jet Dental is thrilled to partner with OnSight Eyes. Jet Dental's mission is to make it easy for people throughout the country to get great oral health. This partnership enables us to provide a more holistic approach to improving the quality of life for employees in corporate America." Said Jordan Smith, Jet Dental President.
About Jet Dental: https://www.jetdental.com/
A mobile, on-site dental provider for corporations nationwide. We improve the health of our client's employees by bringing the dentist to their workplace at no cost to them — we simply bill the dental insurance they already have! We provide preventative and restorative care including cleanings, X-Rays, exams, fillings, and teeth whitening on-site. With proper treatment planning, we can improve your health, while providing a more confident smile at the same time. https://www.jetdental.com/
About OnSight Eyes: https://onsighteyes.com/
As the nation's largest provider of mobile vision services, we bring board-certified optometrists, the latest technologies and a great selection of eyewear to the office, providing all the elements of a doctor's visit right in the workplace. Employees do not have to leave the office, saving time and productive hours. No travel, no hassle. We accept most medical and vision insurance plans. https://www.linkedin.com/company/onsighteyes

"The OnSight Eyes – Jet Dental Partnership gives employers the opportunity to deliver excellent convenience of care options to their employees. By working together we are helping expand access to, and increase engagement with high-quality health care right inside of their office." Said Ben Krysiak,



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Antibacterial Properties of OsteoFab PEKK Implants Defined in New Research, Outperforming PEEK and Titanium

SOUTH WINDSOR, CONN. (PRWEB) NOVEMBER 18, 2020
Oxford Performance Materials, Inc. (OPM), an industry leader in advanced materials science and high performance additive manufacturing (HPAM), today announced additional results of an ongoing scientific study analyzing the antibacterial properties of 3D printed PEKK (poly-ether-ketone-ketone). These new results definitively establish a mechanism of action for how 3D printed PEKK exhibits inherent antibacterial characteristics, further confirming PEKK's role in combatting implant infections. In a continued partnership with Dr. Thomas Webster of Northeastern University, this research builds upon a September 2017 study(1) where samples produced by OPM's proprietary OsteoFab process "demonstrated for the first time the promise that nanostructured PEKK has for numerous anti-infection orthopedic implant applications."
In a second set of experiments conducted by Dr. Webster in December 2019, it was determined that 3D printed PEKK demonstrated significant reductions for all bacteria colonization(2) when measured via colony forming units, crystal violet staining, and live/dead assays. This was true for all tested bacteria strains, which included S. epidermidis, P. aeruginosa, and MRSA, and all tested materials, as 3D printed PEKK significantly outperformed commercially available titanium and PEEK controls. This study was important for two primary reasons: it confirmed the results seen in the 2017 study(1) in the presence of titanium and PEEK controls and it raised the question of why PEKK is superior in this aspect, hinting that 3D printed PEKK may have a biologically optimal surface energy in the context of bacterial aversion.
In April of 2020, a follow-up study was conducted to determine the mechanisms of the antibacterial properties of 3D printed PEKK after 24 hours of culture, specifically examining protein adsorption and correlating that adsorption to bacteria response. Based on the test results(2), 3D printed PEKK exhibited a surface energy (35.7 mN/m) that was much closer to proteins lubricin (40 mN/m), mucin (42-46 mN/m), and casein (48 mN/m), which are all proteins known to reduce bacteria attachment and colonization naturally in vivo. When compared to the surface energies of PEEK (16.3 mN/m) and titanium (62.5 mN/m), it was evident 3D printed PEKK is optimal in terms of similarity to these naturally occurring proteins. As expected, the experiment showed greater protein adsorption of lubricin, mucin, and casein on PEKK in comparison to PEEK and titanium controls.
This greater protein adsorption was then correlated to greater bacteria inhibition of 3D printed PEKK compared to commercially available PEEK and titanium. For this portion of the study, samples were coated with lubricin, mucin, and casein, and bacteria attachment was characterized using colony forming unit counts, crystal violet staining, and live/dead assays. All results correlated the increased protein adsorption to decreased bacteria colonization for S. epidermidis, P. aeruginosa, and MRSA, again compared to PEEK and titanium controls.
This finding is extremely important as it provides objective evidence explaining why OPM's 3D printed PEKK exhibits inherent antibacterial effects. "We have been continually impressed with the strong bacteria resistance and pro-bone cell responses of OPM's PEKK samples," said Dr. Webster. "All resulting from optimal surface properties without resorting to the use of antibiotics or the release of growth factors, as our studies have shown." Equally significant are the implications of lubricin adsorption onto 3D printed PEKK, in terms of future joint and cartilage applications of the OsteoFab technology platform. Lubricin is a naturally occurring protein that is secreted in synovial joints; it coats surrounding cartilage and contributes to the overall integrity of the joint. With demonstrated adhesion to 3D printed PEKK, new devices could provide even more benefits in an increasing number of orthopedic applications.
The antibacterial attributes of 3D printed PEKK are significant since they address a key area of growing concern in medicine – orthopedic implant infections. 3D printed PEKK's antibacterial properties, as detailed in this new study, will provide another important layer of differentiation for the performance of OsteoFab medical devices in the marketplace. Results from these experiments will be available in a forthcoming publication.
About Oxford Performance Materials, Inc.
Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world's highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM's Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand for biomedical and industrial applications. The Company is a pioneer in 3D printing. OPM Biomedical's OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices. OPM is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed, patient-specific polymeric implants, and the company has six 510(k) clearances in its portfolio. OPM Industrial produces 3D printed OXFAB production parts for highly demanding applications in the energy, transportation, and semiconductor markets. OXFAB structures offer significant weight, cost, and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. For more information, please visit: http://www.oxfordpm.com
References
"Antibacterial Properties of PEKK for Orthopedic Applications," International Journal of Nanomedicine, Dovepress 15-Sep-2017, Mian Wang, Garima Bhardwaj (Department of Chemical Engineering, Northeastern University, Boston MA) and Thomas J. Webster (Department of Chemical Engineering, Northeastern University, Boston MA and Wenzhou Institute of Biomaterials and Engineering, Wenzhou Medical University, Wenzhou, China). The full study by Mian Wang, et al. may be viewed at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592909/
2. https://oxfordpm.com/uploads/files/OPM-T._Webster_AM_Med_Summit_19Oct2020_website.pdf?v=1605303394194
Company Contact:
Bernie Plishtin
Oxford Performance Materials
860-656-9446
bplishtin@oxfordpm.com

We have been continually impressed with the strong bacteria resistance and pro-bone cell responses of OPM's PEKK samples," said Dr. Thomas Webster of Northeastern University. "All resulting from optimal surface properties without resorting to the use of antibiotics or the release of growth factors




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Alan J. Sedley, former general counsel of two California hospital health systems, has joined the law firm of NelsonHardiman, LLP as Senior Counsel.

LOS ANGELES (PRWEB) NOVEMBER 18, 2020
Alan J. Sedley, former general counsel of two California hospital health systems, has joined the law firm of Nelson Hardiman, LLP as Senior Counsel. "We are thrilled to add an attorney with the wealth of healthcare experience that Alan brings," said Managing Partner Harry Nelson. "Alan brings not only expertise, but also leadership that will strengthen our firm and extend support to our clients."
Sedley's addition marks the firm's ongoing growth and extension into Orange County, where he is based. "I am honcored and delighted to join Nelson Hardiman," said Mr. Sedley. "It is a pleasure to be part of the best team of healthcare lawyers in the State." Nelson Hardiman was recently recognized by U.S. News & World Report for yet another year as a "Tier 1 Law Firm for Healthcare and Regulatory Compliance Law".
At Nelson Hardiman, Alan will draw on three decades of experience, including service as corporate in-house general counsel to two large California hospital health systems. As a hospital general counsel, Alan advised on numerous health system corporate matters, and managed transactions, litigation, regulatory compliance and operational processes at the hospitals. In his private practice and as outside counsel, Alan regularly advises and represents hospitals, health systems, physicians and other health professionals, ambulatory surgical centers and multi-specialty medical groups in their oft-challenging operational issues, addressing the traditional business and legal concerns within the context of the healthcare marketplace. Alan has pursued a specialized focus and offers highly experienced and dedicated counsel to large medical group and hospital medical staffs on issues relating to medical staff credentialing, privileging, physician recruitment, peer review analyses arising from suspected practitioner clinical deficiencies or disruptive conduct, and peer review body and committee investigatory processes. He provides detailed guidance on peer review hearing procedures as well as statutory reporting requirements. A civil litigator for the past thirty-five years, Alan has successfully litigated dozens of lawsuits in federal court on behalf of DSH hospitals and GME academic medical centers against the Centers for Medicare and Medicaid, alleging misapplication of rules and regulations during the course of computing hospital reimbursement payments.
About Nelson Hardiman
Nelson Hardiman LLP is the premier healthcare and life sciences firm in Los Angeles, serving healthcare and life science providers, investors, and organizations that need a hard-to-find level of quality advice on the most sensitive industry issues. The firm's litigation practice specializes in defending fraud and abuse and whistleblower actions, government investigations, and other complex business disputes. Nelson Hardiman's transactional group handles healthcare organization acquisitions, sales, investment, and financings, and Nelson Hardiman's regulatory team advises on compliance with licensing, operational, and reimbursement issues across the full continuum of healthcare industry sectors, with expertise on Medicare and Medicaid requirements, privacy and data security, FDA, and other regulatory matters. The firm has earned a singular position reputation nationally for its leadership in addressing issues in behavioral health and telehealth. More information about the firm is available at http://www.nelsonhardiman.com or at 310.203.2800.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare Leader Identified as Trusted Testing Partner

BIRMINGHAM, ALA. (PRWEB) NOVEMBER 18, 2020
American Family Care (AFC), the nation's leading provider of urgent care and accessible primary care, is at the top of a new list of trusted medical care providers partnering with the state of Hawaii to provide pre-travel COVID-19 testing for anyone planning to visit the tropical islands. AFC is now offering the pre-travel tests at more than 200 of its centers across the country.
"It is a great honor to have been selected as a trusted testing partner for the Safe Travels Hawaii program," says AFC's founder and CEO, Dr. Bruce Irwin. "AFC's expansive healthcare network has been a leader in the COVID-19 fight since day one. Our centers were among the first in the nation to offer rapid COVID testing, and we are thrilled to have been chosen to provide these crucial tests to travelers heading to Hawaii."
The state of Hawaii commenced pre-travel testing as part of a multi-layered screening process to allow travelers to safely come into the state without having to go through a 14-day quarantine. Travelers who follow all the processes, including getting a negative test from a Trusted Testing Partner, such as AFC, are not required to quarantine for 14 days.
Here is how the testing process works for anyone age 5 or older:
Hawaii Pre-Travel COVID-19 Testing

Complete a Nucleic Acid Amplification Test (NAAT) no more than 72 hours before flight travel time to Hawaii.

Hawaii will accept test results ONLY from participating locations of trusted providers like American Family Care.

Establish an account at the Safe Travels Hawaii program.

After testing, AFC staff will print out results so the information can be uploaded to the program's website.

If test results are not available when arriving in Hawaii, travelers must self-quarantine until results are received and reported to Hawaii's Department of Health.

If a traveler receives positive test results after arriving in Hawaii, they will be required to go into isolation until fully recovered.

Travelers who do not enter Hawaii with results from a Trusted Tested Partner will be required to self-quarantine for 14 days after their arrival.
About American Family Care:
Founded by Dr. Bruce Irwin with a single location in 1982, American Family Care has pioneered the concept of convenient, patient-centric healthcare. Today, with more than 200 clinics and 600 in-network physicians caring for nearly 3 million patients a year, AFC is the nation's leading provider of urgent care, accessible primary care and occupational medicine. Ranked by Inc. magazine as one of the fastest-growing companies in the U.S., AFC's stated mission is to provide the best healthcare possible, in a kind and caring environment, while respecting the rights of all patients, in an economical manner, at times and locations convenient to the patient. For more information, visit http://www.americanfamilycare.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease. Prostate tumors can metastasize to a number of different organs, including the liver, lymph nodes and bone.

BUFFALO, N.Y. (PRWEB) NOVEMBER 18, 2020
- People with prostate cancer often face painful bone metastases

Study identifies enzyme vital to the metastatic growth of prostate cancer cells

Findings reveal potential strategy for treating bone-metastatic prostate cancer

While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease. Prostate tumors can metastasize to a number of different organs, including the liver, lymph nodes and bone.
People with advanced prostate cancer often develop bone metastases — lesions of prostate cancer growing on distant bones — that are very painful and difficult to treat. Given the significant differences between the microenvironments surrounding the bone and prostate, a team from Roswell Park Comprehensive Cancer Center set out to learn more about how prostate tumors survive and grow in the bone.
Led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in Roswell Park's Department of Cell Stress Biology, the team determined that prostate tumors change their metabolism to produce more fats, which helps them survive within the bones. The team's findings have been published online in Cancer Research, a journal of the American Association for Cancer Research.
Data from this study suggest that a mitochondrial enzyme called aconitase plays a key role in the development and viability of prostate cancer cells. The Roswell Park research team discovered that prostate tumors are able to alter their metabolism and produce additional fats by stimulating this enzyme.
"There's a fundamental gap in knowledge regarding how prostate tumor cells survive inside the bone," explains Dr. Dasgupta, senior author of the new work. "In this study, we provide evidence that prostate tumor cells alter their mitochondrial metabolism to increase synthesis of fats, which serve as a sort of food source enabling the prostate cells to take root and survive in a new location."
The team reports that activation of aconitase is enabled by suppressing a deacetylase enzyme named sirtuin-3, or SIRT3, resulting in increased lipid synthesis.
Previous studies have associated increased expression of another protein, SRC-2, with aggressive prostate cancer. In the current study, Dr. Dasgupta and colleagues determined that patients with high SRC-2 in their tumors simultaneously saw low expression of SIRT3, helping those aggressive tumors to spread to new sites. Through their preclinical work in the lab, the investigators showed that the loss of SRC-2 significantly reduced metastatic growth of prostate cancer cells in the bone microenvironment.
The team's findings highlight the importance of mitochondrial metabolic adaptation in the growth of advanced bone metastatic prostate cancer, and suggest that blocking SRC-2 in order to enhance SIRT3 expression may be a viable treatment strategy.
"This is an early-stage discovery identifying potential pathways that could be targeted to block prostate tumor growth inside the bone," notes Dr. Dasgupta. "We've begun additional work to investigate the clinical benefits of our research findings and identify particular drugs or new agents that could block this pathway."
Abhisha Sawant Dessai, a predoctoral trainee, and Mayrel Palestino Dominguez, PhD, a Postdoctoral Fellow, both from Dr. Dasgupta's lab team, are co-first authors on the paper.
This work was supported by grants from the National Cancer Institute (project numbers K22CA207578, P30CA016056 and DP2CA260421, the NIH Director's New Innovator Award) and Department of Defense (award number W81XWH-16-1-0297, and by donations to Roswell Park.
For an online version of this release, please visit: https://www.roswellpark.org/newsroom/202011-what-drives-painful-bone-metastasis-prostate-cancer-can-it-be-prevented
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

PHAB Awards Accreditation and Reaccreditation to High-performing Health Departments

ALEXANDRIA, VA. (PRWEB) NOVEMBER 18, 2020
Working with partners and their communities, public health departments provide expertise, data and population health services as they serve as key leaders in improving the health and well-being of communities. To demonstrate accountability and adopt cultures that promote continuous performance improvement, many health departments strive to achieve national accreditation. Today, the Public Health Accreditation Board (PHAB) is pleased to announce the names of four public health departments that have achieved accreditation or reaccreditation status, after completion of a systematic review process against national standards. These health departments have successfully demonstrated a commitment to a focus on accountability, equity and performance as they work to improve the health of their communities.
PHAB, the nongovernmental, nonprofit organization that administers the national accrediting program, works to improve and protect the health of the public by advancing and transforming the quality and performance of governmental public health departments in the United States and abroad.
"PHAB is incredibly proud of the four health departments awarded accreditation and reaccreditation this November," said Paul Kuehnert, President and CEO of PHAB. "It is important to shine a light on this important work, especially during such challenging times, as we recognize their achievement in advancing public health practice through continuous quality improvement and using accreditation to transform their communities."
"We have reached an important milestone for Ross County in our achievement of PHAB accreditation. This achievement moves us closer to our vision of strong partnerships, healthy communities and healthy people," said Garrett Guillozet, Health Commissioner for the Ross County Health Department in Chillicothe, Ohio. "As we reflect on the hard work it took to get here, we are grateful to our partners and community for their continued commitment to public health and invite them to join us in celebrating this bright spot during a particularly challenging time for all."
"The Central Michigan District Health Department could not be more proud of being recognized for reaccreditation this week. As one of the early adopters in the country to be nationally accredited, we continue on our performance improvement journey, the importance of which has been highlighted during the pandemic," said Steve Hall, Health Officer. "I applaud our entire team, our partners and our community for their commitment to safeguarding public health and the environment."
PHAB, the nonprofit organization that administers the national public health accreditation program, aims to advance and transform public health practice by championing performance improvement, strong infrastructure, and innovation. Launched in 2011 with support from the Centers for Disease Control and Prevention and the Robert Wood Johnson Foundation, PHAB's accreditation program has become the national standard for public health in the United States.
National reaccreditation was awarded November 13, 2020 to:

Central Michigan District Health Department, Mount Pleasant, MI

El Paso County Public Health, Colorado Springs, CO

National initial accreditation was awarded November 13, 2020 to

Ross County Health District, Chillicothe, OH

Unified Government Public Health Department, Kansas City, KS

For more information, contact Jessica Solomon Fisher at jfisher@phaboard.org. Learn more about PHAB and accreditation at http://www.phaboard.org. Be in the know: subscribe to PHAB's e-newsletter.
About the Public Health Accreditation Board
The Public Health Accreditation Board (PHAB) was created to serve as the national public health accrediting body and is funded in part by the Centers for Disease Control and Prevention and the Robert Wood Johnson Foundation. The development of national public health accreditation has involved, and is supported by, public health leaders and practitioners from the national, state, local, Tribal, and territorial levels.

"It is important to shine a light on this important work, especially during such challenging times, as we recognize their achievement in advancing public health practice through continuous QI and using accreditation to transform their communities," said Paul Kuehnert, PHAB CEO.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Specific Diagnostics today announced the appointment of Jeff Holman as Vice President of Global Marketing, as Specific begins its market launch in Europe.

MOUNTAIN VIEW, CALIF. (PRWEB) NOVEMBER 18, 2020
Specific Diagnostics today announced the appointment of Jeff Holman as Vice President of Global Marketing, as Specific begins its market launch in Europe. Mr. Holman comes from a 14-year tenure in both sales and marketing at Roche Diagnostics Corporation, having most recently served as Head of Sales for the Core Laboratory vertical with $55M in revenue in 2019. At Roche Diagnostics Mr. Holman led multiple successful system launches into both the pre-clinical and clinical segments, and was the training leader for the Women's Leadership Initiative (WLI). Mr. Holman will lead all marketing and branding activities related to Specific's Reveal System and market launch in Europe, and subsequent launch in the US.
"Jeff is coming in at a pivotal moment and is going to be a great asset to our team at Specific," said Tony Bazarko, Specific's CCO. "As we continue commercialization in EMEA, Jeff's experience and knowledge will enable us to continue building our premier brand."
"I am gratified that Jeff has chosen to join Tony's commercial team at Specific," added Paul A. Rhodes, Ph.D., Specific's CEO. "Jeff's choosing to leave a highly successful career at a global market leader such as Roche Diagnostics to join Specific at this time speaks to the important opportunity we now have to bring rapid susceptibility testing to hospitals throughout Europe and worldwide."
"With the Reveal System, Specific Diagnostics' team has developed a truly remarkable product to address global antibiotic resistant infection," said Mr. Holman. "Because of Specific Diagnostics' focus on the affordability of rapid antibiotic susceptibility testing (AST), health systems all over the world will now be able to treat patients more quickly and accurately, leading to better outcomes. It is an absolute privilege to lead Specific Diagnostics' global marketing team for the launch of the Reveal System and to ensure patients worldwide can benefit from the life changing impacts of rapid AST."
About Specific
Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application applies this fundamental new platform to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions. Specific is based in Mountain View, CA.
For press inquiries, please contact: press@specificdx.com

With the Reveal System, Specific Diagnostics' team has developed a truly remarkable product to address global antibiotic resistant infection.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Attributes 195% Revenue Growth to a high-performing team and Healthcare's need to engage with patients.

NASHVILLE, TENN. (PRWEB) NOVEMBER 18, 2020
Relatient, a SaaS-based patient engagement company, today announced it ranked 464 on Deloitte's Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 26th year. Relatient grew 195% during this period.
Relatient's chief executive officer, Michele Perry, credits Relatient's team and Healthcare's need to engage with patients with the company's 195% revenue growth. She said, "The Relatient team is honored to be included on Deloitte's Fast 500 List for the third year in a row. The need to bridge the gap between healthcare providers and their patients to drive better outcomes and improve patient experiences has increased in past years, but especially during the pandemic. We are growing to reflect this need."
"For more than 25 years, we've been honoring companies that define the cutting edge and this year's Technology Fast 500 list is proof positive that technology — from software and digital media platforms, to biotech — truly does permeate so many facets of our lives," said Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader. "We congratulate this year's winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic."
"Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive," said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte's audit and assurance practice. "We extend sincere congratulations to these well-deserved winners — who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible."
Overall, 2020 Technology Fast 500 companies achieved revenue growth ranging from 175% to 106,508% from 2016 to 2019, with median growth of 450%.
About Deloitte's 2020 Technology Fast 500
Now in its 26th year, Deloitte's Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
About Relatient
Relatient, Inc., the 2020 KLAS Category Leader in Patient Outreach, is a SaaS-based patient-centered engagement company that utilizes a modern and mobile-first approach to improve patient and provider communication. On behalf of U.S. medical practices and health systems, Relatient engaged patients with more than 132 million messages in 2019. Relatient's platform integrates with over 87 practice management systems and electronic health databases to drive operational efficiency, appointments and reviews, reduce no-shows, speed patient payments, and improve patient satisfaction, all while supporting health and care quality initiatives. For more information, visit http://www.relatient.net.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see http://www.deloitte.com/about to learn more about our global network of member firms.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Fast Track Designation augments previously granted Breakthrough Device Designation

NEWTON, MASS. (PRWEB) NOVEMBER 18, 2020
Lumicell, Inc., an innovation leader in image guided cancer surgery, today announced it has received Fast Track designation with rolling review from the FDA Center for Drug Evaluation and Research (CDER) to expedite the development and review of the LUM Imaging System in the treatment of Breast Cancer. Fast Track designation represents another major milestone in Lumicell's path to FDA approval.
"The FDA's decision to grant Fast Track Designation is an important step in bringing the Lumicell Imaging System closer to FDA approval and providing surgeons with this innovative technology to detect and remove cancerous tissue more confidently and efficiently than ever before," said Kevin Hershberger, President and CEO at Lumicell. "We are very excited with the progress as we continue enrollment in our Breast Cancer Pivotal Trial which we expect will further build on the strong clinical data Lumicell demonstrated in our multi-center feasibility clinical study."
Fast Track is a program designed to facilitate the development and expedite the review of new drugs that treat serious conditions and fill an unmet medical need. Filling an unmet need is defined as providing a therapy where none exists or providing a therapy that may be potentially better than available therapies. As a Fast Track designee, Lumicell will have access to early and frequent communications with the FDA to discuss Lumicell's development plans and ensure collection of appropriate data to support the approval process. Additionally, with rolling review Lumicell plans to submit modules for the New Drug Application (NDA) for FDA review as they are ready, rather than submitting the full NDA package upon the completion of clinical trials.
This latest milestone complements our previously received FDA Breakthrough Device designation for breast cancer and all solid tumors from the FDA Center for Devices and Radiological Health (CDRH). Similar to Fast Track, Breakthrough Device Designation is awarded to medical devices or combination products that provide more effective treatment of life-threatening diseases or conditions with the goal of providing physicians and patients access to these technologies.
"Lumicell's technology is a paradigm shift – we're now looking at the surface of the cavity instead of lumpectomy margins," said Irene Wapnir, MD, Surgical Oncologist at Stanford Health Care. "It's a fresh approach to in-vivo cancer surgeries. Instead of focusing on what was in the lumpectomy specimen, we prioritize what's left behind in the cavity."
Existing surgical tools often fail to identify and remove all of the cancerous tissue in the initial surgical intervention, resulting in 20 – 40% of breast cancer patients requiring a second surgery to remove additional cancerous tissue. The LUM Imaging System was developed to allow surgeons to see and remove residual cancer in real-time—significantly reducing the risk of leaving cancer behind, second surgeries and cancer recurrence.
For more information about the LUM Imaging System and Lumicell's clinical trials, visit http://lumicell.com/clinical-trials/clinical-trials.php.
About Lumicell, Inc.
Lumicell is a technology leader in the field of image-guided cancer surgery. The company is developing a novel system that enables real-time detection of tumor tissue in patients so that no cancer cells are left behind during surgery. The company's LUM Imaging System has unprecedented ability to see and guide removal of cancer cells remaining in the surgical cavity – beyond the margin of the specimen – and has the potential to significantly improve surgical outcomes and reduce healthcare costs by eliminating the need for repeat surgeries. Lumicell is investigating the LUM Imaging System in patients undergoing surgery for breast cancer, ovarian cancer, prostate cancer, brain cancer, colorectal, esophageal and pancreatic cancers. Additional future indications are planned to include perfusion, wound care and infection, and surgeries for lung, and liver cancers. For more information, please visit http://www.lumicell.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Windsor Care Centers participate in Corporate Compliance and Ethics Week, focusing on the importance of acting lawfully and ethically

LOS ANGELES (PRWEB) NOVEMBER 18, 2020
Windsor care centers ("Windsor") across California and Arizona announced their participation in this year's Corporate Compliance and Ethics Week. The Society of Corporate Compliance and Ethics & Health Care Compliance Association (SCCE & HCCA) organized the annual event, which was scheduled this year from November 9 through November 13, 2020. This is the fourth year that Windsor participated.
Corporate Compliance and Ethics Week is an extension of Windsor's ongoing compliance and ethics program, which is overseen by Marissa Kirby, Compliance Director at S&F Management Company, LLC, a healthcare consulting company.
As a part of its efforts, Windsor celebrated Corporate Compliance and Ethics Week a bit differently this year to ensure that protocols to prevent the transmission of COVID-19 remain in place. The Compliance Committee decided on a Jungle Theme. Each Compliance Liaison received a safari hat identifying them as the Compliance Liaison. A Compliance Safari Map was given to each employee to identify areas that support and/or violate the company's Compliance Program. Items, such as prepackaged animal crackers, were given to employees when they submitted their completed Compliance Safari Map.
"Windsor is pleased to participate in Compliance and Ethics Week as it builds awareness, reinforces rules and regulations, and promotes an overall culture of compliance," says Josh Sable, Esq., General Counsel for Windsor Care Centers.
Company-wide compliance and ethics education, held upon hire, and at a minimum annually, provides the opportunity to roll-out new and updated compliance and ethics program policies and reinforces an employee's compliance and ethics obligations. Participation in Corporate Compliance and Ethics Week gives an additional opportunity to shine a spotlight on the importance of compliance and ethics and boost compliance culture.
About Windsor:
Windsor Care Centers provide advanced clinical programs in a warm and compassionate environment. From state-of-the-art therapies and preventative interventions for common medical conditions, to customized, patient-specific care plans, Windsor delivers consistent clinical expertise that minimizes hospital readmissions and promotes speedy recovery and discharge. Windsor employs professionals that provide nursing, therapeutic, sub-acute and rehabilitation care to over 4,000 patients daily in California and Arizona. For more information, please contact 310-854-8424.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pets relocating across the USA or overseas all require proof of specific vaccinations and treatments keeping them and other animals they may encounter safe and healthy.

TAMPA, FLA. (PRWEB) NOVEMBER 18, 2020
Planning a move across the U.S. or moving abroad with a pet? Air Animal Pet Movers has the experience needed to ensure that the pet move will be safe, comfortable and comply with all government and airline regulations. Air Animal pet move managers specialize in geographic regions of the world. They advise clients about requirements and veterinary protocols for every destination. Air Animal posts the most common destination protocols at airanimal.com.
Air Animal can take care of:

Country-specific microchips-- complimentary for Air Animal clients

Origin health certificates

Country-specific health certificates

Vaccination and parasite treatment explanations

Import permits

Air cargo bookings

Mandatory quarantine arrangements where applicable

"Vaccinations and other treatments required vary widely," advises Walter Woolf, Air Animal veterinarian founder and CEO. The most common requirements are:

Proof of two rabies vaccinations the most recent administered within the past year.

Proof of DA2PPL/DAPPL vaccinations (distemper, hepatitis, parvovirus, parainfluenza and leptospirosis) for dogs.

Proof of FVRCP vaccinations (feline rhinotracheitis, calcivirus, and panleukopenia) for cats.

Internal and external parasite treatments within 10 days of relocation.

"We strongly urge clients who move overseas immediately register with a local veterinarian to keep their pet's rabies and other vaccinations up to date. Veterinarians typically send reminder notices when vaccinations are due. If another move is in their future, they and their pets will be ready," said Cory Robinette, Air Animal COO.
"We work with families relocating for a military Permanent Change of Station, contract employees with the Department of Defense, corporate transferees and relocation management firms," she added.
Pet Moving Made Easy. It's their focus, their passion, their promise and their clients' peace of mind.
About Air Animal
Air Animal has helped more than 55,000 families move their 110,000 furry, feathered and scaly pets around the globe since 1977. They welcome pet move authorizations and referrals from major corporations, relocation management agencies, household goods movers, veterinarians, families, U.S. military and government transferees. Get the best in animal care and transportation. Air Animal is an appointed and endorsed IATA air cargo sales agency working with all airlines that move animals. They are an Indirect Air Carrier cleared for tendering live animals to airlines by the U.S. Transportation Security Administration. See airanimal.com to learn more about Pet Moving Made Easy.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Hammes Healthcare, a leading provider of consulting and project delivery services, participated in the November 17th groundbreaking ceremony for the Orlando Health Jewett Orthopedic Institute in downtown Orlando. Hammes is serving as project manager for the hospital component of the new Orlando Health Jewett Orthopedic Institute, which is set to open in 2023.

MILWAUKEE (PRWEB) NOVEMBER 18, 2020
Hammes Healthcare, a leading provider of consulting and project delivery services, participated in the November 17th groundbreaking ceremony for the Orlando Health Jewett Orthopedic Institute in downtown Orlando. Hammes is serving as project manager for the hospital component of the new Orlando Health Jewett Orthopedic Institute, which is set to open in 2023.
The hospital is intended to serve as the premier destination orthopedic facility dedicated to the latest and safest technologies in orthopedic care as well as outstanding customer service and exceptional patient outcomes.
The new Institute includes a 197,170-square-foot inpatient hospital with 75 beds and 10 Operating Rooms (ORs); a 64,900-square-foot ambulatory surgery center comprised of 12 ORs; and a 108,600-square-foot medical office building with 67 exam rooms, outpatient rehab, retail pharmacy, imaging suite and a café.
During the planning phase for this project, Orlando Health created a mock OR, which allowed physicians and nurses to provide feedback before the OR design was finalized.
"This unique step served as an opportunity to make the prototype absolutely perfect before we build a large number of new ORs," said Wade Milligan, Regional Vice President of Hammes Healthcare. "Every aspect of this ambitious, large-scale project has been very deliberate and well thought out. We're looking forward to executing this project with the same level of care as we move into the construction phase."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading healthcare consultancy brings depth in strategic communications and change management to The Chartis Group and the U.S. healthcare providers it serves.

NEW YORK (PRWEB) NOVEMBER 18, 2020
PALAZZO is pleased to announce it has served as exclusive financial advisor to Jarrard Phillips Cate & Hancock ("Jarrard"), a Nashville-based strategic communications and change management firm serving the healthcare industry, on its sale to The Chartis Group ("Chartis"), a leading healthcare advisory and analytics firm and a portfolio company of Audax Private Equity.
Founded in 2006, award-winning Jarrard ranks among the top 10 healthcare communications firms in the nation. Specializing in areas such as issue navigation, transformation adoption, change management, strategic positioning, and M&A, Jarrard has served more than 500 healthcare provider clients.
Jarrard joins Chartis at a time of great promise and challenge in the nation's healthcare delivery landscape. U.S. hospitals, health systems, and other providers are confronted with dynamic operational, clinical, and financial challenges while simultaneously being presented with unlimited opportunities for disruption and innovation. In both cases, organizations are facing the need to evolve and continue to grow and transform – which requires not only new strategic, clinical, digital, and operating models – but also the ability to ensure their effective implementation and adoption. To that end, Jarrard brings great complementary strengths to Chartis.
"The power of what our two organizations can do together to help clients fully achieve their strategic and operational objectives could not be greater," said Ken Graboys, CEO of The Chartis Group. "We believe successful, sustainable transformation requires effective change management and communications. By partnering with Jarrard, we can more effectively deliver results for our clients and the healthcare industry at large."
"We are combining the power of effective communications with the exceptional strategic, financial, technological, and operational expertise of Chartis," said David Jarrard, CEO of Jarrard. "We are bringing together the art and the science of change to a rapidly-evolving industry and in service to a mission – shared by both organizations – to work to make healthcare better."
The acquisition of Jarrard furthers Chartis' commitment to providing U.S. healthcare providers best-in-class advisory capabilities. Under the partnership, like other sister companies, Jarrard retains its brand, culture, leadership, and approach to client service, while being augmented by the expertise and resources of Chartis.
Matt Hasson, Managing Director of PALAZZO, remarked on the transaction, "Jarrard is among the best in the business when it comes to advising healthcare providers on important strategic internal/external communications and change management initiatives. Inasmuch as the Jarrard and Chartis offerings are highly complementary, the businesses are also very much aligned with respect to their overarching missions of helping healthcare provider clients navigate the complexities of an ever-changing healthcare environment. On behalf of PALAZZO, it has been a pleasure and a privilege to work with the Jarrard team on this successful transaction, and we wish them all the best in this exciting new partnership with Chartis."
On working with PALAZZO, David Jarrard expressed, "We needed expert advisors who we could trust to not only guide us through the transaction, but also to translate the intricacies of the process so we could make thoughtful, informed, confident decisions at every milestone. The PALAZZO team were valuable partners to us in what was easily one of the most important decisions in the life of our firm."
Terms of the transaction were not disclosed. Under the agreement, Jarrard will continue to operate with its existing leadership and staff as a wholly owned subsidiary of Chartis.
About PALAZZO
PALAZZO is a New York City-based investment bank that provides M&A advisory, capital raising, and strategic advisory services to entrepreneurs/founders, private equity firms, and strategic acquirers in the marketing services, consulting services, media, and technology sectors. Founded in 2009, PALAZZO has played an integral role in industry-defining transactions, becoming the leading investment bank in the sectors it covers. http://www.palazzonyc.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss the relationship between sarcopenia and chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). They will explore treatment options and implications for patients after liver transplant, sarcopenia and metabolic health assessment, as well as the benefit of focusing on muscles in clinical research. They will also discuss the use of MRI to follow muscles and body composition in patients being treated for liver disease.

TORONTO (PRWEB) NOVEMBER 18, 2020
Recent studies highlight an important and independent relationship between sarcopenia and chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). While the impact of sarcopenia in patients with end-stage liver disease (ESLD) or decompensated cirrhosis is well established, emerging data underscores the importance of detecting sarcopenia in patients with early NAFLD.
Current muscle-based sarcopenia definitions fail to detect sarcopenia in the population with obesity, which is overrepresented in NAFLD. Until recently, the skeletal muscle-liver crosstalk and the impact of interventions on skeletal muscle have been largely overlooked in the research for NAFLD treatments. Growing evidence places skeletal muscles' impact on insulin resistance and systemic inflammation at the center of the NAFLD pathogenic cascade.
In this webinar, experts in liver and metabolic diseases, as well as imaging, will review the latest research on how to assess and monitor sarcopenia in chronic liver disease. Research regarding how sarcopenia may impact chronic liver disease treatment, the current pathophysiological mechanisms linking skeletal muscle metabolism and sarcopenia to liver disease, as well as how these may be used to discover and develop new treatments will be explored. Finally, they will also discuss how rapid whole-body magnetic resonance imaging (MRI) has been utilized for quantitative, standardized and objective body composition assessments in recent sarcopenia research.
Join Manu Chakravarthy, MD, PhD, Executive Vice President of Clinical Development, Chief Medical Officer, Axcella Health Inc.; Mohammad Shadab Siddiqui, MD, Associate Professor of Medicine at Virginia Commonwealth University; and Mikael Forsgren, PhD, Senior Scientist, Liver Disease Lead Scientist, AMRA Medical Research, for a live webinar on Tuesday, December 8, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Muscle-Liver Crosstalk and Sarcopenia in Chronic Liver Disease: Novel Techniques and Clinical Evidence.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will provide hands-on advice on how to streamline paths to aseptic filling readiness, either through using a contract development and manufacturing organization (CDMO) or building in-house operations. They will also discuss how new technologies for aseptic filling can influence speed to market.

TORONTO (PRWEB) NOVEMBER 18, 2020
Pharmaceutical companies have spent the past eight months strategizing and waiting for clinical trials to resume. Now that product development has resumed, aseptic filling is a crucial step — and possible bottleneck — to regaining lost time.
Whether companies are looking for a contract manufacturing organization (CMO) or bringing filling operations in-house, this webinar will help to drive faster decision making around the establishment of a manufacturing strategy.
The featured speakers will be looking at how companies can prepare themselves to get filling started quickly, covering topics such as:

The influence of filling technologies on key quality and performance metrics

The benefits of selecting standardized containers and closures

The importance of creating user requirements, specifications and batch documentation

This webinar will share examples of how Vanrx and Singota have worked with customers to advance drugs through the clinic and establish filling operations.
Join John Harmer, Vice President, Marketing, Vanrx Pharmasystems; and Brent Lieffers, Senior Director of Operations, Signota Solutions, for a live webinar on Tuesday, December 8, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit How Aseptic Filling Can Make Up Lost Time in a Drug Development Program.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The guide provides tips and considerations for shoppers purchasing gifts this holiday season

GREEN BAY, WIS. (PRWEB) NOVEMBER 18, 2020
With the holiday season quickly approaching, Shopko Optical is encouraging shoppers to keep eye safety a priority when purchasing gifts for children. Through its guide, Shopko Optical hopes to equip parents and gift-givers with the knowledge and resources to make informed decisions on how to protect children's eyes.
"According to the U.S. Consumer Product Safety Commission, an estimated 166,200 toy-related injuries of children under the age of 15 were treated in hospital emergency departments in 2018, and of those injuries, 46% were to the head and face area," said Russ Steinhorst, CEO of Shopko Optical. "We are dedicated to reducing the contributing number of toy-related eye injuries by educating parents and holiday gift-givers on what to look for when purchasing toys for children."
Promoting its "R.A.P.I.D." guide, Shopko Optical's top suggestions to prevent child toy-related eye injuries are as follows:

R – Read labels, instructions, and online reviews to ensure that the safety, skill, and technical level of the toy is age-appropriate for the child

A – Avoid toys with small parts, magnets, and sharp or projectile parts

P – Provide the child with protective eyewear when playing with a potentially hazardous toy

I – Inspect toys for wear and tear such as rips, peeling paint, and loose pieces, and throw away immediately if pieces are broken

D – Demonstrate proper use of the toy and make sure children are supervised when playing

"We fully support American Optometric Association's guidelines for choosing safe toys," said Steinhorst. "Toys that fly, spin, or shoot, are sports-related, have chemical reactions, or cause eye strain are more likely to injure a child without proper precaution and care."
Common eye injuries caused by accidents with toys range from minor scratches to the surface of the eye to serious injuries such as bleeding, retinal detachment, corneal ulcers, and traumatic cataracts.
"We hope that these guidelines will help parents and gift-givers make safe toy selections this holiday season," Steinhorst said. "If you have any doubts as to if a toy is safe for children, its best to err on the side of caution."
To learn more about Shopko Optical's work to better vision care for children, visit shopko.com/project-eyecare. To learn more about toys that aid vision development, visit aoa.org.
###
About Shopko Optical
Shopko Optical, is the trade name of Shoptikal LLC, an affiliate of Monarch Alternative Capital LP. For more than 40 years, Shopko Optical has provided excellent patient-centric care and high-quality eyewear through its dedicated team of nearly 700 optometrists (independent doctors of optometry in IA, ID, MT, SD and WA) and opticians. Shopko Optical expects further growth in 2020 and beyond. For more information, visit shopko.com.
For More Information, Contact:
Chloe Albrecht
Public Relations Manager, Element
Email: chloe (at) goelement (dot) com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss how the COVID-19 pandemic has accelerated innovation in clinical trial design and how to adapt to the limitations of clinical trial design during the COVID-19 pandemic. Attendees will learn how to meet the needs of vulnerable and pediatric patient populations while ensuring high-quality data as well as the importance of relationships with physicians, patient advocacy and support groups.

TORONTO (PRWEB) NOVEMBER 18, 2020
This webinar will discuss how the COVID-19 pandemic has impacted clinical studies for rare diseases and how patient-centric trial design with regulatory consideration can be utilized to mitigate and manage potential delays and support patient recruitment in rare and orphan clinical trials.
COVID-19 is a serious, life-threatening and fast-spreading viral infection that has had an unexpected global impact. As the world is learning to adapt to a "new normal," so have clinical trials.
Rare diseases are an emerging global public health priority. There are more than 7,000 identified and classified rare diseases, 71.9% of which are genetic and 69.9% which are exclusively pediatric onset. Following the European definition of the incidence of a "rare disease" (no more than 5 in 10,000 individuals), it is estimated that there are over 440 million individuals globally who are affected by a rare disease at any point in time, excluding rare cancers, infectious diseases and poisonings. Rare diseases are numerous, heterogeneous in nature and geographically disparate. Few of them are preventable or curable, most are chronic, degenerative and many lead to early death. The inherent challenges are derived from their low prevalence, poor scientific knowledge and the scarcity of expertise, as well as their chronic, degenerative and life-threatening nature.
Patient groups, physicians and regulators are eager to support the delivery of rare and orphan clinical trials, allowing flexibility while maintaining the standards necessary to deliver high-quality data. Orphan drugs companies are looking for support and guidance on how to navigate this new challenging clinical landscape and CROs are working to deliver solutions that meet the needs of patients and drug developers.
Join experts from Simbec-Orion, Dr. Carlos Camozzi, Chair, Rare and Orphan Advisory Board; and Dr. Chirag Patel, Director of Regulatory Affairs, in a live webinar on Tuesday, December 8, 2020 at 9am EST (2pm GMT/UK).
For more information, or to register for this event, visit Meeting the Needs of Rare Disease Patients in Clinical Trials During the COVID-19 Pandemic.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Digital identity innovator Airside has teamed up with intuitive biometrics leader Tascent Inc. to deliver an integrated, biometric recovery solution for the travel industry, heavily-impacted by COVID-19.

LOS GATOS, CALIF. (PRWEB) NOVEMBER 18, 2020
Digital identity innovator Airside has teamed up with intuitive biometrics leader Tascent Inc. to deliver an integrated, biometric recovery solution for the travel industry, heavily-impacted by COVID-19. Developed to help airlines and airports deliver their services in a safe and timely fashion, the Airside-Tascent solution offers secure, seamless, and touchless biometric technology for travelers to use across many points along their journey. The partnership is a result of the synergy between the two U.S.-based technology pioneers that combines years of technical expertise and top-performing products, based on providing superlative user experiences and built in accordance with data privacy standards and regulations.
Airlines and airports have quickly adapted to COVID-19, innovating at record speed to meet public health guidance. In parallel, travelers are proving their ability to manage a multitude of important safety measures at every step of the journey, from trip planning to returning home. However, the emerging safety and security processes have been met with new challenges, such as long queues, shared touchpoints, and unqualified and ineffective temperature check products.
"What's more, is that most of these digital transactions involving sensitive personal information needed for identity proofing end up in some sort of database, making them available for marketing purposes and vulnerable to theft and fraud," said Jessica Patel, Chief Revenue Officer at Airside. "We don't think data privacy should be sacrificed for the sake of convenience."
Airside and Tascent have integrated COVID-based solutions into their industry-leading technologies and, today, announce their interoperability and applied use in air travel.
"We've seen incredible changes in the aviation industry," said Alastair Partington, CEO of Tascent, Inc. "We're focused on helping to solve the big-picture issues across the system, rather than just implementing a stand-alone tool. By innovating and combining best-of-breed capabilities, we addressed specific challenges faced by aviation stakeholders today – improving safety for everyone on the ground and on board, keeping operations agile, and boosting traveler confidence and overall satisfaction." Both companies consider efficiency, accuracy, and self-service as key requirements for today's air travel experience.
The Airside-Tascent end-to-end solution provides travelers with personalized service, empowering them to control how their personal information and biometrics are used as part of their air travel experience.
The process starts with an easy mobile enrollment using the Airside Digital Identity App. This consent-driven digital identity management app connects travelers and businesses by enabling biometric identity verification and the sharing of personal information, such as driver's licenses, passports, and lab test results. Travelers can conveniently add and verify their personal information in one single install, then decide when to securely share this information with their airline or other relying party.
On the day of travel, the person can breeze through the airport using Tascent's InSight Face cooperative facial recognition system. Optimized for the aviation environment and integrated with airlines' self-service check-in kiosks and bag drop units and airports' security checkpoints, the InSight Face captures high-quality biometric images, enabling best-in-class facial matching via Tascent's Enterprise Suite against the personal information already provided via the Airside App. The InSight Face device is available with additional capabilities, including External Body Temperature checking (InSight Face EBT), which meets current FDA Guidelines for Telethermographic Systems used for COVID-19 EBT measurements.
The combination of the Airside and Tascent technologies creates an important recovery solution that enables large-scale, seamless, and, most importantly, safe operations while sharing the sensitive information needed for air travel today.
Using the Airside-Tascent solution, the travelers maintain control of their personal information while moving swiftly along their journey in a streamlined, intuitive way. The Airside-Tascent integrated recovery solution provides new options for airlines, airports, and travelers, and is available for immediate application.
About Tascent
Tascent harnesses the power of biometrics to enable the frictionless flow of people and transactions in a connected world. We focus on creating intuitive hardware, software, and services, providing comprehensive capabilities for tailored identity solutions. Through partnerships, we deliver the strength of trusted identity to positively impact travel, financial services, ticketing and events, workplace access, government services, and humanitarian efforts.
While many biometric companies offer products that are complex and counterintuitive, Tascent makes it easy for our partners to integrate and deploy robust, intuitive approachable, and multimodal biometric identity systems. Today, our biometric solutions serve tens of millions of people each year in some of the most challenging environments. We strive to innovate and create products that address unmet needs for critical-yet-routine identity processes, making lives simpler and easier.
Based in Silicon Valley, CA, Tascent supports customers and partners globally through our partner network. https://tascent.com
About Airside
Airside builds secure and convenient digital identity technology in a manner that protects personal information and meets privacy regulations around the world. With Airside's products and services, people are empowered to control their personal information with transparent consent protocols, and businesses can protect against fraud, reduce the burden of complying with privacy regulations and ensure a duty-of-care by appropriately managing sensitive information. Airside's first product, Mobile Passport, has been downloaded by more than 9 million people and is counted on by more than 30 U.S. airports and cruise ports to reduce shared touchpoints, long lines, and crowding. Airside is headquartered in Arlington, Virginia. Learn more at: https://www.airsidemobile.com or follow us on Twitter, Facebook, Instagram, and LinkedIn.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Elizabeth "Libba" Affel, named President for Ophthalmic Photographers' Society (OPS) and Denise Armiger, named to the OPS Board of Education

PLEASANTON, CALIF. (PRWEB) NOVEMBER 18, 2020
Today, Phoenix Technology Group (Phoenix), a leading provider of advanced ophthalmic imaging solutions for researchers and clinicians, is pleased to congratulate Elizabeth (Libba) Affel, global ophthalmic imaging trainer, as the new President for the Ophthalmic Photographers' Society (OPS) for a two-year term. We are also pleased to congratulate Denise Armiger, global ophthalmic clinical trainer for her new post on the Board of Education at OPS, as well as her appointment to a board position with the Foundation Fighting Blindness. The OPS is the premier educational and training resource for ophthalmic imaging in the medical profession and includes photographers, physicians, optometrists, ophthalmic technical personnel, and scientists.
Affel has nearly 40 years of ophthalmic imaging and visual diagnostic experience. After her first job in animal research at Hahnemann Hospital, she joined the clinical lab at Wills Eye Hospital, followed by a role imaging in the ultrasound and electrophysiology department where she was the first woman hired. In 1990, Affel was promoted to lead the department and in 2008, she became the first ever Director of the Diagnostic Testing Center. Affel has also spent the last ten years certifying physicians and imagers for clinical trials with Annesley Eye Brain Center. She joined Phoenix in 2017 as Global Clinical trainer, working with clinicians and ophthalmic imagers around the world. Affel joined OPS in 2000 and was elected to the OPS Board of Directors in 2012. Her storied career includes awards from JCAHPO and Wills Eye Hospital. She also serves as a committee member for the Center for Academic and Global Ophthalmology, and Board positions with the Philadelphia Regional Ophthalmic Society and the Ophthalmic Medical Technology Program with Camden County College.
The Ophthalmic Photographers' Society has been the premier society for ophthalmic photographers for the past 50 years. The organization's main focus is to educate and certify ophthalmic photographers, ensuring imagers are taking routine, standardized images for ophthalmologists to successfully screen patients for various eye diseases. OPS convenes two meetings per year with various lectures, certification trainings, "crash-courses" for novices and professional development to the ophthalmic imaging community. Upon being elected president Affel notes "I have loved being a part of the OPS Board these past eight years and appreciate how it has helped make me a better imager and a better trainer for Phoenix. It is fulfilling to serve as a mentor and to help pave the way for the next generation of photographers."
Affel's fellow global clinical trainer at Phoenix, Denise Armiger, was recently elected to serve on the OPS Board of Education for a four-year term. This arm of OPS, composed of eleven members, functions specifically to set the education standards for the organization, as well as to plan and produce the curricula for the annual program, regional and mid-year programs and coordinate the increasingly crucial online education modules. Armiger's focus for her term will include creating technical summary documents for CME credits and serving as a mentor for ophthalmic imagers.
Armiger joined Phoenix last year from Leica Microsystems (formerly Bioptigen), where she managed global clinical training and product marketing and trained on the first Intraoperative OCT in the operating room. Prior to that, she was a Senior Applications Specialist with Heidelberg Engineering, where she installed equipment onsite, and trained in clinical and research imaging. Earlier in her career, Armiger held roles as the Director of Diagnostic Imaging at Columbia University and ophthalmic photography with Emory University. Her past work with OPS includes multiple lectures on OCT, Fluorescein Angiography, rare eye diseases and most recently, she built content and training programs for the Phoenix team to present and train virtually during the COVID-19 pandemic. Armiger was also recently named to the Board of Directors for the nonprofit Foundation Fighting Blindness which focuses on research and public health education programs concerning inherited blinding eye diseases.
"We are so thrilled for Libba and Denise and gratified that OPS has recognized not only their expertise but also their tireless dedication helping fight blindness," says Scott Carr, CEO of Phoenix. "For both Libba and Denise, ophthalmic imaging and training is not merely a vocation. It's a passion. They show their commitment everyday training imagers and photographers globally to use Phoenix ICON imaging systems while continuing to pay it forward by helping to attract more talented imagers into the profession."
About Ophthalmic Photographers' Society: (OPS) is the premier educational and training resource for ophthalmic imaging in the medical profession, including photographers, physicians, optometrists, ophthalmic technical personnel, and scientists. The OPS is the only organization providing certification in the fields of fundus photography, fluorescein angiography and OCT imaging and is open to anyone having an interest in any aspect of photography/imaging of the eye and ophthalmology. With members from 27 countries, OPS is the oldest established society in the world dedicated to ophthalmic imaging. Imaging technology continues to evolve at a rapid pace; the OPS sponsors regional, national, international and online educational programs that provide the most comprehensive and diverse training for ophthalmic technical personnel. A hallmark of the society is its emphasis on education, certification and mentoring – imagers learning skills from other imagers. Networking with other imaging professionals facilitates new insights and career development. http://www.opsweb.org
About Phoenix Technology Group: Phoenix Technology Group empowers people to see: we empower researchers to see more in their fight to prevent blindness; we empower clinicians to see more in their fight to save sight. We do that by providing clinicians and researchers around the world with stunning retinal images, coupled with timely and accurate data about the retina and the eye. Founded by Bert Massie, Ph.D., inventor of the first digital camera for pediatric retinal imaging, our company created the Phoenix MICRON platform for in-vivo imaging of animals in eye research. Phoenix MICRON is the standard of excellence for researchers worldwide: ten of the top twelve research institutions employ a Phoenix MICRON solution. In 2017, the company launched the Phoenix ICON platform which reinvented wide-field retinal imaging for human clinical applications. In 2020, Phoenix launched the Phoenix ICON GO portable imaging system, enabling clinicians and ophthalmic imagers the ability to take the camera system to the patient, while delivering the same stunning high-contrast, high-resolution images as the cart-based system. Recognizing that telemedicine is the future of ROP screening, in 2018, Phoenix acquired FocusROP and relaunched it as Phoenix CONNECT, the most widely adopted telemedicine platform for ROP screening. With this acquisition, retinal images from any wide-field retinal imaging camera can, in seconds, be delivered to physicians remotely, saving them time while providing better documentation.

We are so thrilled ...and gratified that OPS has recognized not only their expertise but also their tireless dedication helping fight blindness.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Farlong offers both consumer products and a white label professional line for licensed practitioners and dietary supplement brand owners

WALNUT, CALIF. (PRWEB) NOVEMBER 18, 2020
Farlong Pharmaceutical, a vertically integrated, plant-based ingredient and supplement company, is offering formulas and ingredients to relieve seasonal influenza-related symptoms including a sore throat, cough and fever amongst others. These products include Lung Booster 1 (Ling Dan Cao Granules), Revitalize Immunity Boost (Nan Ban Lan Gen Granules), Rescue Respiratory Relief (Ping Chuan Granules) and Renew Lung Support (Qing Wen Xuan Fei Granules). These formulas have been used in clinics across the U.S. such as Acupuncture Corporation of America (ACA)'s franchised clinics, and are widely favored by both practitioners and patients.
"This winter, both consumers and practitioners are looking for natural ways to boost their immune systems and remain healthy," Jing Struve, CEO and executive director of Farlong Pharmaceutical. "Traditional Chinese medicine (TCM) has been in practice for thousands of years, and we are proud to provide top quality ingredients that are recognized for their effectiveness to help relieve the symptoms of numerous ailments."
Due to the Coronavirus pandemic and increased demand, Farlong introduced Lung Booster 1, a dietary supplement, earlier this year. Lung Booster 1 is derived from Ling Dan Cao Granules and is used to protect the throat, lung and respiratory tract system, which in turn can help to relieve influenza symptoms. It helps to relieve a sore throat within hours when mixed in warm water and sipped slowly. The granules are developed from the whole plant extract from Chou Ling Dan Cao that is geologically unique to Yunnan Province, a region known for harvesting herbs used in TCM. For more than 500 years, Chou Ling Dan Cao has been used to cool the body's internal temperature, detoxify and soothe the throat, clear lung-heat and resolve phlegm. Lingdancao was recently named by Guangzhou Medical University, Yunnan University of Traditional Chinese Medicine, and Yunnan Health Department Health Supervision Bureau as one of the recommended natural herbs for relieving symptoms of COVID-19.
Revitalize Immunity Boost, Rescue Respiratory Relief and Renew Lung Support are available through Farlong's professional line for TCM practitioners, acupuncturists or dietary supplement brand owners to white label. Especially during influenza season, individuals can strengthen their immune system with Revitalize Immunity Boost, made from Nan Ban Lan Gen Granules which are used for clearing internal heat, cooling blood, supporting the health of the throat and lung, and rebuilding the body's natural balance. The formula is made of Baphicacanthus cusia extract (Ban Lan Gen) and Isatis indigotica extract (Da Qing Ye). Rescue Respiratory Relief contains Ping Chuan Granules which help to relieve asthma related coughs, throat and lung infections, dissolve phlegm, and strengthen the immune system. The formula is made of Rhododendron dauricum extract (Man Shan Hong), Platycodon grandiflorum extract (Jie Gen), and Glyeyrrhiza uralensis extract (Zhi Gan Cao). Renew Lung Support is formulated using Qing Wen Xuan Fei Granules, which are popular among practitioners due to its immediate effectiveness to suppress influenza symptoms, such as sore throat, phlegm, and fever related body aches.
For more than 20 years, Farlong has created natural and herbal supplements to promote a healthy and natural life, focusing on top quality ingredients and ancient Chinese roots. Farlong produces Ginseng Plus Panax Notoginseng, Lifeflower breviscapine and AstaBest Astaxanthin from seed to shelf, beginning at their GAP certified farms located in Yunnan Province, China. The geographical area of the farm's location is known for harvesting specific medicinal Chinese herbs, proven to benefit the health and improvement for a variety of health conditions. Farlong combines traditional processing methods with the most advanced techniques, ensuring that all decoction ingredients are transferred to full-spectrum concentrated ingredients while achieving greater levels of quality, stability and effectiveness.
About Farlong Pharmaceutical:
Since 1998, Farlong Pharmaceutical combined ancient Oriental medicine and modern technology to create a line of natural and safe products that promote a healthy life. Farlong is a vertically integrated herbal ingredient and supplement company with its own GAP (Good Agricultural Practice) certified cultivation base, cGMP (Current Good Manufacturing Practice), certified manufacturing facilities and distribution channels for its unique and effective ingredients and formulas, including InnerPure for colon detoxing, Lifeflower breviscapine for cognitive health, Ginseng Plus Panax Notoginseng for heart health and AstaBest Astaxanthin for antioxidant nutrition. For more information, visit Farlong.com for supplements and 300+ ingredients, and follow on Facebook, Twitter and Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Black Book surveyed thousands of healthcare organizations and coding professionals to determine the top-performing vendors in outsourced medical coding services. Aviacode earned a top 5 ranking in its 2020 survey.

SALT LAKE CITY (PRWEB) NOVEMBER 18, 2020
Black Book surveyed 3,144 medical practices, hospitals and healthcare organizations, including 1,908 coding professionals, to determine the top-performing vendors in outsourced medical coding services. Aviacode earned a top 5 ranking in its 2020 survey.
"We are extremely proud that healthcare providers and coding professionals placed such high confidence in Aviacode," said Keith Hagen, Board Chairman and Chief Executive Officer. "We strive every day to deliver a high quality and high customer service coding experience for our providers."
Black Book conducts polls and surveys with healthcare executives and front-line users about their current technology and services partners and awards top-performing vendors based on the performance on 18 qualitative indicators of client experience, loyalty and customer satisfaction, among other critical KPIs.
"The latest wave of COVID-19 challenges accompanying the progressive shift to value-based care finds most providers navigating through empowering virtual health, initiating highly positive patient experiences, and sinking margins," said Black Book's President Doug Brown in its news release.
Black Book's 2020 coding and health information management solutions survey results can be viewed at https://blackbookmarketresearch.com/coding-health-information-management.
About Aviacode
Aviacode has been delivering superior medical coding and compliance services to large-scale healthcare systems, individual hospitals, physician groups, surgery centers, imaging centers and payers for over 20 years. Our certified coders are experienced in facility, pro-fee, and risk adjustment coding for a wide range of specialties. Using innovative technology, our proprietary workflow helps improve coding quality, reduce risk, accelerate the revenue cycle, and optimize reimbursements. At Aviacode, our goal is to find a better way — building medical coding solutions that maximize revenue efficiency, strengthen cash flow, improve coding accuracy, and enforce coding standards. For more information, visit https://www.aviacode.com or call 855.438.2634.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

To expand patient care and access to advanced breast reconstruction techniques, PRMA Plastic Surgery is excited to welcome board-certified plastic surgeon Dr. Andrew Gassman to the team!

SAN ANTONIO, TEXAS (PRWEB) NOVEMBER 18, 2020
PRMA Plastic Surgery | Center for Advanced Breast Reconstruction opened its doors to serve the local San Antonio, Texas breast cancer community over 25 years ago. Since the practice welcomed its first patient in 1994, PRMA has grown to be one of the leading breast reconstruction centers in the world.
To expand patient care, PRMA is excited to welcome Dr. Andrew Gassman to the team!
Dr. Gassman is a board-certified plastic surgeon and breast reconstruction surgeon with extensive experience in autologous reconstruction options like the DIEP flap.
To date, PRMA has performed over 10,000 state of the art breast reconstruction procedures on patients following a mastectomy or lumpectomy. The practice continues to welcome patients from across Texas and around the world!
Dr. Gassman says he is "honored to join a practice dedicated to serving patients with a mission of rebuilding lives after breast cancer."
Dr. Gassman earned his medical degree from Loyola University Stritch School of Medicine in Maywood, Illinois. He completed his plastic and reconstructive surgery residency at UCLA David Geffen School of Medicine in Los Angeles, California and a general surgery residency, as Chief of Surgical Resident Education, at Loyola University Medical Center in Maywood Illinois. Following his residency, Dr. Gassman completed his fellowship in breast and reconstructive microsurgery, with a subspecialty in facial reanimation at UTSW Department of Plastic and Reconstructive Surgery in Dallas, Texas.
An active researcher with a number of publications, book chapters and abstracts, Dr. Gassman's clinical research interests include pain reduction after breast reconstruction, enhanced patient recovery after reconstruction, and multi free flap breast reconstruction and perforator free flap reconstruction. Dr. Gassman's also has a passion for teaching and has spent many years as an associate professor teaching future plastic surgeons advanced breast reconstruction techniques.
His specialized training led him to PRMA where he joins plastic surgeons Peter Ledoux, Steven Pisano, Chet Nastala, Minas Chrysopoulo, Gary Arishita, Oscar Ochoa, and Ramon Garza III performing the latest microsurgical breast reconstruction techniques and lymphedema surgery.
Dr. Gassman is available for appointments starting in January of 2021 at PRMA's Medical Center office located at 9635 Huebner Road, San Antonio, TX 78240. To schedule call 800-692-5565



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Helixmith announced today enrollment of the first patient in a second Phase 3 clinical trial targeting diabetic peripheral neuropathy (DPN), REGAiN-1A, using Helixmith's flagship gene therapy product Engensis (VM202). REGAiN-1A has an initial target enrollment of 152 DPN patients at approximately 15 clinical sites across the US.

SAN DIEGO (PRWEB) NOVEMBER 18, 2020
"Patients with DPN experience high levels of pain and discomfort, with no medicine available that treats the underlying disease," says Miguel Trevino, MD, Medical Director, Innovative Research of West Florida. "REGAiN-1A will inform the ongoing clinical efforts to develop a new potentially regenerative medicine therapy."
DPN is one of the most common complications of diabetes. Of approximately 30 million US adults with diabetes, up to 50% may develop DPN, and disabling neuropathic pain (painful DPN or PDPN) may affect approximately 25% of patients with diabetes (Shillo et al., 2019) . Painful DPN typically manifests as burning or stabbing pain in the lower extremities. Currently approved medications for PDPN are palliative, limited to managing existing pain, and have the potential for serious side effects.
The primary efficacy endpoint for the REGAiN-1A trial compares the change in average daily pain scores from the 7 days prior to the first injection on Day 0 to the 7 days prior to the six-month visit in participants treated with Engensis versus placebo. Secondary endpoints include the statistical significance of (1) reduction in worst pain at the end of a six-month period versus placebo, (2) the ratio of patients with an average pain reduction of 50% or more at the end of the six-month period versus placebo, and (3) safety of Engensis versus placebo.
"Engensis represents a truly novel approach to treating neuromuscular diseases, including DPN," notes Dr. Sunyoung Kim, CEO and Head of Global Clinical Development at Helixmith. "This latest clinical study will add to the considerable body of knowledge and evidence we've gathered to support the optimal use of Engensis in patients needing treatment options. "
Patients and clinical investigators seeking more information about the REGAiN-1A Phase 3 Clinical Trial can visit
https://www.clinicaltrials.gov/ct2/show/NCT04469270?term=NCT04469270&draw=2&rank=1
About Engensis
Helixmith's Engensis (VM202) is a gene therapy based on plasmid DNA. To date, more than 500 patients have been treated with Engensis across ten clinical trials in six different diseases and conditions. Data from previous clinical studies suggest that Engensis is well tolerated and has the potential to provide durable analgesic and/or symptomatic relief in a variety of disease settings. Beyond potentially alleviating pain, Engensis is designed to target the underlying causes of neuropathy through its predicted angiogenic and neuroregenerative properties. The US FDA recognized the potential for Engensis to meet the unmet need for this condition in 2018 by designating it as a Regenerative Medicine Advanced Therapy (RMAT), making it the first RMAT-designated gene therapy for a prevalent disease with over one million patients. This designation grants all the benefits afforded by the fast track and breakthrough designations, including priority review, to Engensis.
About Helixmith
Helixmith is a gene therapy company headquartered in Seoul, Korea, developing new and innovative biopharmaceuticals to tackle previously untreated diseases, and is listed on KOSDAQ. The company has an extensive gene therapy pipeline, including a CAR-T program targeting several different types of solid tumors and an AAV vector program targeting neuromuscular diseases. Engensis (VM202), the most advanced pipeline candidate, is a plasmid DNA therapy being studied for DPN, diabetic foot ulcers, claudication, amyotrophic lateral sclerosis (Phase 2 beginning in late 2020), coronary artery disease and Charcot-Marie-Tooth disease.
Helixmith clinical development and manufacturing activities are based in San Diego, California, where the company co-owns a cGMP-ready DNA production facility, Genopis, Inc., an affiliated CDMO also in San Diego. Genopis serves both Helixmith and external customers in need of plasmid DNA for medical purposes.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Family Practice Center in Atlanta continues to expand in an effort to provide top-rate medical services to more patients in the metro Atlanta area.

ATLANTA (PRWEB) NOVEMBER 18, 2020
Family Practice Center, PC, one of the metro Atlanta area's leading healthcare providers, is excited to announce the opening of their newest location in Alpharetta. The Alpharetta office is located at 3400 Old Milton Parkway, Suite A-510, Alpharetta, GA 30005. Their doors officially open on Monday, December 21st, 2020. This comes on the heels of recently expanding their flagship office in Sandy Springs and adding multiple new healthcare providers over the last year.
The new Alpharetta office will feature the same top-quality medical care for patients of all ages that has made Family Practice Center one of the highest rated family medicine practices in the Southeast. This new practice location will serve as the home of award-winning healthcare provider, Dr. Leah Tobin. Additionally, Dr. Steven Schramm and Dr. Tyler Wheeler will also be taking appointments there on selected days. They will be aided by a full team of skilled, experienced physician assistants, nurse practitioners, medical assistants, and other healthcare professionals.
In addition to a wide variety of healthcare services including full-service primary care, women's health services, and preventive medicine, Family Practice Center will be offering on-site diagnostic testing. This includes ultrasound and X-ray technology. The new, easy to find location will also offer free parking as an additional bonus for patients.
"This is an incredibly exciting moment for our entire team," says Family Practice Center founder and lead physician, Dr. James Wheeler. "The northern suburbs are growing and so are we. This new location will allow us to service our patients who live up the 400 North corridor and share our personal brand of expert, patient-focused medical care with more people than ever before."
About Family Practice Center
Founded in 1979, Family Practice Center is a comprehensive medical practice offering a wide variety of healthcare services to patients in the metro Atlanta area. In addition to internal family medicine, the experienced healthcare providers at Family Practice Center perform women's health services, dermatology treatments, sports medicine, and preventive medicine. Family Practice Center is able to provide in-house diagnostic testing including X-rays, blood work, ultrasounds, echocardiograms, and more in their office. In an effort to provide each patient they see with the courtesy, care, and comfort they deserve, Family Practice Center offers additional services including telemedicine visits with eVisit, waiting room concierge service, and more. This is why the team at Family Practice Center is among the highest-rated in the entire Southeast.
To learn more about Family Practice Center or to schedule an appointment, visit https://familypracticecenterpc.com or contact their office by phone at (404) 256-1727.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This in-depth guide covers the gamut of considerations for medical device companies to connect their device to the cloud.

HOUSTON (PRWEB) NOVEMBER 18, 2020
Galen Data Inc., announces the release of a 28-page whitepaper entitled "The Definitive Guide to Medical Device Connectivity," which offers in-depth guidance on device-to-cloud connectivity for medical device companies. The guide is co-authored by a team of leading experts in medical device design and development, who have a combined 50+ years of experience in healthcare technology, medical devices, and regulatory compliance.
Cloud computing technologies have transformed countless industries. Over the last six years, there has been an ever-growing number of companies developing medical devices with a cloud dependence. Safely connecting devices to the cloud can be an incredibly time-consuming process and poses critical regulatory and financial risks. Knowing these risks and mitigation strategies early in the development process is critical to commercial success.
This comprehensive whitepaper provides guidance across a range of connectivity considerations, and answers the following questions:

Why should I connect a medical device to the cloud?

How is cloud computing and IoT (the Internet of Things) technology set to disrupt healthcare?

What are the steps needed to prepare for medical device connectivity?

What are the regulatory, cybersecurity, and privacy implications for a medical device?

What can I expect when building cloud connectivity in-house as compared to leveraging a third-party platform?

"This whitepaper was written for anyone interested in medical device connectivity, but especially for founders and executives of medical device companies who are considering cloud connectivity for their devices," said Chris DuPont, co-author, and CEO and cofounder of Galen Data. "Cloud-enabled healthcare innovation is poised to help millions across a range of conditions. Understanding the realistic costs and risks associated with medical device cloud connectivity is critical (and often overlooked) in the early stages of development."
The newly released whitepaper clarifies device connectivity needs, including hardware and software considerations, regulatory, security, and privacy issues, and more. Armed with this knowledge medical device innovators can confidently make decisions about connecting their medical devices to the cloud.
About Galen Data:
Galen Data, Inc. provides a turnkey cloud solution for medical device makers that is configurable, secure, and compliant. The company was founded to make device-to-cloud connectivity possible in a matter of weeks instead of months, and at a fraction of the cost. The Galen Cloud collects and securely stores data, and includes tools to visualize and analyze that data. Dashboards and alerts for the manufacturer, medical team, and patients are also provided within the platform. The Galen Cloud is compliant with FDA, HIPAA, and CE Mark standards, and is ISO 13485:2016 certified. Dozens of companies have partnered with Galen Data to solve their medical device connectivity needs.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

To support a growing customer base, the company is also expanding its wig line to include seven new styles and a new color option.

BOSTON (PRWEB) NOVEMBER 18, 2020
Coils to Locs, a supplier of coily, curly synthetic wig styles, today announced the expansion of the company into Houston, Texas, bringing their wig line to Canopy at Memorial Hermann The Woodlands Medical Center. Canopy is a first-of-its-kind survivorship center and a place where cancer patients, survivors and their families can come for free support, resources, and programs. Building on this momentum, the company also introduced seven new wig styles available in medium auburn or golden copper ombre color options. The company, founded by sisters Dianne Austin and Pamela Shaddock after Dianne's personal experience with cancer, was created to address a health care disparity that has traditionally been overlooked - until now.
"We are honored and excited to be able to offer Coils to Locs wigs to our guests here at Canopy. It is so important that we are representative of all of the women who come to us looking for a safe haven. Cancer is hard enough – you should be able to find a wig that is true to who you are and makes you feel beautiful and empowered. It is important to us that every patient feels seen and valued," said Amanda Poole, Canopy Manager.
"I know all too well the struggles that Black women experiencing medical hair loss face," said Dianne Austin, CEO and Co-Founder of Coils to Locs. "When I was losing my hair during my cancer battle, my first thoughts were how ironic it was that I went down this path of embracing my natural hair just to lose every strand of it. I was unable to find wigs in my natural coily, curly style that were both fit for someone with hair loss and available through my insurance. Coils to Locs was founded to empower women everywhere to maintain their unique personal style while experiencing medical hair loss. All women, regardless of hair type, should be able to walk into a cancer center boutique or medical salon and find something that looks like the hair that grows out of their heads. Our expansion into a new market means the demand for these wigs is universal and we're so excited to bring these wigs to new guests at the Canopy at Memorial Hermann The Woodlands."
Based on their own market research, Coils to Locs is the only medical wig company offering coily, curly styles for women to be sold within cancer center boutiques and available through insurance. One of the main differences between a medical wig and traditional wig is that a traditional wig cap uses combs to attach to the wearer's head – something that is not feasible for medical wigs when most wearers do not have any hair. Because medical hair loss often causes a sensitive scalp, patients don't want a comb scratching their head - medical wigs are made of a softer, more comfortable material without any combs. Coils to Locs has a deeply personal understanding of the needs of their target customer and, because of this, have been sought after by numerous Cancer Centers and Boutiques.
"We were so happy to find a line that was so realistic looking," said Patricia A. Wrixon, owner and founder of the Salon at 10 Newbury, Boston. "These high quality wigs are easy to style, durable and are of good quality. In addition to carrying these coily-curly wigs at the salon, donors can purchase the wigs and gift them to Wigs for Wellbeing, our non-profit fund for cancer patients who do not have the means or insurance to purchase these natural textured wig styles."
In addition to expanding to a new market, Coils to Locs also announced several new wig styles including a "faux locs" style and wigs in a variety of lengths from fashion-forward short tailored styles, to trendy long coily, curls. The company is also piloting a hat with hair sewn in that can be worn as an alternative to a full wig.
For more information about each product Coils to Locs offers, and to find your nearest cancer center boutique, visit coilstolocs.com.
About Coils to Locs
Coils to Locs is on a mission to provide access to a variety of ethnically inspired wigs that can be purchased through healthcare reimbursement at cancer center hospitals. Coils to Locs is a supplier of coily, curly synthetic wig styles for Black women (or any woman with textured hair) experiencing hair loss due to a medical diagnosis. The company is addressing a healthcare disparity for cancer patients of color who lack access to high-quality coily, curly textured wigs covered by health insurance through a medical prescription. The business is a family affair; founded by Dianne Austin and her sister and co-founder, Pamela Shaddock, Coils to Locs is also supported by their cousin Cheryl McCloud, VP of Communications & Business Development.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Santa Clarita based Santa Clarita Valley Dental Care comments on a recent article that patients should be mindful of any jaw clenching habits to avoid breaking or chipping their teeth.

SANTA CLARITA, CALIF. (PRWEB) NOVEMBER 18, 2020
A September 29 article on CNN reports on the unusual number of broken teeth dentists are treating lately during the COVID-19 pandemic. While the article points out that there is no evidence to suggest that coronavirus directly weakens teeth, there is a consensus among the dental and medical communities that the virus has put many people on edge, worsening all kinds of health conditions. This collective stress may have contributed to a rise in bruxism, or involuntary jaw clenching and grinding, which is the likely culprit in the increased rate of broken teeth. Santa Clarita Valley Dental Care says that, as a general dentist office, it can't treat the underlying psychological conditions that may be causing broken teeth, but it can help those who find themselves suffering stress-related dental issues.
Santa Clarita Valley Dental Care says patients should, of course, try and be mindful of their jaw clenching or tooth grinding habits. Taking a few moments out of every day to relax and get away from the stress of the pandemic can ease many problems, the dental center notes. The oral health care group says that patients who have already broken a tooth have outstanding options open to them. It adds that, while it can be fairly traumatic and painful to experience such an injury, the vast majority of cases are easily treatable with dental crowns or other prosthetics.
The most important thing for patients to remember, the center says, is that it is always crucial to promptly seek dental assistance in cases such as these, as delaying treatment will only exacerbate the problem. Santa Clarita Valley Dental Care notes that infection and tooth decay are far more likely in broken teeth as the more vulnerable inner portions of the tooth typically become exposed. Waiting too long for help can result in increased treatment costs, pain, and time off from work.
The Santa Clarita dental office says that in addition to being mindful of the pressure patients are putting on their teeth, they can reduce the chances of a break by practicing good dental hygiene. The dental center notes that, while the connection may not be abundantly clear at first, it adds that a strong dental hygiene routine can limit or prevent the development of harmful conditions such as gum disease, which is known to weaken both the soft and hard tissues of a patient's mouth. Santa Clarita Valley Dental Care says that if a healthy mouth is even slightly beneficial in reducing the chances of a break, great dental hygiene—which offers many great benefits in itself—is worth it.
Readers can learn more about Santa Clarita Valley Dental Care by visiting their website at https://scvdentalcare.com/ or by calling (661) 259-9674.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Christie CounterAct uses Ushio's patented narrowband filtered Care222 excimer lamps that emit far-UVC 222nm light - the only UV technology shown to continuously and significantly reduce pathogens, like coronaviruses, that may also be used while people are present...

CYPRESS, CALIF. (PRWEB) NOVEMBER 18, 2020
Christie is pleased to announce the launch of the Christie CounterAct line of commercial UV disinfection products with patented Care222 far-UVC light technology for cinemas, theme parks, museums, sports complexes and other indoor spaces. Unlike comparable products, the Christie fixture uses Ushio's patented narrowband filtered Care222 excimer lamps that emit far-UVC 222nm light - the only UV technology shown to continuously and significantly reduce pathogens, like coronaviruses, that may also be used while people are present, when used in accordance with specified parameters. Mass production of the new Christie CounterAct fixture starts in January 2021.
Developed by Christie's parent company, Ushio Inc., using IP licensed from Columbia University based on research by Columbia University's Center for Radiological Research, the revolutionary Care222 far-UVC, mercury-free excimer lamp—highlighted in FORTUNE magazine's annual Change the World list1 in 2020, includes a proprietary short pass filter that prevents the emission of longer wavelengths of UV light (230nm and higher) that are capable of penetrating human skin and eyes, an especially important feature that other 222nm and far-UVC products do not have.
Christie CounterAct introduces an added layer of defense against pathogens in indoor venues when guests and staff are present
Christie CounterAct is a line of fixtures that are simple to control remotely and can be installed on ceilings as easily as a commercial lighting fixture. It is well suited for use across a wide range of occupied, commercial areas such as entertainment venues, including lobbies, auditoriums, and restrooms, as well as other indoor spaces. Our first Christie CounterAct fixture contains two Care222 excimer far-UVC lamps that significantly reduce pathogens on surfaces of any indoor space. The fixture, with fast instant on/off at full output power and its Care222 technology lamps, has been shown effective at reducing pathogens in laboratory tests2. And unlike other UV technology, these fixtures with patented Care222 lamps may be used when people are present.
The background on UV light
It has been known for many years that UV light is a highly effective disinfectant that can reduce pathogens in indoor spaces. Businesses and other institutions have long used germicidal UVC light to stop the spread of viruses. The main drawback with most UVC technology is that it uses a 254nm wavelength that can penetrate human skin and eyes, which means these germicidal lights can only be used when people are not present or while they're wearing personal protective equipment (PPE) that protects the eyes and skin. These shortcomings constrain how these devices must be operated and limit their widespread use in occupied indoor spaces.
A study3 conducted by Kobe University published in August 2020 concludes that, due to its shorter wavelength, far-UVC 222nm light does not penetrate the skin and therefore may be used when humans are present. Another recent study4 published in the American Journal of Infection Control shows that far-UVC 222nm light can effectively reduce more than 99.7% of surface contamination of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
Researchers at Columbia University have also tested far-UVC 222nm light, and in particular its effect on aerosolized seasonal coronaviruses (that cause the common cold). A scientific paper published by this group in the Scientific Reports5 in June 2020 found that 99.9% of aerosolized seasonal coronaviruses (the cause of the common cold) were inactivated when exposed to far-UVC 222nm light in just 25 minutes.
These studies' findings suggest that the filtered 222nm far-UVC light emitted by Care222 lamps in Christie's CounterAct fixture, which can operate continuously even when people are present, offers a significant improvement over traditional manual cleaning alone, which requires professional cleaners, and the repeated use of harsh chemicals, in which the results are temporary.
Zoran Veselic, president and COO, Christie, added: "People are essential to the entertainment industry, and their level of comfort in public venues is paramount to the industry's success. We are very proud to be able to offer this product with Ushio's Care222 technology to our partners, and we are excited about the possibilities the technology will have in bringing customers back to the places they love, such as movie theaters and theme parks. The fact that far-UVC light – specifically, our new Christie CounterAct far-UVC fixture – can be used in the presence of people is a real differentiating factor. By harnessing these benefits as part of a user-friendly product that can be quickly deployed, we hope to provide a much-needed boost to our partners across the entertainment industry who are currently struggling to attract wary customers."
For more information visit Christie's CounterAct website.
1.FORTUNE Magazine's Change the World highlights Ushio's achievements in developing Care222 filtered Far UV-C disinfection modules, and the research conducted in collaboration with Japan's Kobe University and Columbia University. Represented at number 40, Ushio stands alongside other companies that demonstrate measurable social impact and innovations within their industries by pioneering new technology or services.
2.The pathogen-reducing efficacy of Christie CounterAct products with patented Care222 technology and their use in occupied spaces is dependent on proper installation and operational specifications, in accordance with theAmerican Conference of Governmental Institutional Hygienist (ACGIH) guidelines. Link to ACGIH
3. Fukui T, Niikura T, Oda T, Kumabe Y, Ohashi H, et al. (2020) Exploratory clinical trial on the safety and bactericidal effect of 222-nm ultraviolet C irradiation in healthy humans. PLOS ONE 15(: e0235948. Link to report
4. Kitigawa H, Nomura T, Nazmul T, Shigemoto N, Sakaguchi T, Ohge H, et al. (2020) Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination. American Journal of Infection Control. Link to report
5. Buonanno, M., Welch, D., Shuryak, I. et al. (2020) Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci Rep 10, 10285. Link to report
Notes:
Christie CounterAct products with patented Care222 technology are not for use on humans or animals or to disinfect medical devices.
The pathogen-reducing efficacy of Christie CounterAct products with patented Care222 technology and their use in occupied spaces is dependent on proper installation and operational specifications, in accordance with American Conference of Governmental Industrial Hygienists (ACGIH) guidelines
Any references to "disinfection" and "disinfecting" are referring generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency.
"Christie" is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In response to FDA's request for additional clinical trials evaluating elamipretide in individuals with Barth syndrome, BSF rallies the patient community in a global advocacy campaign.

BOSTON (PRWEB) NOVEMBER 18, 2020
Barth Syndrome Foundation (BSF) today announced a series of advocacy initiatives directed toward U.S. Food and Drug Administration (FDA) and Stealth BioTherapeutics requesting immediate access to the investigational drug elamipretide. Specifically, BSF and the Barth syndrome community are petitioning the drug developer to submit a new drug application (NDA) to FDA requesting approval of the investigational compound elamipretide in people with the ultra-rare and life-threatening disease Barth syndrome. "In the last 13 months alone, seven people with Barth syndrome in our community have died," says Emily Milligan, BSF Executive Director. "This represents nearly 3% of our worldwide living population. Every person with Barth syndrome deserves a chance."
People with Barth syndrome who were enrolled in the elamipretide clinical trial and open-label extension period over the last three years showed positive changes in functional assessments such as fatigue, muscle strength, and endurance as well as improvements in some cardiac measures. One participant in the clinical trial stated that "I HAD Barth syndrome as I don't live with the symptoms of Barth syndrome anymore." Another described the benefit he experienced as life-changing; "I have energy to live now. I feel as if I had never understood before what it meant to live."
Given the life-threatening nature of the disease and acceptable safety profile of elamipretide, the community is appealing to FDA to forgo the need for additional pre-approval studies and provide immediate access. "Considering the significant loss of life within our community and that there are no other FDA-approved treatment options, it is absolutely critical that the agency truly incorporate the patient voice in their decision-making process," said Milligan. "We are asking FDA and Stealth BioTherapeutics to hear our voice and work together to provide access to elamipretide to people with Barth syndrome as soon as possible."
Among BSF's efforts is a petition signed by over 4200 supporters, accompanied by more than 730 written testimonials. This petition calls for "Stealth and FDA to address this issue with urgency by submitting and approving an NDA for elamipretide in Barth syndrome based on existing evidence from clicnial trials." We also are aware that a letter from 26 Barth syndrome clinical specialists and key healthcare providers has been sent to the FDA advocating for the treatment. In part, the letter states "As physicians, we view the potential benefit afforded by elamipretide relative to the favorable safety profile exhibited to date as supporting a decision to make this drug immediately available to patients and prescribing physicians."
FDA has repeatedly signaled the importance of incorporating the patient voice in drug development, including passage of the 21st Century Cures Act. This act requires sponsors to include, and FDA to consider, the patient perspective. Consequently, BSF has been actively engaging with FDA to raise awareness of the patient perspective in Barth syndrome in conjunction with the development of elamipretide over the last three years. Activities by BSF have included coordination of an externally led patient-focused drug development meeting in 2018, publication of the subsequent The Voice of the Patient: Barth Syndrome report and additional listening sessions with the community in 2019. Ongoing efforts in 2020 ensure that community members are informed, educated and have ample opportunity to share their experiences on living with Barth syndrome and their perspectives on risk-benefit considerations for potential therapies.
Disclosure: BSF has received sponsorship support for advocacy, clinical education and family-centered support programs from Stealth BioTherapeutics.
ABOUT BARTH SYNDROME FOUNDATION (BSF)
Barth Syndrome Foundation (barthsyndrome.org) is the only global network of families, healthcare providers, and researchers solely driven by the mission to save lives through education, advances in treatment and finding a cure for Barth syndrome. BSF has funded nearly $5.6M USD since 2002 and catalyzed over $31.7M USD in funding from other agencies to advance global scientific discoveries to end the suffering and loss of life from Barth syndrome. Additionally, BSF provides a lifeline to families and individuals living with Barth syndrome around the world, offering individualized support, educational conferences, a robust patient registry and collaborations with specialist healthcare providers to define standards of care, treatment and rapid diagnosis.
ABOUT BARTH SYNDROME
Barth syndrome is a rare, life-threatening, genetic mitochondrial disorder primarily affecting males. Affected individuals may suffer from heart failure, muscle weakness, and infection (caused by neutropenia). Additional characteristics of the syndrome commonly include growth delay, impaired lipid metabolism, extreme fatigue and cardiolipin deficiency. In some individuals affected by Barth syndrome, the symptoms can be very severe, resulting in heart transplantation, potentially lethal infections, and death.

"Considering the significant loss of life within our community and that there are no other FDA-approved treatment options, it is absolutely critical that the agency truly incorporate the patient voice in their decision-making process."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Body Experts from Miami, Careaga Plastic Surgery, continues partnership with Haute Beauty Network, now in their fourth year.

CORAL GABLES, FLA. (PRWEB) NOVEMBER 18, 2020
DANIEL CAREAGA, M.D.
DOUBLE BOARD CERTIFIED PLASTIC SURGEON
Dr. Daniel Careaga is an award-winning plastic surgeon who specializes in a range of body, face, and breast procedures. By utilizing his extensive experience in all these fields, Dr. Careaga has gained a reputation for being a meticulous plastic surgeon with a powerful practice: Careaga Plastic Surgery.
Dr. Careaga holds a rare double board certification in plastic surgery. With the experience of over 8,000 successful operations performed, Dr. Careaga knows beauty and what his patients want.
"I don't believe in cookie-cutter surgery. Each patient has a different body and face style and different goals in mind. By actively involving them in the process, I can consistently deliver the best possible result." -Daniel Careaga, M.D.
PAUL DURAND, M.D.
Dr. Paul D. Durand is a Cleveland Clinic-trained plastic and reconstructive surgeon specializing in procedures of the face and body. Born in Miami and raised in Peru, he obtained all his medical education and training in the United States. Dr. Durand has maintained close ties to his hometown of Lima, which inspired a passion for international mission work in South America, completing his seventh cleft surgery mission trip last year.
Dr. Durand completed a fellowship in Aesthetic Plastic Surgery at the Dallas Plastic Surgery Institute, considered the top program in the nation for cosmetic surgery. Since then, Dr. Durand has gained extensive recognition in both plastic and reconstructive surgery and has presented and published on numerous topics, including invitations to lecture and perform live surgical demonstrations in Latin America and Asia.
Dr. Durand is licensed to practice in the state of Florida, Texas, and Ohio.
REANA MYERS, MMS, PA-C
Reana Myers is a board-certified physician assistant specializing in aesthetic medicine. She was born in Tirana, Albania, and moved to the United States when she was young. After obtaining a master's degree in medical science from Nova Southeastern University in 2007, Reana started her career in cardiovascular medicine before transitioning into the field of plastic surgery. She has over 10 years of experience in the medical field. Reana's professional interests include injectables such as Botox and Dysport, as well as facial fillers such as Juvederm, Voluma, Restylane, Sculptra, Radiesse, etc. She is skilled and knowledgeable in various other non-surgical treatments such as CO2, fractional, IPL, SculpSure lasers, micro-needling, PRP, sclerotherapy, and weight loss. Reana is board certified by the National Commission on Certification of Physician Assistants and is licensed to practice and prescribe in the State of Florida.
"There is beauty in everyone. That is why my goal is to enhance your beauty naturally and safely."  – Reana Myers, PA-C, MMS
WHY CHOOSE CAREAGA PLASTIC SURGERY?
Careaga Plastic Surgery is a state-of-the-art facility that has gained a reputation for being a phenomenal plastic surgery and medspa practice that utilizes the latest and most innovative technology in the industry. This modern facility specializes in a variety of procedures such as breast augmentation, breast lift, body contouring, tummy tuck, and non-surgical procedures, making Careaga Plastic Surgery the best place to start your beauty journey.
Careaga Plastic Surgery, where safety meets luxury, holds the coveted Gold Seal from the Joint Commission (JCAHO). Dr. Careaga has been voted among the top five plastic surgeons in Florida by his patients and peers for five years in a row. Careaga Plastic Surgery is where patients go to be their own masterpiece!
Learn more about Careaga Plastic Surgery by visiting: https://hauteliving.com/hautebeauty/member/careaga-plastic-surgery/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Dr. Careaga has been voted among the top five plastic surgeons in Florida by his patients and peers for five years in a row.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Communicate safely and wirelessly with Mconnect a smart face mask designed for comfort, style and high-tech wearability.

LAS VEGAS (PRWEB) NOVEMBER 18, 2020
Wearing a face mask shouldn't be a hassle since it's now a part of everyday life. Staying safe, stylish and communicating clearly is possible all at once with the Mconnect face mask.
This patent-pending face mask is equipped with Bluetooth 5.0 technology for making phone calls, listening to music and facilitating clear conversations. The lightweight and comfortable fabric is baked in an antimicrobial solution to keep people protected from harmful pathogens. The innovative design paired with comfort and technology finally provides the option of wearing a 'smart face mask.'
Currently, masks are the most important and powerful public health tool. That's according to Robert Redfield, the Director of the Centers for Disease Control. Even with a COVID-19 vaccine, many health experts believe people will be wearing a mask well into 2021.
"The global pandemic has created enough havoc in people's day-to-day routine, now's not the time anyone should be forced to sacrifice health, comfort and the ability to communicate clearly," said Brock Flint, Founder of Mask Capacity.
Mconnect's patent-pending design prevents slipping, sliding or adjusting, and even prevents glasses from fogging up. The unique frame features gentle ear coverings for consumers to listen to their Bluetooth-connected device while still hearing the outside world and the mask lifts slightly off the mouth so users can speak clearly and be understood thanks to the built-in microphone.
The patent-pending Bluetooth feature also makes wearing a mask and staying connected easier than ever with a 45-foot wireless range. Plus, with a two hour charging time, Mconnect can get up to 12 hours of use and the battery offers 100 hours of standby time.
Mconnect is available to pre-order by visiting pr.go2.fund/Mconnect.
The Mconnect face mask helps people stay protected and connected. It's not a new normal, Mconnect is the next normal.
About Mask Capacity
Mask Capacity strives to invent products and solutions that help everyday people prepare for and navigate the next normal of the COVID-19 global pandemic. The team believes everyone needs to do their part to fight this and other future outbreaks. For more information, visit https://producthype.co/mconnect/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

RadSite, a leading accrediting organization promoting performance and quality-based imaging practices, recently launched the MIPPA Accreditation Program (MAP) Standards version 3.1, featuring more than a dozen specialty modules for advanced diagnostic imaging (ADI).

ANNAPOLIS, MD. (PRWEB) NOVEMBER 18, 2020
RadSite, a leading accrediting organization promoting performance and quality-based imaging practices, recently launched the MIPPA Accreditation Program (MAP) Standards version 3.1, featuring more than a dozen specialty modules for advanced diagnostic imaging (ADI).
RadSite's Standards Committee Chair, Eliot Siegel, MD, notes: "RadSite began working on the revised Standards late last year and worked closely with the RadSite Standards Committee members and other stakeholders, including payers and the U.S. Center for Medicare and Medicaid Services, to finalize the new specialty modules." He adds that "RadSite also made several important updates to its professional experience, clinical protocol, and physics requirements."
Currently, RadSite offers three MAP ADI accreditation programs covering CT, MRI, and Nuclear Medicine (i.e., PET, PET/CT and SPECT) imaging providers (also known as imaging suppliers). Successful RadSite applicants will continue to receive a general accreditation seal for each ADI modality, but also may apply and be recognized for one or more clinical subspecialty areas under MAP Standards version 3.1.
"RadSite's accreditation review requirements were augmented to allow imaging providers to apply for each specialty exam type," said Patrick Browning, MD, RadSite's Chief Medical Officer. "Additional imaging exams must be submitted, evaluated, and scored as part of the enhanced technical evaluation to qualify for a specialty certification. Further, the new Standards require applicants to demonstrate experience and proficiency for each specialty module." Dr. Browning also adds, "As part of the accreditation process, RadSite continues to invest time and energy to educate and share best practices with organizations that apply for accreditation."
The following specialty modules will be covered going forward:

CT: Angiography, Body, Cardiac, Maxillofacial, Musculoskeletal, and Neurologic;

MRI: Angiography, Body, Breast, Cardiac, Functional, Musculoskeletal, and Neurologic; and

NucMed: Planar/SPECT - Cardiac and PET or PET/CT – Cardiac, Infection, Neurologic, Oncology.

"RadSite is working with several applicants who have recently applied for one or more of the new specialty modules," notes Garry Carneal, JD, MA, RadSite's President and CEO. "RadSite recently updated its online accreditation portal to ensure a seamless and meaningful review process for new and reaccreditation applicants, who now must apply under MAP Standards v 3.1." RadSite's online accreditation directory will highlight the new imaging specialty designations for each accredited imaging provider."
Interested parties can download the new MAP Standards v 3.1 by clicking here. To register for a webinar discussing the new Standards, click here. To learn more about RadSite, visit http://www.radsitequality.com.
###
About RadSite (http://www.radsitequality.com)
Founded in 2005, RadSite's mission is to promote performance and quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite's programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With funding from the National Institutes of Health (NIH), the University of Maryland (UMD) is leading research that will leverage the conserved replication machinery across all enteroviruses to try to confer broad-spectrum protection against diseases from polio to the common cold in a single vaccine product.

COLLEGE PARK, MD. (PRWEB) NOVEMBER 18, 2020
With a new grant from the National Institutes of Health (NIH), the University of Maryland (UMD) is working to develop a novel approach to vaccination with the potential to provide broad-spectrum protection against hundreds of viruses in a single vaccine, from polio to the common cold. Enteroviruses are a diverse group of viruses creating a huge public health burden, including the poliovirus, rhinoviruses that are the major cause of the common cold, enterovirus 71 that causes hand-foot-and-mouth disease in children, and others that are associated with the development of diabetes like coxsackieviruses. But because of this diversity, only polio and enterovirus 71 have currently available vaccine products. By changing the way vaccines are developed, targeting the conserved replication proteins that are common among most enteroviruses instead of the structural proteins that are distinct to each of the hundreds of known enteroviruses, UMD's College of Agriculture and Natural Resources will explore the potential to confer protection against a broad spectrum of enteroviruses in a single vaccine product, with major implications for public health.
"All viruses are pretty much like a nut," explains George Belov, associate professor in Veterinary Medicine at UMD and lead investigator of this work. "You have the shell or husk, and then the material inside the husk. On the outside, the structural proteins look sufficiently different so that that immune response developed against one virus does not work against another. But inside, you have pretty much the same core of proteins the virus uses to replicate. The replication machinery of all of those viruses is very similar. So the central idea of this grant is to switch from making vaccines that target those individual outer shells to vaccines that target conserved replication proteins to potentially generate a vaccine product that could be protective against a much broader spectrum of enteroviruses."
The technology to achieve this goal has only recently become available with constructs that Belov and his team developed to redirect the immune response when encountering a new virus. "What you need to do is remove the input of the outer structural proteins and present the immune system with only the antigens that come from the conserved replication proteins," says Belov. "And we have a tool now to do this with constructs that don't express the structural proteins. We want to see if this will be protective and if that protection extends across a broader spectrum of enteroviruses."
This is a roughly $500K proof-of-concept grant that, if successful, could represent a shift in the way that vaccine products are produced and significantly reduce the burden of vaccination for a public that is increasingly concerned about the growing number of necessary vaccines.
"It's always a risk-benefit question, because the more vaccines you add, the chances of getting complications from a vaccine product are higher. The risk is very low as a whole, but there is no absolutely risk-free product, and there are always people that will respond differently. So if you can protect against multiple viruses in the same product, that is a very desirable thing."
With this initial funding in collaboration with Konstantin Chumakov at the Food and Drug Administration Office of Vaccines Research and Review, Belov and his team will be focusing on comparing this new vaccine approach to the existing vaccination products for poliovirus.
"You currently have three different serotypes of poliovirus with three vaccines, but the replication proteins are essentially the same," says Belov. "With this grant, we want to vaccinate with the construct we developed that expresses conserved proteins and see if the product will protect against those three different serotypes of polio compared to the current established vaccine products. We have good preliminary data that supports this idea, but the ultimate test is in how the animal immune system will respond. Further, we will test if it works against non-polio viruses. Enteroviruses are a very broad group of viruses, so broad protection is very valuable."
This problem is one that is common not just in enteroviruses, but across all forms of vaccine development. "If you want to develop a vaccine for COVID-19, for example, you currently have to make something that is specific to the structural proteins of COVID-19. But if you could make something that is effective across all types of coronaviruses by targeting the replication proteins, you could protect against a large spectrum of coronaviruses, the ones that we know of now and the ones that may come down the road as new virus threats."
Belov has been working with enteroviruses for more than 20 years and is interested in their functionality on a cellular level. "Vaccine development is very important, but enteroviruses are fascinating in terms of what they do with the cell. A cell with an enterovirus changes its metabolism completely in a matter of hours. It can completely overrun all cell control mechanisms, so the cell basically becomes a zombie that does nothing but produce copies of the virus. It's interesting for both the virologist and the cell biologist because the virus exposes the mechanisms that are difficult to observe in a noninfected cell. And that is my expertise - virus-cell interactions."
While this work has direct application in vaccine development, Belov stresses that it could not be achieved without basic fundamental research. "The most important thing in science is fundamental research because you are only as good in vaccine development and therapeutics as your understanding of how the mechanism works on a cellular level. Applied research without the fundamental research is like trying to fix a TV by just hitting it without understanding what's inside. Sometimes it works, but you don't know why it does or doesn't work without that deeper knowledge."
This work is funded by the National Institutes of Health (NIH), Award #R21AI153976.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The heroic efforts of health systems and hospitals to respond to the pandemic have accelerated innovation that will affect healthcare forever. As traditional healthcare providers emerge from the COVID-19 crisis into the New Health Economy, will they be prepared to do battle for healthcare consumers (and the dollars they direct) against a formidable new set of competitors?

LAFAYETTE, CALIF. (PRWEB) NOVEMBER 18, 2020
Amazon announced this week that they are entering the pharmacy business. And while the online retail behemoth's intention to offer online prescription fulfillment and free delivery to Prime members may not represent a direct threat to hospitals and health systems, the event underscores planning and investment that retailers have been making for years to own a larger share of the primary healthcare market.
The company's move into healthcare has been the object of rampant speculation in recent months. In January of this year, Becker's Health IT reported that the company had entered 2020 with a long list of healthcare-related initiatives. These included Haven Healthcare, in partnership with JP Morgan and Berkshire Hathaway; Acquiring HIPAA approval for Alexa, the company's voice assistant technology; launching its own healthcare program, Amazon Care for certain company employees; and partnered with Cerner, the Electronic Medical Record (EMR) company through Amazon Web Services (AWS).
Amazon, of course, has a well-earned reputation as one of the most disruptive companies in history. Like other companies with sizable penetration into consumer markets, they see an enormous opportunity in healthcare – where a historic lack of transparency and excessive systemic fragmentation have alienated newly empowered healthcare consumers who – more and more – are losing interest in the traditional primary-care-physician (PCP) care delivery model.
Several other retail companies have embarked on or expanded care delivery enterprises built on their existing relationships with consumers. And, unlike many traditional healthcare providers, these companies have a long history of putting their customers first. CVS, Walmart, Walgreens and others have all announced plans to leverage their substantial customer bases and healthcare credentials to woo away some of healthcare's most lucrative business.
We wrote about this phenomenon early this year in an article titled, "Disruption and the "Retailization" of Healthcare." In it, we shared Frost & Sullivan's top eight predictions that will disrupt healthcare in 2020, as reported by Forbes. Of course, healthcare has indeed been disrupted in 2020, but as it has turned out, the disruptor was something other than what anyone expected. Even so, the retail disruptors have been waiting, building infrastructure and capacity to forever transform the way people choose and pay for their healthcare in America.
In the article, we focused on two predictions with particular importance to traditional healthcare providers – especially hospitals and health systems:

Prediction no. 5 – Interoperability by pure play solution vendors will gain ground against standalone systems – "Interoperability will finally take a major step forward in terms of government policies, vendor acceptance and strategic focus." An example is Loyale Healthcare's technology which interoperates with more than sixty applications, EMRs and data sources, enabling healthcare enterprises to manage and deliver seamless, holistic patient financial experiences regardless of setting.

Prediction no. 8 – 2020 will be a year of "Retailization" for the healthcare industry, promoting the comparison-shopping consumer mindset – "2020 will be the year of new or expanded health services offering from new entrants." Based on our experience, this disruption is already taking place. For 2020, this...will accelerate to quickly place much larger market share positions at risk."

Looking back at the extraordinary events of 2020, it's now clear that these predictions did not occur as envisioned late last year. But it's safe to say that the momentum behind these transformations has only grown, even as the pandemic has preoccupied Americans and the American healthcare industry. When the crisis finally passes and the marketplace begins to normalize, the market landscape for healthcare will move quickly.
Fortunately for hospitals and health systems, innovation inspired by the coronavirus could help ensure their continued relevance and improve the probability of market share retention and growth. But only as long as their new tools are used to operationalize a more consumer-centric operating model.
In commentary published by NEJM Catalyst, part of the New England Journal of Medicine, Adrienne Boissy, MD, MA shared a clinician's perspective on patient-centered care in "Getting to Patient-Centered Care in a Post-COVID-19 World: A Proposal for Novel Surveys, Methodology and Patient Experience Maturity Assessment." Writing that, "We need to capture (or recapture) the humanity that is at the heart of health care. We need to design our operations to support true patient-centered care: operationalized empathy. Redesigning patient experience measurement and assessing our organizations' readiness to deliver on the promise of patient centeredness, will empower us to deliver not just care, but actual caring."
The culture described by Dr. Boissy is critical to the operation of a healthcare enterprise that intends to compete with companies like Amazon and CVS Health. These companies routinely analyze, interpret, respond to, and even predict the interests and behaviors of their customers. With operating models that are focused on financial sustainability, they are also inherently empathetic. These companies know that customers – the market – decides who wins and who loses. They know they have to earn that business every day.
Here at Loyale, we're particularly interested in patient-centered financial engagement. Few would argue that the financial dimension of care is an element of the patient experience that consistently falls short of the care delivery promise of most healthcare providers. That didn't used to matter much. Back when a patient's insurance company covered most of the bill, and the patient's financial responsibility was an easily managed deductible or co-pay. But those days are long gone. Today, according to research published last year by the Kaiser Family Foundation, "Americans consistently put healthcare costs at the top of their list when it comes to health care issues they want the government to address."
The same report notes that "one-third of insured adults say it is difficult for them to afford routine (health insurance) costs," and that "Health care costs stop people from getting needed care or filling prescriptions." Further, the research found that "even individuals with employer-sponsored insurance, especially those in high deductible plans, have difficulty affording their health care or health insurance, or report problems paying medical bills." With forty percent of Americans saying they "would struggle to come up with $400 for an unexpected expense," it's easy to conclude that – for too many people – cost has become a barrier to patient care.
But what if hospitals and health systems – traditional healthcare providers – attacked the competitive threats and market pressure head on? What if, instead of continuing to rely on an outdated, transactional, fee-for-service care delivery model, it transformed to a patient-centered model? By leveraging the industry's deep clinical know-how, it could add value to its carefully cultivated caregiver-patient relationships with tools to enhance access, improve affordability and add convenience.
That's the healthcare model Loyale was created to help power. Our patient financial engagement technology was engineered by industry experts who have positively influenced consumer payment behavior for more than thirty years. Large healthcare enterprises use Loyale tools to deliver price transparency, payment plans and user-friendly self-service that feels more like consumers' favorite retail brands. With Loyale as their partner, these health systems are bridging the gap between what their patients want from their financial experiences and what they're getting today. By essentially disrupting themselves, these health systems and hospitals are transforming into patient-centered organizations, taking critical steps to ensure their continued relevance and competitiveness, even against the upstarts. We know who we're betting on.
Kevin Fleming is the CEO of Loyale Healthcare
About Loyale
Loyale Patient Financial Manager is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.
Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale's industry leading technology at all HCA hospitals and Physician Groups.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The nation's care coordination leader selects Vital to improve the patient experience with real-time updates throughout their visit

ATLANTA (PRWEB) NOVEMBER 18, 2020
Collective Medical, delivering the leading real-time ADT-based care collaboration network to healthcare organizations across the country, and Vital, AI-powered software for hospital emergency departments and patients, today announce a collaboration to improve the patient experience in the emergency department by keeping patients and their families informed throughout every step of a visit. Collective's thousands of client partners rely on them for rich, real-time clinical insights to improve care decisions and the patient experience. Now, these providers will also have access to Vital's platform with no additional IT integration to provide real-time updates to their patients so they can contextualize their care process and better engage in their own follow-up care.
Studies have shown that patient satisfaction scores at hospitals are often lower for visits beginning in the emergency department, in part due to wait times, lack of information, and unclear next steps. The partnership between Collective and Vital aims to solve these issues by helping patients feel in control of their visit through automatic and detailed updates that can be easily shared with friends and family.
"The decision to partner with Vital is natural given our shared vision of improving patient care, coordination, and outcomes, including in the emergency department," says Chris Klomp, CEO of Collective. "Patients and their loved ones deserve to know what they are waiting on and how long it will take. Vital makes it easy to keep everyone in the loop."
Collective ensures that providers have access to critical information and health history for patients arriving at and transitioning out of the emergency department. On the patient side, Vital keeps patients up-to-date on the status of their visit and care. By leveraging their existing IT integration, the partnership will allow Collective's existing and future clients to deploy Vital's platform in days instead of months, and engage with patients and families in the emergency department.
Founded by an emergency room doctor and an award-winning technical CEO, Vital uses artificial intelligence (AI) to enhance the patient experience and emergency department flow. Vital's HIPAA-compliant mobile web app requires no download or signup, and has an average patient approval rating of 97%. Hospitals and healthcare systems that have partnered with Vital have seen a 68% increase in emergency department follow-up appointments that have provided hundreds of thousands of dollars in new revenue per facility.
The Vital partnership will enable the following for Collective's network participants:
For Patients:

Visit Information: Patients see a step-by-step "guide" through the emergency room, tailored for each patient's language and unique journey.

Live Updates: Pushes real-time mobile updates on wait times and next steps to patients and loved ones, helping alleviate stress and removing communication barriers.

Schedule Follow Up Appointment: Facilitates scheduling of follow-up appointments, something that two-thirds of patients fail to do before leaving the emergency department.

For Hospitals:

Speed to Market: Able to fully implement in a matter of days to weeks, with opportunities to expand within the organization.

Increase Customer Loyalty: Prioritizes patient-centric care, enabling a better experience for patients, clinicians and care teams.

Increased Revenue: Helps hospitals keep patients in network for follow-up visits after the emergency encounter.

"Our mission at Vital is to improve the patient experience through innovation, and by simply keeping patients informed on what they deserve to know," says Aaron Patzer, Co-founder and CEO of Vital. "We look forward to further developing our partnership with Collective Medical so that we can set a new precedent for how care should be delivered."
About Vital
Vital is a modern software for hospital emergency departments that makes it easier to coordinate care and engage with patients. Using artificial intelligence (AI) and natural language processing (NLP), Vital updates patients and families throughout their ER visit, provides insights to maximize revenue for each patient, and helps decrease length of stay. Founded by Mint.com creator Aaron Patzer, Vital is HIPAA-compliant, and a cloud-based software that sits on top of any existing electronic health record system (EHR): Epic, Cerner, Meditech, and more. The company's investors include First Round Capital, Threshold Ventures (formerly DFJ Venture), Bragiel Brothers, Meridian Street Capital, Refactor Capital, Vivek Garipalli, SV Angel, and Flatiron Health Founders Nat Turner and Zach Weinberg. For more information please visit vitaler.com or follow us on Twitter (@Vital_EHR).
About Collective Medical
Collective Medical is the nation's leading real-time care notification, activation and collaboration platform. Proven to streamline care transitions, improve coordination and reduce unnecessary length of stay and admissions, Collective helps improve patient outcomes and lower costs by closing communication gaps across care settings. With a nationwide network of thousands of hospitals and health systems; primary, specialty and post-acute clinics; health plans and ACOs; Collective integrates alongside EHRs and health information exchanges to empower improved clinical decision making. Collective is based in Salt Lake City. Learn more at http://www.collectivemedical.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Rescued by Cal Fire firefighters from the devastating Zogg and August Complex fires a few weeks ago, all three mountain lion cubs, including severely burned "Captain Cal," have made full recoveries at Oakland Zoo's Vet Hospital and will fly together as a family, accompanied by an Oakland Zoo's Zoological Manager and a Columbus Zoo veterinarian in the coming weeks to their new home

OAKLAND, CALIF. (PRWEB) NOVEMBER 18, 2020
Named "Captain Cal" by the Cal Fire firefighters who found him limping down a burned-out road in Redding on September 30, 2020, the severely burned orphaned mountain lion cub is now fully recovered, 47 days after he was first rushed to Oakland Zoo's veterinary hospital by the California Department of Fish & Wildlife (CDFW). With surgery, antibiotics, supportive fluids, pain medication, hand feedings, daily bandage changes, and round-the-clock care, he is ready to make the journey to his new home at the Columbus Zoo and Aquarium in Ohio sometime within the coming weeks. Captain Cal will be joined by two (unrelated to him) female cubs also orphaned by the California wildfires and rehabilitated by Oakland Zoo's veterinary team.
In the coming weeks, the cubs will travel together on a flight from Oakland to Indianapolis, Indiana, accompanied by Oakland Zoo Zoological Manager, Angela Gibson, and the Columbus Zoo's Vice President of Animal Health, Dr. Randy Junge, to help ensure that the cubs arrive safely. In Indianapolis, they will be met by additional members of the Columbus Zoo's Animal Care team who oversee the Zoo's North America region where the cubs will be residing. This team will also be a part of escorting the cubs during the last leg of their journey as they drive to the cubs' new home at the Columbus Zoo and help get the cubs settled in comfortably.
Though typically solitary, recent research has shown that mountain lions are more social than scientists previously thought. After a mandatory quarantine period, and once the cubs are medically cleared, the Columbus Zoo team hopes to eventually introduce the cubs to female mountain lion, Jessie. At almost 17 years old, Jessie has surpassed the median life expectancy of 16 years for mountain lions in human care at facilities accredited by the Association of Zoos and Aquariums (AZA). While she is now nearly blind, she is still in good health overall. The Columbus Zoo's Animal Care team notes that she has a sweet disposition toward other mountain lions—she was very close to her brother, Billy, with whom she was rescued as part of a wildlife confiscation in 2004. Billy passed away in early 2020, and the team hopes to provide Jessie with the opportunity to form a bond with the cubs in the future.
As another way to highlight the important collaboration of Oakland Zoo and the Columbus Zoo to help wildlife in need, Oakland Zoo staff has offered the Columbus Zoo team the chance to name the female cubs. The Columbus Zoo will announce the cubs' names in the coming weeks.
"Even with the cubs' tragic beginning, their story is actually one of survival and hope. We are proud to work with our friends at Oakland Zoo, whose expertise has given these cubs another chance. We remain committed to the cubs' care, and we will continue to share their important story with others as we work together to protect the future of wildlife and wild places," said Columbus Zoo and Aquarium President/CEO Tom Stalf.
Like Captain Cal, his two new "sister" cubs were rescued by firefighters. The female cubs were orphaned by the August Complex fire, and while they did not suffer from burns like Captain Cal, the sisters were estimated to be only 3-4 weeks old when they arrived at Oakland Zoo's Vet Hospital on October 9, 2020—10 days after Captain Cal's arrival.
Captain Cal was 4-6 weeks of age and weighed only 3.75 pounds when he arrived at Oakland Zoo. His most serious injuries were the severe burns he sustained to the pads of his paws, which made him unable to walk. Director of Oakland Zoo's Veterinary Hospital Dr. Alex Herman, along with her staff and an expert wound specialist from UC Davis Veterinary Medicine Teaching Hospital, performed extensive surgery to remove the pads so they could be allowed to regrow and heal. Daily bandage changes and advanced wound care procedures were successful and he is now fully healed and weighs a healthy 15 pounds. X-rays and an echocardiogram were also conducted by a Board-certified radiologist to ensure his heart and lungs were/are healthy.
A webpage about Captain Cal's recovery journey was created on Oakland Zoo's website in early November to keep the public updated on his progress as a result of the outpouring of interest. As Captain Cal underwent daily treatment, Oakland Zoo vet and animal care staff were eager to provide Captain Cal the companionship of the female cubs, but patience was required so that Captain Cal could recover enough so that the introductions to one other could safely happen.
That day came on October 28, when the cubs were introduced. Their bonding with one another was immediate, and the cubs have been together ever since—playing, cuddling and sleeping together.
Due to the widespread media coverage that helped raise awareness about their important story, many AZA-accredited zoos and other facilities were aware that the cubs needed to be placed and reached out to Oakland Zoo to offer a home for the three cubs. The Columbus Zoo was ultimately selected due to their excellence in animal care, welfare and previous experience in assisting rescued North American animals, including black bears, brown bears, moose and mountain lions.
Dr. Herman and her team at Oakland Zoo have conducted thorough final health exams on all three cubs in preparation for their departure. She and her vet team are ready to take in more wildfire victims as needed, as the effects of global warming make evident that fire threats are increasing yearly. As more wildlife victims are in need of care and rehabilitation, facilities with resources and expertise available to care for these animals are becoming scarce. Collaborating with CDFW and UC Davis School of Veterinary Medicine on the newly formed "Wildfire Relief Network" for burned wildlife was created in October 2020 as a response to the growing problem.
"We're grateful and beyond happy that Captain Cal has made such an amazing recovery and now has a family with the two females. These cubs' poignant faces have made an impact on so many, and helped raise awareness around the issue of global warming and the environment we – and these animals – live in. We're fully committed to continue taking in burned wildlife that need our help, and hopefully, one day that need will no longer exist," said Dr. Herman.
In their native range, mountain lion cubs stay with their mothers until they are around two years of age in order to learn the skills to survive on their own. Because these cubs were orphaned at such a young age, they would be unable to learn how to survive in the wild.
Fifteen mountain lion orphans have been brought to Oakland Zoo since 2017. Aside from wildfires, mountain lions are facing numerous threats in California—often struck by cars and illegally poached. These factors culminate in the human-wildlife conflict, putting them at odds with humans in encroaching urban areas and developments. Oakland Zoo partners with conservation organizations like the Mountain Lion Foundation and the Bay Area Puma Project to educate the public on the issue and help conserve the species in the wild.
Oakland Zoo helped found BACAT (Bay Area Cougar Action Team) in 2013, an alliance with the Bay Area Puma Project and the Mountain Lion Foundation, to help support the CDFW to save mountain lions caught in the human-wildlife conflict.
Contact:
Erin Harrison
Oakland Zoo
eharrison@oaklandzoo.org
Office: 510-632-9525 ext. 120
Cell: 415-601-1619
Isabella Linares
Oakland Zoo
ilinares@oaklandzoo.org
Office: 510-632-9525 ext. 239
Cell: 650-776-9589
Nicolle Gómez Racey
Columbus Zoo and Aquarium
nicolle.racey@columbuszoo.org
Office: 614-645-3411
Cell: 614-843-3611
Jen Fields
Columbus Zoo and Aquarium
jen.fields@columbuszoo.org
Office: 614-645-3579
Cell: 614-595-8989
ABOUT OAKLAND ZOO AND THE CONSERVATION SOCIETY OF CALIFORNIA
Oakland Zoo, home to more than 750 native and exotic animals, is managed by the Conservation Society of California (CSC); a non-profit organization leading an informed and inspired community to take action for wildlife locally and globally. With over 25 conservation partners and projects worldwide, the CSC is committed to conservation-based education and saving species and their habitats in the wild. Oakland Zoo is dedicated to the humane treatment of animals and is accredited by the Association of Zoos and Aquariums (AZA), the national organization that sets the highest standards for animal welfare for zoos and aquariums.
ABOUT THE COLUMBUS ZOO AND AQUARIUM
Home to more than 10,000 animals representing over 600 species from around the globe, the Columbus Zoo and Aquarium leads and inspires by connecting people and wildlife. The Zoo complex is a recreational and education destination that includes the 22-acre Zoombezi Bay water park and 18-hole Safari Golf Course. The Columbus Zoo and Aquarium also manages The Wilds, a 10,000-acre conservation center and safari park located in southeastern Ohio. The Zoo is a regional attraction with global impact, annually contributing privately raised funds to support conservation projects worldwide. A 501(c)(3) nonprofit organization, the Columbus Zoo has earned Charity Navigator's prestigious 4-star rating.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare technology leader recognized as one of the fastest-growing companies in North America

HERNDON, VA. (PRWEB) NOVEMBER 18, 2020
DocASAP, the industry's most advanced patient access and engagement platform for health systems, health plans and physician groups, today announced its inclusion on Deloitte's Technology Fast 500 list, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 26th year. DocASAP grew 215% during the reporting period.
"We're honored to be recognized by Deloitte as one of the fastest growing technology companies in North America," said Puneet Maheshwari, co-founder and CEO of DocASAP. "The world has changed drastically over the last year and this accolade is a testament to our team's resilience and dedication to ensuring optimal health through safe and timely care."
DocASAP is mission-focused on reducing barriers to care. It's patient access and engagement platform enables advanced patient matching and navigation to the right care setting–whether virtual or in-person–based on the provider's specific care delivery protocols. Patient engagement tools, such as actionable reminders and care-driven outreach, help providers improve patient outcomes and loyalty while reducing costs.
"For more than 25 years, we've been honoring companies that define the cutting edge and this year's Technology Fast 500 list is proof positive that technology — from software and digital media platforms, to biotech — truly does permeate so many facets of our lives," said Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader. "We congratulate this year's winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic."
"Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive," said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte's audit and assurance practice. "We extend sincere congratulations to these well-deserved winners — who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible."
For a complete list of Deloitte's 2020 Technology Fast 500 winners visit, http://www.fast500.com.
About Deloitte's 2020 Technology Fast 500
Now in its 26th year, Deloitte's Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
About DocASAP
DocASAP provides the industry's most advanced patient access and engagement platform for health systems, health plans and physician groups. DocASAP empowers organizations to navigate patients to the optimal provider and care setting at the right time throughout their access journey, helping improve outcomes, reduce costs and create a better patient experience. Backed and promoted in the market by Aetna, Optum and UnitedHealthcare, DocASAP builds unique payer-provider connections with an eye toward simplified access, increased care compliance and improved population risk management. For more information, visit http://docasap.com or follow on Twitter @DocASAP.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see http://www.deloitte.com/about to learn more about our global network of member firms.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Appreciation for What Contraception Makes Possible is Stilled Celebrated

WASHINGTON (PRWEB) NOVEMBER 18, 2020
A new national poll released by Power to Decide shows that 51% of respondents (including 59% of birth control users age 18-34) are concerned about the ability of the public to afford or access their preferred method of contraception considering the most recent change in the Supreme Court. In addition, looking at all respondents (age 18 and older), Democrats were significantly (69%) more likely to be concerned than Independents (49%) or Republicans (32%) about the shift in the Supreme Court. This and other survey findings were released today from Power to Decide in recognition of its eighth annual Thanks, Birth Control Day.
"We must be cognizant of how recent changes in the Supreme Court might impact people's ability to access reproductive health care," said Gillian Sealy, Interim CEO, Power to Decide. "That's why on this Thanks, Birth Control day we need to celebrate everything that birth control makes possible and we must continue to work to ensure that all have access to the full range of contraception no matter who they are, where they live or what their economic status is."
The vast majority of respondents age 18 to 34 (94%), compared to 72% in 2019, said they are thankful that birth control allows them or their partner to decide if, when and under what circumstances to get pregnant and have a child. Further, 84% appreciate birth control, compared to 57% in 2019, for the ability to work toward educational or professional goals, and 74%, compared to 57 % in 2019, are thankful that birth control allows them to manage health conditions.
"This year, there is no denying that appreciation for birth control has increased noticeably," Sealy stated. "Our work in reproductive health tells us that in recent years birth control has become less accessible. We believe the pandemic and shift of the Supreme Court help to explain the increase in people's concerns over their ability to access the health care they need to stay healthy and live their best life. And that's why today is a special day for all of us to recognize how access to birth control can help ensure that everyone has the power to decide if, when and under what circumstances to get pregnant and have a child."
Power to Decide's Thanks, Birth Control survey results are being released in conjunction with the eighth annual Thanks, Birth Control Day, taking place today, Wednesday, Nov. 18. Birth control is cited as one of the 10 greatest public health achievements of the 20th century (according to the Centers for Disease Control and Prevention), because of its profoundly positive impact on women, families and society.
When more people talk openly about why they use—and are grateful for—birth control, everybody wins. Here are five quick and easy ways to say, "Thanks, Birth Control" with us today:
1. Rock our new masks and snap a selfie or take a Boomerang, and post on Instagram sharing why you're thankful for birth control with #ThxBirthControl.
2. Share your story about the benefits of birth control, why you love birth control, how birth control allows people to live their best worry-free sex life for Thanks, Birth Control Day.
3. It's time to dominate the conversation online with messages about birth control. Today, from 2-3pm ET, join our Twitter Storm using #ThxBirthControl.
How you can participate:

Show your love for accessible, affordable, and amazing contraception. Share what birth control gives you the power to decide and how birth control allows people to live their best worry-free sex life.

Share our graphics or use our stickers on your social channels by typing "Birth Control" or "Bedsider" through GIPHY.

4. Spread the word on social. You can browse through our toolkit to see pre-written social copy or write your own using #ThxBirthControl.
5. Check out our Thanks, Birth Control swag on our store and rock it year-round, as we celebrate birth control all-day, everyday! Don't forget to snap a selfie and post using the hashtag #ThxBirthControl.
Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.
About the Survey: The telephone survey was conducted for Power to Decide by SSRS, an independent research company. A total of 1,004 interviews were conducted between September 29, 2020 and October 4, 2020, among the general population (age 18 and older). The margin of error for total respondents is +/-3.58% at the 95% confidence level.

"We believe the pandemic and shift of the Supreme Court help to explain the increase in people's concerns over their ability to access the health care they need to stay healthy and live their best life," said Gillian Sealy, Interim CEO, Power to Decide



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Local magazine nominates renowned Austin plastic surgeon as a great choice for women.

AUSTIN, TEXAS (PRWEB) NOVEMBER 18, 2020
Dr. Edward Buckingham, founder and director of the Buckingham Center for Facial Plastic Surgery, was recently recognized by Austin Monthly as a Top Doctor for women in the area. The local publication uses a peer-based system to identify nominees for the list, which recognizes the top 10-15% of submitted candidates after a voting process and review. It is an honor that showcases Dr. Buckingham's commitment to his patients' results, safety, and comfort.
Dr. Buckingham is certified by both the American Board of Otolaryngology-Head and Neck Surgery, and the American Board of Facial Plastic and Reconstructive Surgery (ABFPRS). He is renowned for his ability to create natural-looking results and works hard to stay on the cutting edge of cosmetic facial technologies, both surgical and non-surgical.
His specialty skills include surgical procedures such as reconstructive surgery, rhinoplasty, and revision rhinoplasty. Other surgeries include eyebrow lifts, facelift, chin implants, limited incision facelifts and facial fat transfer. Buckingham Center also offers non-surgical treatments including micro-needling, laser resurfacing, and Botox.
Dr. Buckingham spends a great deal of time with each patient. The initial consultation allows him to make detailed recommendations, reduce surgical concerns and anxieties, and help the prospective patient manage their own expectations. Being fully prepared for the procedure is critical to a safe and effective result. Buckingham Center's patients in Austin feel safe and supported by Dr. Buckingham throughout the entire process, from consultation to aftercare.
At the end of the initial consultation, the prospective patient will typically walk away with a customized treatment plan and detailed information on:

How to prepare for the procedure

Any risks to consider prior to scheduling the surgery

Standard recovery time

Best aftercare practices

Buckingham Center for Facial Plastic Surgery is a true specialty practice, focusing solely on facial surgery and non-surgical rejuvenation. Dr. Buckingham's double certification demonstrates his commitment to providing patients with the very best in facial plastic surgery. He has extremely high standards and works only with medical professionals who share his dedication and professional values.
The comfort and security of patients are critical to the entire staff at the Buckingham Center for Facial Plastic Surgery. Dr. Edward Buckingham has built a culture of professionalism that offers prospective patients the chance to express their concerns and explore their options with the expectation of patience and respect.
Dr. Edward Buckingham completed his medical degree at the University of Texas Medical Branch in Galveston, Texas. He went on to study facial plastic surgery and reconstructive surgery at the Albany Medical Center and the New England Laser and Cosmetic Surgery Center in Albany, New York. His current focus on rhinoplasty, blepharoplasty and facelift make him an excellent information source for the people of Austin who are considering any cosmetic procedure.
###
To learn more, schedule a consultation with the professionals at the Buckingham Center for Facial Plastic Surgery. You can contact the office at any time online or schedule a consultation over the phone at 512-401-2500. Buckingham Center is located at 2745 Bee Cave Road, #101, Austin, TX 78746.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Makers Nutrition has donated over 800 pounds worth of non-perishable food and household items to Island Harvest Food Bank.

HAUPPAUGE, N.Y. (PRWEB) NOVEMBER 18, 2020
Makers Nutrition has donated over 800 pounds worth of non-perishable food and household items to Island Harvest Food Bank.
For many, Thanksgiving is a time to cherish those surrounding the dinner table. As many fill their plates, others are without food and necessities that are often taken for granted. Each year, the Makers Nutrition team comes together to donate as much as possible to a Long Island-based charity organization. Considering all that Island Harvest Food Bank does to help people in need and seeing how much more they are doing in response to the COVID-19 crisis, Makers Nutrition knew this organization would be receiving a special donation.
Island Harvest Food Bank has gone above and beyond, running a COVID-19 response program across Suffolk and Nassau counties specifically to veterans, seniors, and children, and homebound individuals who are struggling with food insecurity.
"We are so pleased to give to those in need, especially when those in need are our neighbors," said Vice President of Sales Patrick Gillespie. "As an Inc. 5000 company and Grand International Business Award winner, our employees understand the value of effort and teamwork. It's just a great feeling when that effort and teamwork go toward a good cause."
This is Makers Nutrition's third time donating to Island Harvest Food Bank, and the team encourages all able to donate what they can. Any amount matters and can make a difference.
About Island Harvest Food Bank
Island Harvest Food Bank is a leading hunger-relief organization that provides food and other resources to people in need. Always treating those it helps with dignity and respect, its mission is to end hunger and reduce food waste on Long Island through efficient food collection and distribution; enhanced hunger-awareness and nutrition-education programs; job training; and direct services targeted at children, senior citizens, veterans, and others at risk of food insecurity. As a result of Island Harvest Food Bank's dynamic business model, more than 94 percent of expended resources go directly to programs and services that support more than 300,000 Long Islanders facing hunger. Island Harvest Food Bank is a lead agency in the region's emergency response preparedness for food and product distribution. It is a member of Feeding America, the nation's leading domestic hunger-relief organization. For five consecutive years, Island Harvest Food Bank has earned a four-star rating from Charity Navigator, a leading independent charity watchdog organization. Island Harvest Food Bank is among just 9% of the organizations rated by Charity Navigator to merit the four-star designation. More information about Island Harvest Food Bank is at http://www.islandharvest.org.
About Makers Nutrition
Makers Nutrition, an Inc. Fastest-Growing Business in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels, and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Operation Smile is hosting its first Virtual Regan Resident Leadership Conference with the support of the Harbourton Foundation on Friday, Nov. 20, 2020. Dr. John G. Meara is scheduled to deliver the keynote speech. The exclusive virtual event, "The Changing Landscape and Innovation in Global Surgery and Implications for Comprehensive Cleft Care," will offer opportunities for shared learning, networking and collaboration between Operation Smile Regan fellows, residents, recent graduates and world-renowned experts regarding global surgery, innovations and its implications for comprehensive cleft care.

VIRGINIA BEACH, VA. (PRWEB) NOVEMBER 18, 2020
Operation Smile is hosting its first Virtual Regan Resident Leadership Conference with the support of the Harbourton Foundation on Friday, Nov. 20, 2020. Dr. John G. Meara is scheduled to deliver the keynote speech. The Kletjian Professor of Global Surgery, Director of the Program in Global Surgery and Social Change and Professor of Surgery in the Department of Surgery at Harvard Medical School, Dr. Meara has a particular interest in augmenting the delivery of quality surgical and anesthesia care in low-resource settings through long-term capacity building. His clinical interests are in the area of craniofacial conditions and cleft lip and cleft palate. Dr. Meara will address the changing global surgery landscape in recent years and in the wake of COVID-19's impact.
The exclusive virtual event, "The Changing Landscape and Innovation in Global Surgery and Implications for Comprehensive Cleft Care," will offer opportunities for shared learning, networking and collaboration between Operation Smile Regan fellows, residents, recent graduates and world-renowned experts regarding global surgery, innovations and its implications for comprehensive cleft care.
"To see the next generation of leaders in plastic surgery, anesthesia and pediatrics come together as part of the Operation Smile Regan Resident Leadership Program is inspiring," says Operation Smile Chief Medical Officer Dr. Ruben Ayala. "These are professionals who believe that medicine, humanitarian assistance and capacity building have the power to bring humanity together. Through the Regan fellowship, mentors and mentees forge a clear path towards the fulfillment of their service and the positive changes in the lives of children and communities we all hope for."
Supported by the Harbourton Foundation, the Operation Smile Regan Resident Leadership Program plays a pivotal role in increasing the capacity and skills of senior residents specializing in surgery, anesthesiology and pediatrics, empowering them to deliver high-quality care. Through this program, senior residents have the opportunity to volunteer on an Operation Smile medical program and other training opportunities. This provides the residents with the unique opportunity to develop professional skills, collaborate with a diverse care team while bringing high-quality care to people living with cleft lip and cleft palate around the world.
The virtual conference starts Friday, Nov. 20 from 9:00 a.m. to 2:15 p.m. EST and will feature presentations from a variety of industry experts including Operation Smile Co-Founder and CEO, Dr. Bill Magee; Dr. Donald Lalonde, a professor in the division of plastic and reconstructive surgery at Dalhousie University in Saint John, New Brunswick, Canada; Dr. Jeffrey R. Marcus of Duke Children's Health Center Plastic Surgery Clinic; and Dr. Nicole Ann Shilkofski, assistant professor of pediatrics and anesthesiology and critical care medicine at the John Hopkins University School of Medicine.
About Operation Smile
Operation Smile revolutionized cleft surgery globally in 1982. With nearly four decades of experience as one of the largest surgical volunteer-based nonprofits, Operation Smile staff, its private-public partnerships and thousands of volunteers have improved the health and dignity of patients with cleft conditions, helping them to better breathe, eat, speak and live lives of greater quality and confidence. While one cleft surgery can bring immediate transformation to a child's life in as little as 45 minutes, Operation Smile is committed to providing patients with health that lasts—being there to offer patients additional surgeries, dentistry, psychological services, speech therapy and other essential cleft treatments. Its training and education programs elevate local surgical standards and entire health systems to aid safe surgery and strengthen a global network to reach more people earlier in their lives. You can learn more about their transformative and healing work by visiting operationsmile.org or by following @operationsmile on social media.
About the Harbourton Foundation
Established in 1985 in Princeton, New Jersey, the Harbourton Foundation is the philanthropic arm of the Regan family, founded by James (Jay) Regan and his wife, Amy. The foundation's giving focuses on organizations that tackle issues within human rights and the environment, among others. The Harbourton Foundation has been committed to cultivating emerging medical talent since 2006, when the Resident Leadership Program launched. In 2017, the Regan family made a five-year commitment through the Harbourton Foundation to continue the Resident Leadership Program's growth and progress.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Part of Madonna University's plans to reopen its Livonia, Michigan campus this fall involved working with ReturnSafe. To keep students, staff and faculty safe and healthy during the Coronavirus pandemic, Madonna utilized ReturnSafe's BioSecurity Platform.

AUSTIN, TEXAS (PRWEB) NOVEMBER 18, 2020
Part of Madonna University's plans to reopen its Livonia, Michigan campus this fall involved working with ReturnSafe. To keep students, staff and faculty safe and healthy during the Coronavirus pandemic, Madonna utilized ReturnSafe's BioSecurity Platform.
"Over the summer we saw the devastating impact of COVID-19 and recognized that we would need to find a solution that our students, staff and faculty could use on a daily basis in order to bring everyone back safely," said John Montgomery, Chief Information Technology Officer at Madonna University. "ReturnSafe is a simple health-screening and contact-tracing solution that gives us the reassurance needed in order to keep our doors open and our community safe. With ReturnSafe, we're able to quickly identify those who have been potentially exposed to the virus and, in turn, those with whom they have been in contact. We have a university community of 2,400 students, faculty and staff who come to campus regularly, so it's critical to be able to identify potential risk areas and respond rapidly to minimize the risk of an outbreak."
Students and faculty register their health status using the ReturnSafe app by answering COVID-specific screening questions. Once cleared to come to campus, students, faculty, staff, and visitors receive a daily electronic "badge" that can be shown to faculty and staff as they attend classes or other events on campus. Those not cleared are requested to stay away from campus, and are provided with directions on necessary COVID-19 testing, isolation and quarantine procedures. In addition to identifying potentially-exposed or infected people, the ReturnSafe BioSecurity Platform helps Madonna University's Chief Health Officer rapidly notify those who were potentially exposed.
"As a mission-driven company, we want to help educational institutions with a solution that allows them to confidently reopen their schools. Unfortunately, contact tracing or a vaccine alone are not the answer to keeping our communities healthy and safe," said Tarun Nimmagadda, Chief Executive Officer of ReturnSafe. "Historically, we have seen other contagious diseases similar to the Coronavirus continue to spread in communities even with a vaccine so additional safety systems have to be in place. ReturnSafe features daily screening, test data management for those that may be positive and have been tested, and contact-tracing alerts that help slow the spread of the virus."
The ReturnSafe BioSecurity Platform offers organizations an end-to-end solution that slows the spread of infectious diseases by implementing critical daily screening with a symptoms diary and recommendations governed by HR policies; testing data management for quick notification of a positive test; and Bluetooth contact-tracing via smartphone and hardware wearables at the workplace including a built-in social distancing alarm. To learn more, click to read the Madonna University case study.
About ReturnSafe
ReturnSafe is a mission-driven BioSecurity company focused on workplace health safety enabling businesses, healthcare organizations, educational institutions and others to prevent and rapidly respond to biological threats, keeping their communities safe and their doors open. ReturnSafe's BioSecurity Platform is a human-centric solution that focuses on slowing the spread of infectious diseases by implementing critical daily screening, exposure notification and contact tracing case management. For more information, visit http://www.returnsafe.com.
About Madonna
Liberal arts education, career preparation, and service-learning have been the hallmarks of a Madonna University education for more than 80 years. In addition to the beautiful main campus, conveniently located at I-96 and Levan Road in Livonia, Mich., Madonna offers academic programs in Gaylord, Macomb, and online in China, Haiti, and the United Arab Emirates. Michigan's most affordable, independent, Catholic, liberal arts university, Madonna offers more than 100 undergraduate and 35 graduate programs in the colleges of arts and sciences, education and human development, and nursing and health, as well as the School of Business.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Clinical AI leader wins among healthcare technology vendors challenged to improve healthcare delivery in Georgia, will begin beta test with Navicent Health companies

ATLANTA (PRWEB) NOVEMBER 18, 2020
Jvion, a leader in prescriptive clinical artificial intelligence (AI), announced today it was selected as a winner of the 2020 Georgia Healthcare Innovation Challenge (GHIC), in which healthcare technology vendors compete to solve the problems facing medical providers in Georgia and beyond. As a winner, Jvion will begin conducting a beta test of its clinical AI solution with Navicent Health, a nonprofit health system with 1,000 beds and more than 50 facilities across central and south Georgia.
Jvion won Challenge #1, which was presented by TC2, an ACO serving Medicare beneficiaries in Middle Georgia. TC2 was looking for a solution that would identify beneficiaries at "rising risk" for readmissions, ED visits and inpatient utilization, enabling earlier interventions to prevent these adverse outcomes. Jvion's clinical AI solution, the Jvion CORE, addresses the problem by analyzing over 4,500 clinical, socioeconomic, and behavioral risk factors per patient to predict who is at rising risk, why they are at risk, and what interventions can address these risk factors to transform patients' trajectories. A video overview of the solution can be found here.
"We had four great finalists, each able to meaningfully advance TC2's predictive modeling capabilities for rising risk beneficiaries," said Dale Boylston, CEO of TC2. "We ultimately chose Jvion for their ability to rapidly integrate and enhance our current claims data with extensive insights around key social determinants of health. The result will substantially improve our ability to identify, engage, and assist patients before they require expensive inpatient care."
Navicent Health, in partnership with Atlanta Tech Village, Georgia HIMSS, and TAG Digital Health, launched the 2020 GHIC on July 30th. For 13 weeks, the participants met with Navicent company CEOs and mentors, prepared product demos, and developed their company pitches. The challenge came to an end with a pitch competition on October 29th, where seven finalists presented for the chance to conduct beta tests with Navicent Health.
"We're incredibly proud to collaborate with TC2 and Navicent Health to prevent avoidable patient harm and mitigate financial risk," said Jay Deady, CEO of Jvion. "By winning this competition, we've shown that Jvion's prescriptive AI is a potent solution for the issues facing providers in Georgia and around the country. Our hope is that our work with Navicent and TC2 can be a model for value-based care providers everywhere, especially now as they confront the challenge of improving patient outcomes despite widespread deferred care."
Jvion has been actively involved in helping healthcare providers, payers and pharmacy benefit managers navigate the challenges of the pandemic, beginning with a suite of resources to help public health stakeholders prepare and intervene to protect their most vulnerable patients from Covid-19. Jvion has also helped healthcare organizations mitigate the financial impact of the pandemic, with solutions that help prevent uncompensated care and patient deterioration as a result of deferred care. More information on Jvion's provider solutions can be found here.
For more information on the challenge, please visit http://www.gahealthcareinnovationchallenge.com.
About Jvion:
Jvion, a leader in clinical artificial intelligence, enables providers, payers and other healthcare entities to identify and prevent avoidable patient harm, utilization and costs. An industry first, the Jvion CORE goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com.
Jvion PR Contact:
Lexi Herosian
lexi@scratchmm.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This cutting-edge technology supports Burlington's made-to-measure capabilities without the need for in-person fittings.

HAMPTON ROADS, VA. (PRWEB) NOVEMBER 18, 2020
Burlington Medical, engineers of the highest quality and lightest weight radiation protection aprons in the industry, recently partnered with 3DLOOK to offer a touch-free radiation protection garment measuring and fitting experience. 3DLOOK's patented body scanning technology enables Burlington Medical customers to get precise body measurements remotely with just two photos in under 30 seconds.
"This is an industry first," says Murry Pitts, chief executive officer of Burlington Medical. "Digital provides a more accurate experience, from measure-to-measure consistency and the manufacturing of the radiation protection garment. The potential for this type of measuring is endless. Our goal is to continue using this cutting-edge technology well beyond the pandemic."
3DLOOK standardizes the way that Burlington Medical measures for radiation protection garments, so customers will get a more accurate and consistent measurement. There's no subjective measuring by hand or inconsistency from one measurer to the next. The 3DLOOK technology measures seamlessly from any location, any time. After taking or scanning two full-body images and submitting an order, each customer's tailored apron is guaranteed to fit every inch of the wearer's body.
"We spent a lot of time working with the incredible team at Burlington Medical and thinking about the user experience and convenience of digital measurements especially needed as COVID hit," says Whitney Cathcart, CSO and co-founder of 3DLOOK. "There was a huge opportunity to deliver our contactless measuring solution immediately to help Burlington Medical continue to deliver customized radiation aprons efficiently. Their digital-first mindset sets a standard for other apparel companies to embrace our digital scanning solutions."
During the pandemic and beyond, Burlington Medical is committed to the safety of all customers and staff. With 3DLOOK, there's no need to risk person-to-person contact as all measurements can be made digitally. For added convenience, customers are able to store and access their measurements online, paving the way for a more streamlined ordering process.
It's all possible through 3DLOOK's partnership with Gerber Technology's made-to-measure system. This allows companies like Burlington Medical to supplement their in-person fittings, operate online, and meet a greater customer demand, all while remaining digitally competitive and forward-thinking in the industry. The technology offers a simple way to digitize measurement capture and automate the entire workflow, which is needed now more than ever with COVID-19.
"Burlington Medical is a great example of an agile, future-oriented company," says Karsten Newbury, chief strategy and digital officer at Gerber Technology. "The integration between our AccuMark Made-To-Measure platform and 3DLOOK helps Burlington to develop products meant for the shape and size of their actual customers. Systematically connecting their supply chain and leveraging data gives them the agility and efficiency to compete and win in today's new reality."
To learn more about 3DLOOK body scanning technology, visit burmed.com/3dlook/.
About Burlington Medical
Burlington Medical is an expert in the health and safety concerns of providers working in a radiation environment. From their virtual fitting services to industry-best lead times and cost-saving product options, Burlington Medical delivers superior outcomes with greater budget efficiency to all customers.
Burlington Medical is ISO9001 certified and follows all guidelines of the American Society for Testing and Materials (ASTM International). Burlington's 5-year warranty is the best in the industry, compared to most competitors at just two years. Burlington's quality products deliver more for the money, and with a registered nurse on the management team, Burlington brings an unparalleled level of insight and expertise to product development.
About 3DLOOK
Founded in 2016, 3DLOOK has built a patented mobile body scanning technology that uses a proprietary combination of computer vision, neural networks, and 3D statistical modeling to generate a 3D avatar and more than 70 points of measure of the human body from just two photos in under 30 seconds. The company has developed the world's first Body Data Platform and was recognized as the 2019 winners of the LVMH Innovation Award and the IEEE Retail Digital Transformation Grand Challenge. 3DLOOK was previously named by Coresight Research as an emerging company disrupting traditional retail with its 3D body scanning technology.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

First-of-its-kind customer console delivers framework-to-framework compliance mapping across AWS and Azure for comprehensive and continuous risk mitigation and spend optimization

SEATTLE (PRWEB) NOVEMBER 18, 2020
Cloudticity, a next-gen managed services, compliance, and security partner for healthcare companies, has expanded the capabilities of Cloudticity Oxygen—the company's HITRUST-certified managed cloud solution for healthcare. The new Oxygen application client console has been strategically redesigned to easily monitor, manage, and secure multi-cloud deployments. It's the first console to provide a single-source view of framework-to-framework compliance mapping across both AWS and Microsoft Azure cloud environments, satisfying the complex data management and protection requirements of companies working with healthcare data.
COVID-19-inspired trends are driving transformation across the healthcare industry. In the face of surging needs, healthcare organizations are modernizing antiquated data systems and migrating to public clouds such as AWS and Azure. That said, in-house IT teams with limited resources and cloud expertise struggle to rapidly scale and manage cloud environments while also maintaining compliance with HIPAA and similar health data protection standards. Cloudticity Oxygen helps bridge this gap, making the cloud more accessible and continuously ensuring compliance, ultimately enabling greater innovation across the healthcare industry—all while resting on the secure foundation of Cloudticity's HITRUST-certified platform.
Cloudticity Oxygen enables IT to unleash healthcare innovation via groundbreaking automation and deep cloud expertise. By offloading infrastructure operations, security, and compliance management to Oxygen, healthcare IT leaders can free up internal resources to focus on innovation. Unlike traditional managed cloud solutions that can provide a secure environment but offer limited flexibility or visibility, Oxygen frees IT to deploy, retire, and configure multiple cloud services and check controls against requirements from multiple regulatory bodies. Oxygen functions as a monitoring and optimization umbrella that sits over an environment and its resources. Customers have complete control over their production environments, while maintaining full security and compliance oversight.
To address the need for greater clarity and agility in cloud environments, Cloudticity redesigned both Oxygen's user interface (UI) and user experience (UX). Customers are now able to visualize a single screen how their system is working at a universal level. Utilizing framework-to-framework compliance mapping across multiple cloud providers is a big step forward for healthcare IT, and establishes a model for potential application in other highly regulated industries.
"Healthcare companies often ask us how to navigate the spaghetti of frameworks in their cloud environments. They want to know if their cloud strategy is sound, their system is robust and safe, and how they can prove it," said Rob Williams, director of technology and product management at Cloudticity. "Oxygen's next-gen customer console delivers these views and insights by providing a central location to easily monitor multi-cloud configurations, compliance, and security. Customers get a single-pane-of-glass view across their entire environment, both clouds and all the services."
To learn more about Cloudticity Oxygen's revolutionary approach to managed services, read AIOps and Automation: Key Ingredients to Intelligent Managed Service Delivery or schedule a consultation.
About Cloudticity
Founded in 2011, Cloudticity helps healthcare organizations radically reshape healthcare by unlocking the full potential of the cloud. Through groundbreaking automation and deep cloud expertise, Cloudticity solutions empower healthcare organizations to create and scale the next generation of healthcare solutions. Distinguished for having built some of the earliest and largest health systems on the cloud, including the first patient portal, the first health information exchange (HIE), the first FISMA high deployment, and the first Meaningful Use 2 (MU2) compliance attestation for a large hospital system, Cloudticity enables healthcare to thrive in the digital era. Innovate faster, improve care, maintain compliance, and drive long-term growth with Cloudticity managed solutions. For more information, visit http://www.cloudticity.com.
Media Contact:
Sterling Communications
Michelle Denny
+1 (408) 335-7331
cloudticity@sterlingpr.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A Groundbreaking Intact America Survey Finds Doctors, Nurses, and Midwives Actively Solicit Moms to Have Their Sons Circumcised

TARRYTOWN, N.Y. (PRWEB) NOVEMBER 18, 2020
A new study released by Intact America reveals that circumcision of baby boys is routinely and often aggressively pushed by physicians, nurses, and midwives, even if parents have not expressed interest in the procedure. Survey results, tabulated by Qualtrics, a widely used survey provider, show that new mothers are solicited eight times on average by health care professionals, "even though no medical society in the world, including the American Academy of Pediatrics, recommends surgically removing the foreskin of healthy baby boys," said Georganne Chapin, executive director of Intact America, the nation's largest advocacy organization seeking to end routine circumcision in the United States.
The Intact America 2020 survey is the first time researchers have shown the direct correlation between solicitation and an increased circumcision rate. Survey results indicate that solicitation increased circumcisions by 173%. Only 45% of new mothers circumcised their sons without being asked, compared to 78% of new mothers who had been solicited. New mothers agreed to the procedure after only one or two asks. Even a "soft sell," such as giving the mother a consent form to perform the procedure, increased circumcisions by 137%.
Tellingly, the survey also found that 21% of mothers who agreed to allow their sons to be circumcised wished they had done more research on the topic, and 10% regretted their choice.
"For years, we've heard from parents, especially mothers, about having been pressured or coerced by doctors and nurses to circumcise their sons, but the impact and scope of solicitation has never been measured before," said Chapin. "The survey shows solicitation directly and dramatically drives up the infant circumcision rate. Soliciting this unnecessary surgery has to end."
Chapin continued, "Doctors tell us they circumcise boys only because parents want it, but this survey proves otherwise. Both doctors and nurses (including nurse midwives) give mothers the impression that circumcision is, if not necessary, 'normal' or desirable, so parents agree to permanently alter their sons' genitals. But they don't tell parents the whole story: that circumcision is painful, reduces sexual sensitivity for the man the baby will become, and can lead to lifelong trauma."
ABOUT THE SURVEY
Intact America worked with Qualtrics to send the circumcision solicitation survey to a national, random sample of 2,519 mothers who had given birth to a boy in the past four years. The survey defined "solicitation" as every time a physician, midwife, or nurse either verbally asked the mother if she wanted to circumcise her son; recommended she circumcise her son; told her that circumcision was required; handed her a circumcision consent form; or assumed (as perceived by the mother) that she wanted to circumcise her son.
Survey results (with a 3% margin of error) revealed numerous noteworthy facts:
—94% of mothers were solicited to have their baby boys circumcised.
—78% of mothers who were solicited agreed to have their sons circumcised.
—45% of mothers who had not been solicited allowed their sons to be circumcised.
—"Soft sells," such as being handed a consent form, increased circumcisions by 137%.
—The average number of solicitations was 8.
—Solicitation, in all forms, increased circumcisions by 173%.
—71% of mothers said they would have asked about circumcision without prompting.
—18% of mothers said they would not have thought to ask about circumcision.
—21% of mothers who agreed to having their sons circumcised said that they wish they had done more research.
—10% of mothers regretted their choice.
—Physicians were responsible for 3 out of 5 solicitations; nurses and midwives were responsible for the remainder.
WHY THIS MATTERS
Each year, an estimated 1.5 million baby boys are circumcised in American medical settings. Intact America estimates that if circumcision solicitations were to cease, 600,000 boys—and the men they will become—would be spared every year from the trauma and lifelong consequences of the procedure.
Chapin, an attorney with broad knowledge of health law and bioethics, believes that medical solicitation of infant male circumcision breaches several well-established ethical boundaries (see link) and the goal of health care equity.
Chapin said that Intact America will use the survey's findings to mount a major campaign to halt the solicitation of circumcision by U.S. medical professionals, end public and private insurance payments for the procedure, and create an intact-informed society that is foreskin-positive and educated about the male genitalia.
"Instead of handing out consent forms, medical professionals should distribute educational materials on how to care for a baby's intact penis," Chapin said. "It's so easy. Leave it alone and wash his penis like you do his fingers. His foreskin will retract in its own good time, by late puberty, if not before."
The public is invited to begin its research into circumcision by visiting CircumcisionDebate.org, a companion site of IntactAmerica.org.
ABOUT INTACT AMERICA
Intact America is the largest national advocacy group working to end involuntary child genital cutting in America and to ensure healthy sexual futures for all people. It does this by challenging social and sexual norms and empowering supporters and volunteers through advocacy and education. To learn more about the issues involved in the current conversation about newborn male circumcision, visit IntactAmerica.org and CircumcisionDebate.org, and follow us on Facebook, Twitter, and Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

User-Friendly App Helps People with Parkinson's Disease Track Their Symptoms and Communicate With Their Healthcare Team for Better Care. Spanish-language Version Now Available!

NEW YORK (PRWEB) NOVEMBER 18, 2020
The American Parkinson Disease Association (APDA) launches today a new and improved APDA Symptom Tracker App 2.0 – a highly-specialized mobile application for people living with Parkinson's disease (PD). The updated version remains free of charge and features enhanced functionality which will significantly improve the ability of a person with Parkinson's disease (PD) to easily and accurately track their PD symptoms and medications, and relay that important information to members of their medical team; with the ultimate goal of receiving better, more personalized care. A Spanish-language version of the app is now available as well, which enables a much larger audience to take advantage of this technology and builds upon APDA's commitment to better serve and support under-represented PD communities.
With a mission to help everyone impacted by PD live life to the fullest, APDA originally developed the APDA Symptom Tracker App in 2019 as an important tool to help people play a more active role in their PD care. After a year of user feedback and continued research, the APDA app has now been significantly upgraded with features that make it even more useful as part of an integrated PD care plan. The development of this app and its upgrades were made possible by generous financial support from Acadia Pharmaceuticals Inc.
The APDA Symptom Tracker App 2.0 guides people through a simple set of questions that has them rate how certain motor symptoms (such as tremor, rigidity, balance) and non-motor symptoms (hallucinations, delusions, fatigue, anxiety, depression, and others) are affecting them. It then creates a graph indicating which symptoms are most impacting their quality of life in which can be saved in the "My Library" section of the app, and can also be emailed directly to members of their health care team, right from the app. Over time, people can compare the results to see if certain symptoms are getting worse, and determine which symptoms need to be addressed more urgently than others.
The improved APDA Symptom Tracker App 2.0 boasts the following new features:

An interactive medication tracker where you can enter the specific medications/doses and the time of day you take them which helps identify opportunities for better symptom management (medication dosage/timing is an incredibly specific and often tricky aspect of life with PD)

Helpful notifications and reminders including:

             reminders to enter symptom data into the app
             push notifications about helpful education programs and updates on treatments
             reminders to share information with the clinician prior to appointments

A Spanish-language version that has been fully created for and by Spanish-speaking people (not simply translated from the English version)

These newly-added features are important because everyone experiences PD differently, and symptoms can vary greatly day by day. The more specific someone can be with their health care team about the types of symptoms they're experiencing, and the timing of their medication, the better the doctor(s) can tailor a treatment plan specifically for each person. But it can be hard for people to remember how certain symptoms have or have not affected them since the last time they connected with their health care team, or if they missed a medication dose.
"As a movement disorder specialist, the more my patients can tell me about their symptoms, the more I can help them. I can see how they're feeling at that one moment, but to be able to see on a chart how they've been feeling at other times since I last saw them would be hugely beneficial for me" states Rebecca Gilbert, MD, PhD, Chief Scientific Officer, APDA. "And now if they track their medications with the app as well, it will help me see possible correlations between dosing and their symptoms. The upgraded APDA Symptom Tracker App benefits not only the patient, but it helps me as their doctor."
The APDA Symptom Tracker also has a special "Questions for the Doctor" feature that generates a list of suggested follow-up items for people to review with their doctor about symptoms and concerns they are currently experiencing, but also about preventative care. This will help them be more proactive in managing their PD. They can bring a printout of the questions to their appointment, so they don't forget to ask any that are important to them. The app also features a useful list of resources that connects them directly to a wealth of quality, credible PD information.
"Acadia is pleased to support the development of the APDA Symptom Tracker as a helpful tool for patients, caregivers and providers to keep track of motor and non-motor symptoms associated with Parkinson's," said Ponni Subbiah, M.D., M.P.H., Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer at Acadia. "With the features of this latest release, which includes a Spanish-language version of the app, we hope to broaden the reach of this important resource for the PD community."
The APDA Symptom Tracker App can help people have more meaningful conversations with their healthcare team and better manage their disease. The app can be downloaded for free from the Apple App Store or Google Play.
About the American Parkinson Disease Association:
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson's disease (PD) and works tirelessly to help the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $207 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson's disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at http://www.apdaparkinson.org.
Media Contact: Eloise Caggiano, ecaggiano@apdaparkinson.org, 718-981-2950



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Located in Huntsville, Germinator will service businesses and residences throughout Madison County.

HUNTSVILLE, ALA. (PRWEB) NOVEMBER 18, 2020
Germinator Mobile Sanitizing and Disinfecting is continuing its rapid expansion across the country, opening its newest location in the Southeastern United States. The company is proud to announce it has opened its doors in Huntsville, Alabama and will offer high-quality sanitizing and disinfecting services to businesses and residents throughout Madison County.
Germinator Huntsville will be owned and operated by Paul Orton. An educator for over 20 years, the current pandemic led him to open a Germinator franchise in order to provide the community with effective sanitizing and disinfecting services. Germinator has developed a patent-pending process that provides a new generation of microbial protection for both commercial and residential establishments.
"On March 13, with coronavirus on the rise, I was cleaning my classroom after school with a can of disinfectant and was immediately struck by its strong, chemical odor," said Orton. "I wondered to myself whether or not these products were actually safe, and I discovered that some of the ingredients used in disinfectants can contribute to asthma, dermatitis and other health problems. I wanted to provide the community with a better option for sanitizing and disinfecting, which led me to discover Germinator. Germinator's HOCl sanitizing and disinfecting solution does not use harsh chemicals or fumes."
Germinator's patent-pending methodology is the most unique and cost-effective means of providing enhanced antimicrobial protection for businesses and residences. The company first tests surfaces for ATP using a luminometer to detect light that can come from cellular activity. This measurement immediately provides the level of clean on a surface.
The next step is the application of Germinator's Genesis surface treatment. Genesis is a one-step cleaner and broad-spectrum sanitizer and disinfectant treatment that harnesses the power of hypochlorous acid (HOCl). Derived from naturally occurring minerals, Genesis not only eliminates odors at their source, but kills a wide range of bacteria including Staphylococcus aureus, MRSA, Salmonella enterica and Pseudomonas aeruginosa, and viruses including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists (AOAC) germicidal spray standards for Hospital Grade Disinfection and is on the EPA's N List of products determined to meet the criteria for use against SARS-CoV-2, the virus that causes COVID-19. As a result, this treatment will eliminate bacteria and viruses that may reside in your environment without the use of harsh chemicals or fumes.
Following Genesis, Germinator applies its Shield, a water-based quaternary ammonium compound that imparts a durable bacteriostatic finish. It is EPA-registered as effective against mold, mildew, algae and odor-causing bacteria. This application creates an invisible barrier that combats deterioration and discoloration and promotes freshness for up to three months.
The Genesis and Shield products are applied by using an electrostatic sprayer, which is the most efficient and effective means of delivering the products to the intended application sites. After Germinator's surface treatment and protectant services, the company retests ATP levels to ensure the surfaces have achieved the intended results.
Germinator was founded by Jeff Gill in 2015 with the vision of providing an effective method of proper sanitizing and disinfecting for businesses and households. The company continues to rapidly expand across the United States.
"We're looking forward to the opening of our first Alabama location," said Gill. "Paul is a leader by nature and was the perfect choice to spearhead our launch in this new market. He's led generations of students for over 20 years throughout Alabama, Texas, Tennessee and even across the globe. Now, he is leading the charge of providing Madison County with an effective method for proper sanitization and disinfection."
Upholding the highest standards of sanitization and disinfection, Germinator makes claims that are scientifically supported and within EPA regulations. The company's research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr. —who was an Assistant to the United States Surgeon General for five administrations; Dr. Harold Smith, who has extensive expertise in cell biology, molecular biology and biochemistry, along with decades of experience leading sponsored research on infectious diseases for the National Institutes of Health (NIH); Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board; and Chad S. Johnson, Esq., a Harvard-trained corporate, legislative, and regulatory attorney with significant experience in advising health and biotechnology companies.
"During these unprecedented times, the need to focus on sterilizing agents within our country's airports, public spaces and offices in order to help decrease the spread of viral pathogens such as coronavirus is essential," states Dr. Moore. "I am extremely happy to be a part of the Germinator team and lend my expertise in public health and regulatory affairs to what I feel is an immense asset to the containment effort."
With Germinator, society can now have greater peace of mind and the freedom to live or work in a sanitized and disinfected environment. Businesses and residents in Alabama can learn more by visiting https://www.germinatorhuntsville.com/ or calling (256) 272-9000.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Virus is Forcing Mostly Hopeful Americans to Change Their Holiday Plans, Travel, Spending and More as Survey Shows

DELFT, NETHERLANDS (PRWEB) NOVEMBER 18, 2020
As Americans rethink their holiday traditions this year to practice social distancing, protecting themselves and loved ones, a DrawNames survey gives insight into just how many Americans are feeling about the holidays, how they intend to spend them as well as how their spending habits may change. The survey was conducted with a random group of 1000 participants from 49 states and the District of Columbia. Roughly 57% of participants were women and 49% men predominantly age 25-44.
It's supposed to be the "happiest season of all" and yet a new wave of Covid-19 infections is making it more likely that many will spend the holidays with at least a small, select group of people, family or friends, or no one at all. So how exactly are Americans feeling about the upcoming holidays and are they keeping the holiday spirit by finding new ways to stay connected to loved ones?
Mental health awareness is always an important issue around the holidays but now the national conversation around Covid-19's impact on people's mental health is making the topic even more prevalent. DrawNames, which promotes the holiday spirit through its touchless gift exchange platform, conducted the survey to better understand exactly how the virus has impacted Americans this year and this holiday season, in particular.
How Americans Feel About the 2020 Holiday Season:
The survey reveals Covid-19 doesn't appear to have altered American's spirit, hope or desire to celebrate the holidays with 92% of those surveyed saying that they look forward to celebrating the holidays, but it may look a little different. Sixty-five percent said that Covid-19 is causing them to change their traditional holiday plans altogether this year and 72% said that if they don't celebrate the holidays at all it will be due to the virus and safety.
A majority of participants surveyed are feeling hopeful about the holidays noting that they will be different, but technology will help them stay close to loved ones. However, the biggest consequence of Covid-19 on the holidays is the inability to meet fewer or not see family members and friends at all. Sixteen percent of people said they are feeling sad about the holidays and spending them alone or unable to see family, while others say they will miss the holiday experience in stores, on streets and activities.
On Travel and Family:
When asked how the virus has changed holiday plans nearly 40% do not plan on traveling (flying or driving) to see family. Twenty-nine percent will get together with a "safe pod" of friends or family and close to 19% plan to make new traditions at home. Meanwhile close to 11% say they will spend the holiday alone and will use video calling to connect with friends and family.
More than 55% say that they are planning to spend the holidays with family who are local and nearly 15% say they will spend just a few days with family in another city. Twenty-five percent of respondents say that they plan on having dinner or a small gathering with a good group of friends over a large holiday event. Yet, close to 49% of people report that they are still planning on getting together to unwrap gifts, while 26% say they plan to send gifts by mail.
Spending:
And when it comes to spending on holiday gifts, only 18% say that they plan to spend more on gifts in 2020 than the previous year. Roughly 44% plan on spending the same amount and 38% will spend less on holiday gifts mostly because they want to save money, while others' spending will change due to furloughs, layoffs, pay cuts to support employers, and the fact that the household income has reduced from two to one. Those surveyed plan to spend an average of $661 on gifts this year, which comes in under the expectations of the National Retail Federation's annual consumer spending survey, which suggests that Americans plan to spend more – an average of $998, just a 5% decrease from 2019.
While reports have suggested that consumers will be shopping earlier than previous years, the survey shows that more than 60% of people plan on purchasing gifts about the same time they did last year, while 45% saying they shop specifically for deals during sales periods.
To view the full survey and its results, including personal responses from participants, please download the presentation attached to the release.
About DrawNames
For more than 10 years, DrawNames has helped millions of people – companies, friends and families – organize their free online gift exchanges. The service allows groups to create a gift exchange for any occasion, drawing names without the hassle of a hat. The 100% touchless virtual gift exchange includes an Auto Name Generator or choice to hold a Live Name Drawing event, ability to create an online wish list, a gift finder or the ability to exchange wish lists or find the perfect gift through anonymous questions. In 2020, the company introduced the option to send gifts via mail to recipients and hold virtual "Unwrap Live" events. Millions of people rely on DrawNames to simplify their Secret Santa gift exchange whether it be for Christmas, Hanukkah, Eid al-Fitr (Secret Eid), marking the end of Ramadan, or Valentine's Day. http://www.drawnames.com
Facebook: https://www.facebook.com/DrawNames
Twitter: https://twitter.com/drawnames
Instagram: https://www.instagram.com/drawnames/
YouTube: https://www.youtube.com/channel/UCSj3RVlYV80Na196_sSQLpg



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Korean Fishery brand, K-FISH, introduces premium Korean seafood with special events in November in the U.S., Japan, Philippines, Malaysia, and Indonesia with "Activating Overseas B2C with K-Seafood Global Weeks."

NEW YORK (PRWEB) NOVEMBER 18, 2020
The launch in 2017 of the Korean Fishery's national brand, K-FISH, aimed to promote the quality of Korean seafood and enhance its global competitiveness. Each year since then, the Korean Fishery office has held two-week-long promotions in many countries entitled "K-Seafood Global Weeks." This year's more extensive efforts have expanded to include B2C (business to consumers) by also introducing Korean seafood products to consumers online as well as offline. These special showcases are currently running in the U.S., Japan, Philippines, Malaysia, Indonesia, and other countries at the same time.
These events introduce K-FISH seafood products and stress the clean ecological environment for its production, their strict brand usage guidelines, and its rigorous quality management. Their 14 Korean seafood products available for export are: Gim (Laver Seaweed), Miyok (Sea Mustard), Oysters, Abalone, Sea Cucumbers, Fish Cake, Red Snow Crab, Seasoned Squid, Conger Eel, Flatfish, Tuna, Baby Calms, Roes and Mackerel.
These showcases are open to public.
You can also visit our website at http://www.kfish.co.kr & http://www.kseafoodusa.com
About K-FISH
K-FISH is the famous Korean Fishery national export brand that offers premium seafood for global seafood lovers. Based on their clean seas, their advanced management, and their stringent tests, K-FISH's products are of the best quality and very safe. Now you can purchase their wonderful seafood in U.S. markets. Every product is a precious gift from their pure seas and matches their meticulous procedures.
All of their delicious seafood is from Korea!



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dwell CBD is a Premium CBD brand, setting a new standard for health & wellness franchises.

LEXINGTON, KY. (PRWEB) NOVEMBER 18, 2020
While most CBD brands are solely focused on the quick returns of e-commerce, Dwell CBD has diligently and systematically developed an ultra-premium retail model, which is now poised to outpace its already extensive e-commerce sales.    
By combining best-in-class operations, with a family-friendly atmosphere, Dwell CBD is now among the fastest growing, premium CBD brands in the country. In addition to a welcoming retail space, the new SKIN tm. brand of topicals and comprehensive wholesale portfolio is creating a value proposition unlike anything seen in the industry. Although Dwell CBD has only begun accepting new franchise applications, the model has been reviewed by some of the largest private franchise groups in the country and showing massive promise as a sustainable business.
Forbes is reporting US CBD industry sales are projected to exceed $23 billion by 2025, and the market is distinctly poised for exciting growth at the retail level. Beginning in 2021, Dwell CBD will offer franchisee's a dynamic opportunity to establish themselves as a trusted brand, with exciting product innovations and unmatched quality.
"Our family brand has always focused on purity and community. We truly enjoy sharing the science of CBD and continue to refer our clients and franchisees to published research as a means to illustrate our approach to efficacy and safety," said Louis Police, Co-Founder & CEO
Dwell CBD is a privately held company, established in 2017, and is based in Nicholasville, Kentucky. The company is dedicated to formulating the highest quality CBD oil and CBD-infused products, with an equal commitment to serving customers, and community. Known for their premium quality oil products, produced under cGMP guidelines and without any additives or preservatives, Dwell CBD is among the fastest growing independent brands in the nation.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Enlighten MD joins Haute Beauty Network in the Medspa category representing the Dallas market.

DALLAS (PRWEB) NOVEMBER 18, 2020
Enlighten MD is known as the premier destination in Dallas for beauty and aesthetics with an award-winning selection of services that are combined with highly customized treatment plans to produce what you want... Results. The team is comprised of highly educated professionals who are true problem solvers. They focus on creating solutions to address your concerns while monitoring your progress every step of the way. Proud to be located in the heart of Preston Hollow, they pride themselves on providing discreet service within their state-of-the-art facility.
Enlighten MD is home to renowned endocrinologist Dr. David Feinstein who serves as the medical director, while the tenured team brings with them decades of experience. As a brand, their philosophy is simple, they spare no attention to detail. From the initial client consultation to the personalized treatment plans they create. Enlighten MD Strives to provide best in class service, care, and results, always and in all ways.
Behind the Brand
As a woman who has always valued being pampered and investing in self-care, founder Kari Feinstein is passionate about delivering the best experience possible for each and every client. Kari has invested over 15 years into developing the Enlighten Experience which custom tailors treatment plans for each individual. One size fits all? Kari doesn't believe in it. Which is why her patients see results.
Designed for every type of beautiful, the Enlighten Experience is focused on simplifying client's lives by providing comprehensive medspa services, beauty treatments, styling, and wardrobe options at the onsite clothing boutique, Enlighten Living, and now a full-service hair salon, Enlighten Salon. Spend the day with the team to recharge, rejuvenate, and indulge a little.
Learn more about Enlighten MD by visiting: https://hauteliving.com/hautebeauty/member/enlighten-md/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Enlighten MD is home to renowned endocrinologist Dr. David Feinstein who serves as the medical director, while the tenured team brings with them decades of experience.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Growing nonprofit plans smooth transition of leadership.

RALEIGH, N.C. (PRWEB) NOVEMBER 18, 2020
American Bone Health, the leading nonprofit organization dedicated to promoting healthy bones through community education, announces Kathleen Cody is retiring as Executive Director after 20 years in the position, and that Cheryl Hostinak will succeed her as Executive Director on Jan. 1, 2021. The leadership succession plan will ensure a smooth transition as the fast-growing advocacy organization moves forward after its 30th anniversary.
Cody, who joined American Bone Health in 2001, guided the organization through a major change in its mission. Founded in 1990 in Oakland, Calif., American Bone Health initially conducted clinical research and offered bone density testing. The Board of Directors recognized that the organization could make a greater impact by focusing on empowering consumers to make healthy choices. Cody executed this strategy by developing American Bone Health's signature educational programs and training a national network of volunteer Peer Educators. More recently, Cody has increased the public profile of American Bone Health through collaborations with other disease advocacy organizations, industry partners, and health care institutions.
"Kathleen Cody has been a dynamic and innovative leader for American Bone Health for 20 years, and she has been the face of the organization in the communities we serve and in the bone health field," said Paul Cline, President of the Board of Directors of American Bone Health. "We are delighted to have found in Cheryl Hostinak a successor who brings strong knowledge in the bone health field and a wealth of experience in engaging with consumers. Cheryl has already been working with the American Bone Health team to ensure a seamless transition once she takes over full time as Executive Director at the first of the year. American Bone Health is poised for continued growth and success with Cheryl at the helm."
"I am so grateful for all the great people I've worked with and the relationships that American Bone Health has built in communities all over the country," Cody said. "Raising awareness about bone health and how to prevent osteoporosis and fractures is a critical mission, and we have really made a lot of difference by reaching out to people in the communities where they live. There is still a lot of work to be done, but we have built a great team, and I'm confident that once Cheryl takes over, American Bone Health won't miss a beat."
Hostinak is a highly accomplished leader with a wealth of experience in the life sciences and biopharmaceutical industries, particularly women's health and bone health. Her roles have included patient engagement, advocate relations, marketing, business development, strategic planning, market research and clinical development.
"I am honored to have this opportunity to lead American Bone Health and build on what Kathleen, her team, the Board of Directors and all the wonderful volunteer Peer Educators have accomplished," Hostinak said. "My passion is improving patient health outcomes, and I have worked closely with patient advocacy organizations in my career. I look forward to expanding American Bone Health's reach so we can engage, educate and empower even more people to build and keep strong bones and prevent bone loss and fractures."
About American Bone Health
American Bone Health is a national, community-based organization that teaches people how to build and keep strong and healthy bones for life with practical and up-to-date information and resources to inspire them to prevent bone loss, osteoporosis and fractures. Learn more at https://americanbonehealth.org and @ambonehealth.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

On November 13, stem cell biotechnology company Asymmetrex published a seminal research report confirming the presence of immortal DNA strands in human tissue stem cells. Immortal DNA strands are the molecular basis for the immortality of tissue stem cells.

BOSTON (PRWEB) NOVEMBER 18, 2020
What does it mean for multiplying cells in the body to be immortal? The cell DNA is being replicated over and over again while being divided equally between new cells produced by cell divisions. All the new cell components produced by the DNA code are mixing with the old cell components and being divided between the new cells. So, every cell is a new cell. There is nothing really immortal about any of them. Right?
Not quite. Stem cells responsible for renewing other mature body cells are different. For a long time, tissue cell scientists had a somewhat nebulous idea that stem cells had a special longevity in organs and tissues – that they were immortal cells, lasting for as long as the human lifespan. However, no one had a molecular concept for this idea of stem cell immortality until John Cairns, a pioneer of DNA replication, started thinking about DNA mutations and cancer in the 1970's.
Cairns predicted that stem cells did something unique with their DNA code. He said they held on to one strand of every one of their many chromosomes and never shared those DNA strands with the tissue cells they renewed. Cairns called these immortal DNA strands. Cairns argued that immortal DNA strands must exist to explain how immortal stem cells avoid higher cancer rates.
Asymmetrex director James Sherley calls the immortal strand hypothesis the Carpenter's Rule for stem cells. Good carpenters avoid creeping measurement errors by using a ruler or the same piece of wood to measure duplicates. Too many DNA duplication errors in cells make them cancerous. Cairns proposed that stem cells were smart carpenters, keeping and using the same DNA strands for making their many replicate copies over the human lifespan.
Prior to Asymmetrex's new report, published in a special issue of the peer-reviewed journal Symmetry, there were many publications on the presence of immortal DNA strands in stem cells of other species, including molds, plants, insects, and mice. Low levels of immortal DNA strands were also reported for human cancer cells.
The new report from Asymmetrex describes the presence of immortal DNA strands in human liver stem cells. The SACK-Xs 12(3) stem cells used in the study were developed more than a decade earlier using Asymmetrex's patented SACK tissue stem cell expansion technology. SACK-Xs 12(3) human liver stem cells are distributed for research by Kerafast. They are the first and only commercial human tissue stem cell product supplied with their stem cell-specific dosage, certified by Asymmetrex.
The new report brings an important closure for an ingenious scientific deduction by a remarkable scientist, John Cairns, recently deceased. Now that normal human tissue stem cells are confirmed to have immortal DNA strands, scientists can get on with the business of leveraging this knowledge to a better understanding of tissue stem cells for improving human health.
About Asymmetrex
Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. The company's U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of effective use of human adult tissue stem cells for regenerative medicine and drug development. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations for use in stem cell transplantation therapies and pre-clinical drug evaluations. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA and the Massachusetts Biotechnology Council.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The in-home senior care brand has always fostered a Do Good and Make Money mantra. Now, Ed Dunkel and Paul Kaiser are stepping up amid a pandemic to help the seniors in his community.

READING, PA. (PRWEB) NOVEMBER 18, 2020
This year has been a turbulent year for all Americans — especially seniors. Even so, many amazing stories of community and coming together have come out of what has been a hard time. To help inspire others to do amazing things, Seniors Helping Seniors is sharing its Tougher Than 2020 stories as a way to celebrate the heroes of the brand making a difference.
The in-home care services franchise helps seniors maintain their independence while brightening their lives by pairing them with fellow seniors who are carefully matched to their specific needs, personality and preferences. In this way, not only do Seniors Helping Seniors clients have the opportunity to age in place with dignity, but they receive compassionate and empathetic care — a relationship that certainly underscores one of the brand's core values, The Power of Love.
This week, the brand celebrates Ed Dunkel and Paul Kaiser, franchise owners in Boca Raton, Florida.
"2020 was a tough year for so many people but Ed and Paul's work inspires us to carry on," said Seniors Helping Seniors Executive Vice President Namrata Yocom-Jan.
Dunkel and Kaiser have done amazing things in 2020. When the pandemic first appeared in Florida in March, they worked with other local businesses to find a face mask manufacturer. Then, as other caregivers chose to press pause on their efforts, Dunkel and Kaiser picked up the slack.
In one instance, a client called to express that her husband passed away. Dunkel stayed with the client and her handicapped daughter for hours to provide comfort and guidance.
This story is just another extension of the brand's mission to do good. When wife-and-husband duo Kiran and Philip Yocom founded Seniors Helping Seniors in 1998, they did so with a mission to do good first — then make money. This year, during the brand's 22nd lap around the sun, seniors have battled health challenges, loneliness and depression rates at an all-time high as COVID-19 continues to hammer down on America, meaning Seniors Helping Seniors has relied on that mantra and its strong franchisees more than ever before.
"When I worked alongside Mother Teresa, it was always about the greater good of humans. It was always about the bigger picture of life," Kiran Yocom said. "I live by the mission of treating all people with dignity and respect, and always thinking about the greater purpose of life."
Seniors Helping Seniors provides a variety of services to support seniors so that they are able to maintain their independence and enjoy life, not just in their homes, but also in their neighborhoods. These services include companionship, light housekeeping, cooking and shopping support, assistance with personal care, dementia care, pet care, light handyman services and small repairs, yard work and medication reminders.
"The concept of helping people in need never sleeps. We are there no matter how hard the world is being hit by a pandemic or how much our country is in crisis," said Namrata Yocom-Jan, executive vice president of Seniors Helping Seniors.
For the in-home senior care brand, it comes down to The Power of Love and providing compassionate care that makes seniors feel seen, heard and independent while providing purpose for its senior caregivers.
ABOUT SENIORS HELPING SENIORS
Seniors Helping Seniors was founded by husband-and-wife duo Kiran and Philip Yocom. Kiran, who grew up in India, later worked to advance humanitarian efforts alongside Mother Teresa. After moving to the U.S. in 1995 and marrying her husband Philip, the Yocoms felt called to provide loving care to seniors and to cultivate an exchange of gifts at every generational level. Together, the Yocoms founded Seniors Helping Seniors in 1998, opening the brand up to franchising in 2006. With a mission to be the most respected and rewarding homecare provider in the U.S., Seniors Helping Seniors stands apart from competitors as the only company that prioritizes hiring active seniors to provide care services to their less-active counterparts. Seniors Helping Seniors aligns caregivers and care recipients based on the abilities and needs of both by offering a wide range of care services. Seniors Helping Seniors has grown to nearly 200 locations in 30-plus states and seven international locations, with 110 franchise partners. For more information on Seniors Helping Seniors, visit https://seniorshelpingseniors.com/. To learn more about franchising opportunities with Seniors Helping Seniors, please visit https://franchise.seniorshelpingseniors.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Viscira Captures Awards for Two GSK Programs—an Innovative eLearning Adult Vaccines Module and a Cutting-Edge Augmented Reality Program

SAN FRANCISCO (PRWEB) NOVEMBER 18, 2020
Viscira, a leading provider of innovative digital marketing solutions and software applications for the life sciences industry, announced today that the Academy of Interactive and Visual Arts has selected Viscira as a Gold Davey Award winner for its interactive eLearning module for adult vaccines. Additionally, Viscira secured a Silver Davey Award for an augmented reality (AR) program for lupus patients and caregivers. Both programs were done in close collaboration with GlaxoSmithKline (GSK).
The interactive eLearning module is a dynamic, engaging module that provides pharmacists with information about adult vaccinations. The module includes built-in scenarios and quiz questions that can be used by all pharmacists to help with training needs. Located publicly at http://www.gsk-vaccination.com, pharmacists are able to access the module at their convenience from any device.
"The Viscira team worked with us to bring our online pharmacist module to market. We created exciting and engaging animated superhero characters that came to life with real video to help pharmacists improve adult immunization rates by enabling them to have better conversations with their patients," said Chris Lowry, Marketing Manager, SHINGRIX, at GSK.
The augmented reality program used a small physical house in conjunction with an iPad loaded with a mobile app that came to life with both AR and video components. The physical house has four separate rooms, and each room represents a different type of individual dealing with lupus —the overwhelmed patient, the actor patient, the warrior patient, and the caregiver. The AR and video components of the app experience allow patients to see and identify with someone who has the same thoughts, feelings, and daily struggles with lupus.
The Davey Awards is in its 16th year and is overseen and sanctioned by the Academy of Interactive and Visual Arts (AIVA), an invitation-only body consisting of top-tier professionals from a "Who's Who" of acclaimed media, communications, advertising, creative, and marketing firms. AIVA members include executives from organizations such as Conde Nast, Disney, GE, Keller Crescent, Microsoft, Monster.com, MTV, Push, Publicis, Sesame Workshops, The Marketing Store, Worktank, Yahoo!, and many others.
About Viscira
Viscira is dedicated to the design and development of innovative digital marketing solutions and applications for the life sciences industry. Viscira provides a suite of programs that integrate best-in-class technology to deliver engaging and memorable user experiences and content via various electronic channels. Viscira is part of WPP, the largest agency holding company in the world. For more information, please visit the company's website at http://www.viscira.com or contact Noёl Ashekian at (617) 429-0834.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Experienced periodontist in Diamond Bar and Garden Grove, CA, Dr. Jin Kim, offers transformative same-day dental implants with or without a referral.

DIAMOND BAR, CA (PRWEB) NOVEMBER 18, 2020
Dr. Jin Kim, an esteemed periodontist in Diamond Bar, CA welcomes new patients with or without a referral to restore their dental function, health, and quality of life in just one visit with same-day dental implants. Dr. Kim offers predictable and streamlined treatment for patients with tooth loss, completing numerous procedures during a single appointment to minimize in-person interaction amidst the COVID-19 pandemic.
Patients with one or more missing teeth can now receive dental implants in just one day with treatment from board-certified periodontist, Dr. Kim. This protocol eliminates unnecessary office visits and surgical appointments spanning several months to a year or more. Instead, with same-day dental implants, Dr. Kim can extract unsalvageable teeth, provide bone grafting if necessary, and place the implant all during the same surgery. In most cases, a temporary tooth can be placed immediately after dental implant placement. Patients can return home on the same day with a smile restored to function and beauty as they heal from surgery. Following this protocol, Dr. Kim can replace one, several, or all missing teeth during a single surgical appointment.
Patients who qualify for same-day dental implants can enjoy the convenience of all their surgical care completed in one day at a single office location. Those concerned about safety during the COVID-19 pandemic will attend significantly fewer appointments to minimize potential health risks. Dr. Kim and his staff follow all guidelines set in place by the Centers for Disease Control and Prevention (CDC) and use advanced sanitization techniques to ensure their surgical suites are safe for dental implant surgery.
Eliminating unnecessary visits, patients can commit less time to treatment while experiencing high-quality and long-lasting results. With same-day dental implants, they can immediately receive the benefits of a permanent tooth replacement, including restored dental function, smile aesthetics, and oral health. A complete, painless smile free from infection or tooth decay also makes it possible to eat a variety of healthy foods that boost overall health and the body's immune system, which is needed to help fight off threatening diseases and viruses.
Dr. Kim has decades of clinical experience in periodontics and dental implants. A gum tissue expert and skilled dental surgeon, he has mastered the technologies and techniques needed to offer same-day dental implants with amazing functional and aesthetic outcomes; in fact, he has lectured on this technique numerous times. Dr. Kim is highly credentialed and is dual board-certified by the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry. A teacher, researcher, and international speaker, he is regarded as a leader in periodontics and dental implants and is currently a consultant to four major dental implant companies. At his two esteemed practices in Garden Grove and Diamond Bar, CA, he offers comprehensive dental implant treatment using the latest technologies, techniques, and materials in implant dentistry.
Patients with missing teeth who are interested in receiving same-day dental implants from the experienced periodontist in Diamond Bar, CA are encouraged to contact the practice. Appointments with or without a referral can be made by visiting http://www.drjinkim.com or calling 909-860-9222 for the Diamond Bar location or 714-898-8757 for the West Garden Grove location.
About the Doctor
Dr. Jin Kim is a periodontist dedicated to providing personalized dental care in Diamond Bar and Garden Grove, CA. Dr. Kim attended the University of Sydney Faculty of Dentistry before furthering his education with an advanced degree in pathology from the Medical School of the same University. Dr. Kim completed a periodontics and implant surgery residency at UCLA School of Dentistry and is board-certified by the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry. He is a past president of the Western Society of Periodontology and was also inducted to be a Fellow of the prestigious American College of Dentists and earned Fellowships in the International Congress of Oral Implantologists and the American Academy of Implant Dentistry. Dr. Kim lectures and holds faculty positions at a number of universities including UCLA School of Dentistry and abroad. He has spoken at no less than 36 different countries across the globe as well as national and international academic and clinical associations and universities including the International Association of Dental Research, American Academy of Periodontology and Academy of Osseointegration. To learn more about Dr. Jin Kim and the services he offers, visit his website at http://www.drjinkim.com or call 909-860-9222 for the Diamond Bar location or 714-898-8757 for the West Garden Grove location to schedule an appointment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

First Emergency Hospital in Michigan Providing SignalPET Screening Tool

ANN ARBOR, MICH. (PRWEB) NOVEMBER 18, 2020
Emergency Veterinary Hospital, Ann Arbor, (EVH) a leading local emergency pet hospital, announces its partnership with SignalPET, offering a revolutionary new artificial intelligence technology for reviewing pet x-rays for faster, higher-quality patient care.
SignalPET provides a "second set of eyes" for routine veterinary radiology screenings, offering objective, reliable assessment of more than 50 radiographic tests on every study, in 10 minutes or less. There is no hardware involved, and films can be reviewed from any screen connected to the internet — all at an exceptionally low cost.
"We founded SignalPET to help veterinarians deliver the highest standards of care in their practices," said SignalPET Co-founder and CMO Dr. Neil Shaw, DACVIM. "We found a way to make the everyday use of x-rays as a diagnostic tool achievable for the majority of veterinarians by creating an incredibly easy-to-use solution that leverages artificial intelligence in a way no one was doing before. And the results are remarkable. It's rapidly raising the bar on the standard of care in our industry."
"In emergency situations, time is of the essence! At EVH, we believe in utilizing innovative technology that helps us merge efficiency and accuracy to provide quick, high-quality care to our patients. With SignalPET, our team can rapidly evaluate radiographs, share them in a team setting for additional input, and this has drastically improved our ability to initiate treatment for patients sooner. I cannot speak highly enough about this amazing technology!" says Dr. Lindsay Ruland, Practice Owner and Chief of Medicine for EVH.
With the SignalPET technology, veterinarians benefit from increased confidence in assessing each radiograph, leveraging consistent, objective results for each study. The technology automatically examines the complete study, helping clinicians confirm nothing has been overlooked. Plus, pet owners have a report immediately available, as well as access to their pet's x-rays.
"SignalPET rapidly uploads our images directly from our x-ray machine and within just a few minutes we have an AI interpretation that we can use to enhance our clinical picture of our patient," Dr. Ruland says. "And that is what is so unique about this program. Even with its incredibly advanced technology, it is not designed to replace a veterinarian's interpretation of a patient's diagnosis, but instead is there as another puzzle piece to help supplement care. At EVH we know each patient is unique and diagnostics may not tell the whole story which is why we use these puzzle pieces to help us understand the story and then initiate targeted, timely care."
About Emergency Veterinary Hospital, Ann Arbor
Founded in 2012, Emergency Veterinary Hospital is an AAHA-accredited 24-hr emergency hospital that treats small animals and exotic species. At EVH, we believe that achieving the highest quality of medicine begins with approaching each patient as a unique individual whose needs are not necessarily the same as another. We utilize advanced technologies and state-of-the-art equipment to bring a severely needed service in which veterinary diagnostics are gold-standard while still being affordable to the client, which creates far more opportunities for pets to receive the treatments they need. Learn more at https://emergencyvetannarbor.com/.
About SignalPET
SignalPET was created to help clinicians gain more diagnostic value from traditional radiographs. Powered by patented artificial intelligence, SignalPET provides objective, reliable AI results on over 50 of the most common routine radiology findings seen by general and emergency veterinarians. Learn why veterinary professionals around the country are choosing SignalPET for high-quality radiology results that lower costs and save time at http://www.signalpet.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Two leaders in medical innovation—Robert Niichel of SmartTab Founder and CEO, and Kent Thiry Founder of Colorado Thrives—discuss what's on the horizon for medical innovation and what will be the next advancements for Colorado.

DENVER (PRWEB) NOVEMBER 19, 2020
Robert Niichel sits down with Kent Thiry, Former Chairman and CEO of DaVita. In 2018, Kent founded a CEO group, called Colorado Thrives, focused on advancing the quality of life of all Coloradans. Thiry will discuss Colorado Thrives' goals to improve equity, health, and prosperity for future generations. He shares the inspiration that drives Colorado Thrives and their vision to take Denver and Colorado to the next level of innovation and wellbeing. Thiry will explore the Economic Mobility focus of the organization and the specific initiatives they're working on now and what's to come, exploring critical questions:

With so many digital technology and healthcare startups in Colorado, what steps can these companies take to grow and evolve in the next 5-10 years?

What does Colorado's future as an innovation hub look like?

How can Denver leverage the talents of the bright young people in Colorado to accomplish those goals?

Thiry offers invaluable experience from his work at DaVita, a leading Fortune 500 healthcare provider. He will share the inspiration and goals behind Colorado Thrives, and how small, innovative companies can expand and take on a much larger footprint in Colorado in the next five to ten years. Despite the pandemic young people continue to flock to Colorado, and especially Denver. This is a critical time to leverage the talent of young, bright people in the community. Thiry offers valuable insight as to where he sees Colorado Thrives in five years, and discuss how he thinks workforce readiness, homeless and mental health issues, and transportation issues can be solved.
About Kent Thiry:
The former executive chairman of DaVita's board of directors, he served as chairman and CEO of DaVita from 1999 until June of 2019. Kent Thiry sits on the Harvard Business School's advisory board and is regularly invited to speak on leadership and culture at top business schools, companies and not-for-profit leadership groups. In 2018, he founded a CEO Group, called Colorado Thrives, focused on advancing the quality of life of all Coloradans. He is committed to bringing a village of leaders together to drive innovation and improve the wellbeing of everyone in Colorado and beyond.
About the Podcast:
Who Would Have Thought is a digital health innovation podcast, about what we know now and what we have yet to discover about the future of healthcare. Explore the perspectives of digital health leaders today and inquire into digital technologies of tomorrow.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

$40,000 Grants Will Be Awarded Annually to Young Scientists Pursuing Innovative Studies For the Treatment and Cure of Prostate Cancer

PLAINVIEW, N.Y. (PRWEB) NOVEMBER 19, 2020
The National Cancer Center is pleased to announce the launch of the Prostate Cancer Project to fund post-doctorate fellows pursuing promising and innovative research in prostate cancer. This project will be the National Cancer Center's sixth research program focused on finding better diagnostic tools, better treatments and ultimately a cure for cancer.
The Prostate Cancer Project builds on the NCC's success in providing financial support to researchers undertaking promising studies that seek to cure breast cancer, childhood leukemia, aggressive cancer and other childhood cancers. The NCC awards grants of $40,000 annually to eligible young scientists. If the grantee demonstrates good progress at the conclusion of the first year, he or she is eligible for an additional grant of $42,000 for a second year. The NCC has awarded more than $500,000 in grants this year.
"More than three million men in the U.S. are living with prostate cancer. Determining the most effective treatment plans for men at different stages of the disease proves to be one of the largest challenges, and is one reason we are so passionate about this project," said Regina English, Executive Director, National Cancer Center.
Applications, which can be found here, will be considered through December 23, 2020; grantees will be notified on May 18, 2021.
For nearly 70 years, the NCC has been dedicated to providing financial support to research with the promise of conquering cancer. The NCC runs six cancer research programs: Aggressive Cancer Project; Fighting Childhood Leukemia; The Breast Cancer Project; Children's Cancer Project; Prostate Cancer Project and the NCC Project. The organization also provides education on the prevention, diagnosis and treatment of cancer.
About National Cancer Center
National Cancer Center was founded by Dr. J. Ernest Ayre in 1953 as a non-profit organization committed to research and education about cancer. Dr. Ayre was a pioneer in refining and promoting the Pap test for women, a major factor in reducing deaths from cervical cancer. He was also one of the first researchers to recognize the enormous potential of Interferon for cancer treatment. NCC currently funds research at Duke University, Yale University, Dana-Farber Cancer Institute at Harvard University, the Salk Institute, Children's Hospital of Philadelphia and other prominent universities and research institutes throughout the U.S.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

UNYQ's personalized prosthetic wears are now available in a new version of the iPhone UNYQ App. The industry leading app is now available in it's 3rd version to be downloaded from the Apple App store.The new version makes remote ordering even simpler, it includes a completely new look and feel and an easier way to capture the biometrics through the smartphone camera. It also includes new designs and thinner 2 mm prosthetic covers.

SAN FRANCISCO (PRWEB) NOVEMBER 19, 2020
UNYQ App that for the last 5 years has been successfully used to create and design thousands of prosthetic wears, guides the user and clinicians through the design and buying experience. Using state of the art photogrammetry software it enables the user to capture all the biometrics through an iPhone or an iPad. After orders are placed it informs the buyer when mock-ups are ready and order status, a process that takes 2 to 3 weeks from the time of final approval.
All lower limb UNYQ Covers, designs and colors are available on the app and now it includes a feature that enables virtual reordering of the covers without even visiting an UNYQ clinic.
"Selection, fitting and service of prosthetic wears are going virtual. The new version of the UNYQ App is particularly suitable in these times, giving users and clinicians the power to personalize prescription medical wears capturing biometrics remotely. The newly designed collections provide in these challenging times uplifting experience and are easy to take off to disinfect and put on again" said Eythor Bender CEO and Co-Founder of UNYQ.
The new app is available now to be downloaded from the Apple App store together with 9 new designs and new 2MM designs. The new 2MM covers that are available in 3 designs are more flexible and lighter than the original designs.
Detailed overview of the process and the features here in this blog: http://unyq.com/an-app-like-no-other/
ABOUT UNYQ
UNYQ is a designer of prescription prosthetic and orthotic wears. UNYQ uses digitization and 3D printing to enable mass customization and personalized design. UNYQ was founded in San Francisco and Seville Spain with over 700 UNYQ Clinics in over 30 countries across the world. To learn more about UNYQ, its Hub Network and complete product lines, visit http://www.unyq.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This new autism treatment clinic has been in planning for over a year, a development phase coinciding roughly with the leadership handoff to CEO Mark Jackson in December 2018. The plans do not stop with the opening. The vision for the new facilities includes camps during school breaks, a shuttle service, an outdoor playground, and general site expansion. For now, ATG is focused on safety, distancing, and meeting or exceeding all CDC guidelines.

LOMBARD, ILL. (PRWEB) NOVEMBER 19, 2020
"This clinic is a critical step forward for ATG's mission: To provide high-quality, clinically proven services to clients and families impacted by autism."
Those are CEO Mark Jackson's remarks on the opening of The Autism Therapy Group's new treatment center here in Lombard, IL.
The New Autism Treatment Group Center
The center, at 991 Oak Creek Drive, occupies 16,000 square feet and has dedicated areas for offices, conferences, one-on-one teaching, and activities. Over the course of its development and growth, the center will create many new jobs for area residents in high-paying, specialized fields.
ATG was previously focused entirely on home therapy. The group has patients all across western Chicagoland. The Lombard location is an easily accessible home base — an opportunity to expand access while staying close to clients' homes.
This new autism treatment clinic has been in planning for over a year, a development phase coinciding roughly with the leadership handoff to Jackson in December 2018. The plans do not stop with the opening.
The vision for the new facilities includes camps during school breaks, a shuttle service, an outdoor playground, and general site expansion. For now, ATG is focused on safety, distancing, and meeting or exceeding all CDC guidelines.
The Difference at ATG
The ABA industry has up to 75% turnover for Registered Behavior Technicians, as reported on Forbes. On the low end, the estimate is about 30% turnover annually. This leads to retraining costs, interruptions in care, and lack of consistency in many clinics.
ATG stands out with high employee satisfaction. Jackson has cited respecting employee time as one of the primary contributors to this — caregivers get the personal time they need to stay committed to the organization's vision. This, in turn, allows everyone to focus on quality of care.
The goal is not just to keep people on board, but to build community by generating internal referrals of new employees. If the opening of the expansive new center is any indication, the people-first strategy seems to be working for everyone's benefit.
The Need for More Treatment Centers
Lombard already has one ABA treatment center: a branch of a large, regional chain. There are several others dotting the western suburbs. However, the need for more is obvious — the nationwide status quo consists of waiting lists, delayed assessment times, and at-capacity facilities.
The cause of these overfull centers: An increase in the prevalence of ASD. As more data begin to emerge, the scope of the issue is becoming clearer.
The change is dramatic. In 2000, CDC data identified about 1 in 150 children as having an ASD. In 2016, that estimate had already risen to 1 in 54.
Rather than a cause for alarm, this indicates advances in data collection and autism diagnosis. In fact, it is good news for most parents of children with autism: More accurate, earlier identification of ASDs often leads to improved treatment outcomes.
What are the specific influences on the increase? More accurate identification of ASD, more widespread awareness of the specific symptoms of the condition, and technical changes to the diagnosis in the Diagnostic and Statistical Manual of Mental Disorders — the handbook for mental health professionals — have all been factors in the rising number of known cases, according to Scientific American. The CDC plans to expand sampling in upcoming studies, so we can expect the number to change again soon.
A Clear Path Forward
It seems that all of these statistics are secondary to the overarching vision of The Autism Therapy Group. When asked why he worked in ABA, Jackson replied, "I get to wake up each morning focused on a single goal: making a difference in children's lives."
For now, there is no waitlist at the new center. ATG invites parents or other caretakers to call (847) 465-9556 at any time.
Answering services are available in Spanish and English.
https://atgtogether.com/lombard-clinic/
References
https://www.forbes.com/sites/forbesbooksauthors/2018/11/07/improving-retention-in-aba-services/
https://www.cdc.gov/ncbddd/autism/data.html
https://www.scientificamerican.com/article/the-real-reasons-autism-rates-are-up-in-the-u-s/
Media Contact:
Mark L. Jackson
Chief Executive Officer
mark.jackson@theautismtherapygroup.com
Office: 847-465-9556
Cell: 312-339-5137




START your own Wordpress site, business or personal website, or online store at www.siteground.com

A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.

BUFFALO, N.Y. (PRWEB) NOVEMBER 19, 2020
A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.

Ovarian cancers often recur, with no curative treatment options

Roswell Park assessed a new combination of older treatments with immunotherapy

95% of patients benefitted from the treatment, with many long-term responses

In a new article in JAMA Oncology, the researchers report that one-quarter of patients who received the combination of pembrolizumab (brand name Keytruda), bevacizumab (brand name Avastin) and a pill form of cyclophosphamide (brand name Cytoxan) experienced long-term disease control along with excellent quality of life — far outpacing the effectiveness of either existing approved therapies or newer immunotherapies alone.
The idea to combine the two widely used systemic chemotherapy agents with pembrolizumab, an immune checkpoint inhibitor, grew out of the desire to improve immune response while preserving quality of life, notes Emese Zsiros, MD, PhD, FACOG, a staff physician and faculty member with the Department of Gynecologic Oncology and Center for Immunotherapy at Roswell Park.
"Pembrolizumab works by activating immune cells against cancer, but checkpoint inhibitors haven't worked well in ovarian cancer because the T cells often can't get to the tumor," says Dr. Zsiros, first author on the new paper. "We combined bevacizumab, to normalize the tumor microenvironment and achieve better penetration of T cells into tumor tissue, and oral cyclophosphamide, which can deplete 'bad' regulatory T cells that actually help cancer cells to avoid immune attack, with checkpoint blockade in order to activate the 'good' killer T cells to fulfill their function."
The results of the team's phase 2 clinical study suggest a significant benefit for patients receiving this combination regimen.
Among 40 patients with recurrent or treatment-resistant ovarian, fallopian-tube or peritoneal cancer — which together represent the most-fatal gynecologic cancers — 95% experienced clinical benefit from this treatment. Progression-free survival nearly doubled, from an expected survival of 5-6 months to 10 months. And the combination generated durable responses, with 47.5% of patients on the study responding to the treatment and 25% demonstrating long-term disease control.
The team assessed participants' quality of life at several junctures. Patients on the study maintained high and stable functioning throughout the study. Some indicators — body image and emotional/social functioning — actually improved overall over the course of the trial.
"The quality of life of our patients who took part in this clinical trial was excellent," says Dr. Zsiros. "Most of them were able to travel, spend good time with their families and resume their hobbies — cooking, hiking, things that they were not doing before. And approximately 30 percent of our patients were still living more than a year and a half after going on this combination, which we did not anticipate. These are very striking results."
Approximately 70% of people diagnosed with ovarian cancer will experience a recurrence. Studies have shown that the available "second-line" chemotherapies for those whose cancers return are associated with limited clinical benefit, with overall response rates ranging from 10-25%, and result in significant treatment-related toxicities. And only 8% of patients with recurrent ovarian cancer have been shown to respond to pembrolizumab alone.
"This clinical trial represents a significant conceptual advance in the use of combination therapy to enhance the efficacy of immunotherapy, demonstrating that we can generate long-term disease control in ovarian cancer without compromising quality of life," says the paper's senior author, Kunle Odunsi, MD, PhD, FRCOG, FACOG, who is Deputy Director, the Robert, Anne & Lew Wallace Endowed Chair in Cancer Immunotherapy, Executive Director of the Center for Immunotherapy, and the M. Steven Piver Professor of Gynecologic Oncology at Roswell Park. "The combination assessed in our trial is an option that should be considered for many patients with recurrent ovarian cancer based on its high tolerability and strong signal of efficacy."
Along with Drs. Zsiros and Odunsi, contributing authors are Sarah Lynam, MD, Kristopher Attwood, PhD, Katy Wang, MA, Shanmuga Chilakapati, PhD, Eduardo Cortes Gomez, MS, Song Liu, PhD, Stacey Akers, MD, MBA, FACOG, Shashikant Lele, MD, FACOG, and Peter Frederick, MD — all from the Department of Gynecologic Oncology, Department of Biostatistics & Bioinformatics and/or Center for Immunotherapy at Roswell Park.
This study was designed by the Roswell Park investigators with the support of the Merck Investigator Studies Program (MISP).
###
An online version of this release is available on our website.
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Amid global pandemic, Heart to Heart Hospice continues providing person-centered care to patients and families.

PLANO, TEXAS (PRWEB) NOVEMBER 19, 2020
National Hospice and Palliative Care Month, observed each November, is the ideal time to highlight the response of hospice caregivers to those with life-limiting illnesses, especially in the midst of the COVID-19 health crisis, according to Heart to Heart Hospice.
"We are proud to recognize the compassionate efforts of the nurses, aides, physicians, social workers, therapists, chaplains, bereavement coordinators, volunteers – all those who provide comfort, support, and dignity to our patients and their families," said Kelly Mitchell, Chief Executive Officer of Heart to Heart Hospice.
"Caring for those at the end of life is difficult work, even in ordinary times," he noted. "But during these extraordinary times, our team members have truly become 'heroic caregivers,' stepping up to the challenge, despite the unknowns, to ensure our patients and families receive the care they need and deserve."
The hospice philosophy holds that end-of-life care should emphasize quality of life, and hospice is designed to help patients remain in the place they call home. This is precisely where 90 percent of adults would prefer to be if diagnosed with a terminal illness, according to a nationwide Gallup survey conducted for the National Hospice and Palliative Care Organization.
The survey results revealed other significant ways that hospice provides what Americans want at the end of life:

When asked to name their greatest fear associated with death, survey respondents most cited "being a burden to family and friends," followed by "pain" and "lack of control." Through an interdisciplinary team, hospice care addresses the whole range of physical and psychological needs faced by patients and their families at life's end.

90 percent of adults believe it is the family's responsibility to care for the dying. Hospice provides families with the support needed to keep their loved one at home and can take over fully to give the caretaker short "respite" periods.

Most adults believe it would take a year or more to adjust to the death of a loved one. Hospice programs offer one year of grief counseling for the surviving family and friends.

An overwhelming majority of adults also indicated they would be interested in the comprehensive program of care at home that hospice programs provide. Yet most Americans know little or nothing about their eligibility for or availability of hospice.
Hospice provides the most appropriate, highest quality, patient- and family-centered care available for people at life's end. National Hospice and Palliative Care Month is a time to encourage people to increase their understanding of the benefits of hospice care and to discuss their end-of-life wishes with their families.
About Heart to Heart Hospice
Heart to Heart Hospice, founded in 2003, is one of the largest private providers of hospice care in the United States. Headquartered in the Dallas-Fort Worth Metroplex, Heart to Heart provides a broad range of hospice services to patients with life-limiting illnesses across 37 locations in Texas, Michigan and Indiana. At Heart to Heart, we understand both the physical and emotional challenges for our patients and their loved ones and our care team is committed to providing them with what they need most: comfort, support, and dignity. Learn more about Heart to Heart Hospice.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In an ongoing podcast series called "The Krush Brain Game", Jeff Krushell talks with leading experts and industry insiders about the role of the brain in human performance and the methods and technologies that are being used with professional and elite athletes.

MONTREAL, QUEBEC (PRWEB) NOVEMBER 19, 2020
Podcaster and performance consultant, Jeff Krushell, interviews Thought Technology, Ltd Co-Founder, Lawrence Klein, in the final podcast of his series "The Krush Brain Game" where he explores the role of the brain body connection in optimal performance training.
Asked about his focus on the brain, Jeff replied, "We know the brain is a huge piece of the performance puzzle and new advances in technology are not only allowing us to map and track brain performance like never before but also allowing us to train the brain – IN REAL TIME and in ways that we have NEVER been able to until recently."
Thought Technology's products have been used by Olympic and professional athletes and other high performers for decades. A key component in peak performance training is learning to keep stress at bay, so that both mind and body can focus a hundred percent on the task at hand. According to Lawrence Klein, "Each individual processes stress differently. A psychophysiological stress assessment looks at multiple modalities such as heart rate, respiration rate, skin conductance, temperature, and muscle tension. When you are able to measure the body's physiological reaction to stress, you can learn to change how it responds and over time can call upon this skill whenever needed."
Included in this ongoing series, are interviews with several influential people from the biofeedback field including: Dr. Erik Peper, psychologist, author and president of the Biofeedback Federation of Europe; Dr. Inna Khazan who combines the use of biofeedback and mindfulness.
Click here to listen to Jeff Krushell's interview with Lawrence Klein.
About Jeff Krushell
Jeff Krushell is the founder of Krush Performance and an Athlete Development Specialist & Organizational Performance Consultant. He is regarded as a noted expert in the area of talent development in sport and through his work has gained unique insights into the process of improving performance.
Over the last 25 years Jeff has worked in the world of high-performance sport helping athletes tap into their potential to truly understand what it is like to achieve Human Maximum Performance. Jeff currently consults for Major League Baseball International; CTV News, Edmonton; Vauxhall Baseball Academy; Link Management and has previously worked as the strength and conditioning coach for both the Toronto Blue Jays and Edmonton Eskimos.
About Lawrence Klein
In addition to being the Co- Founder of Thought Technology Ltd. with Dr. Hal Myers (1974), Lawrence Klein is:

Co-author in 1974 of Mind Over Muscle with Major Nory Laderoute

Member since 1965 of the CSCF/CSIA - Canadian Ski Coaches Association / Canadian Ski Instructors Alliance

Co- Founder in 1996 of The Biofeedback Federation of Europe

Life-time Member of the WTFCA – World Track & Field Coaches Associate

About Thought Technology Ltd.
Founded in 1975, Thought Technology is the world's leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.
Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The American College of Lifestyle Medicine has announced the addition of plant-based food brands certifier Plantricious to its Corporate Roundtable. Plantricious, which certifies plant-based food brands based on defined nutrition guidelines, helps the public and health professionals in making food-as-medicine decisions.

ST. LOUIS (PRWEB) NOVEMBER 19, 2020
The American College of Lifestyle Medicine (ACLM) has announced the addition of plant-based food brands certifier Plantricious to its Corporate Roundtable. The Corporate Roundtable convenes thought leaders and industry professionals to explore effective clinical innovations, activate marketing strategies, accelerate reimbursement and policy adoption, and pursue research and demonstrations of Lifestyle Medicine in practice. Plantricious, which certifies plant-based food brands based on strictly defined, evidence-based nutrition guidelines, helps the public and health professionals in making food-as-medicine decisions.
The Roundtable launched in 2015 and has grown to include more than 30 active member organizations. In pursuit of sharing scientific findings and best practices, Plantricious will now work alongside fellow roundtable members and key leaders within ACLM as a contributing partner and will play an active role at ACLM's annual conference.
It is widely recognized that a lifestyle including a predominantly whole food plant-based diet may help prevent, arrest, or even reverse chronic diseases such as heart disease, stroke, type 2 diabetes and cancer. According to the International Food Information Council, while 78% of consumers change their eating habits per their health care professional's recommendation, patients can find it difficult to gauge the nutritional merits of plant-based options. The Plantricious seal is the first certification that makes it easy for consumers to find brands that meet a strict criteria of being 100% whole food plant-based, minimally processed, have no added oils, sugar, or artificial flavors and preservatives, while also containing a maximum of 1miligram of sodium per calorie and containing a minimum of 2 grams of fiber per 100 calories.
"This partnership also offers many new opportunities for Plantricious certified brands to connect with the 5,000-plus clinicians who are members of ACLM," said Plantricious founder and CEO Paige Ohliger. "Given physicians see an average of 3,000 to 6,000 patients a year and there are almost 1 million practicing physicians in the U.S., there are endless possibilities to mutually benefit food companies as well as medical professionals and patients. "
"This strategic partnership creates a first-of-a-kind bridge between the health care community and Plantricious certified brands, forging a new way to help physicians and other health care professionals fulfill the food-as-medicine promise," said ACLM President Cate Collings, MD, FACC, MS, DipABLM. "The Plantricious seal offers a simple way to identify health-promoting, nutritious foods that physicians and other health professionals can trust and rely upon when directing their patients to make healthful, plant-nutritious choices."
"We worked with the nation's leading health care experts to define the Plantricious seal standards, so ACLM was a natural fit to join our mission in providing a trusted and transparent way to identify plant-nutritious foods," said Ohliger. "Our carefully cultivated ecosystem also gives food brands access to a thriving community of health care practitioners and health conscious consumers, helping us all to live more healthfully."
ABOUT ACLM: The American College of Lifestyle Medicine (ACLM) is the medical professional society for those dedicated to the advancement and clinical practice of Lifestyle Medicine as the foundation of a transformed and sustainable health care system. Lifestyle Medicine is the use of an evidence-based whole food, plant-predominant dietary lifestyle, regular physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connection as a primary therapeutic modality for treatment and reversal of chronic disease. Learn more at http://www.lifestylemedicine.org.
ABOUT PLANTRICIOUS: Plantricious is on a mission to make plant-nutritious food choices easy. Our Plantricious seal provides the food industry and the public a trusted and transparent way to identify healthy, plant-nutritious foods, and our curated ecosystem provides food brands with access to a large community of health care practitioners and health-conscious consumers. Learn more at http://www.plantricious.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Cancer Support Community Central NJ (CSCCNJ) has remained a critical resource during this difficult time in partnership with Gilda's Club South Jersey, Gilda's Club Philadelphia, and Cancer Support Community Greater Lehigh Valley by modifying the in-person Strengthening Our Schools conference to be offered virtually and at no charge. Now more than ever, these "kid-centered" professionals are on the front lines for students as they manage through a pandemic. The three-day series included breakout sessions on topics ranging from mindfulness and games to cancer, loss, and COVID-19. The series brought together a range of professionals from social workers and nurses to teachers and child life specialists, all of whom work with school-age children.

BEDMINSTER, N.J. (PRWEB) NOVEMBER 19, 2020
Children and teens impacted by a cancer diagnosis are experiencing increased fear, anxiety, and isolation due, not only to the diagnosis, but to the COVID-19 pandemic as well. Cancer Support Community Central New Jersey (CSCCNJ), a nonprofit organization located in Bedminster, NJ, understands the importance of providing support for these vulnerable students, as well as the school and childcare personnel with whom they spend the majority of their day. CSCCNJ recently hosted its annual Strengthening Our Schools conference virtually to equip school professionals with the tools they need when a child is impacted by a cancer diagnosis either personally or through a loved one.
CSCCNJ has remained a critical resource during this difficult time in partnership with Gilda's Club South Jersey, Gilda's Club Philadelphia, and Cancer Support Community Greater Lehigh Valley by modifying the in-person conference to be offered virtually and at no charge.
Now more than ever, these "kid-centered" professionals are on the front lines for students as they manage through a pandemic. The three-day series included breakout sessions on topics ranging from mindfulness and games to cancer, loss, and COVID-19. The series brought together a range of professionals from social workers and nurses to teachers and child life specialists, all of whom work with school-age children.
"There is an increased level of concern regarding mental health and quality of life, and this further exposed the myriad health disparities for our participants and their loved ones. There were families with young children in the home whose academics came to a halt and are now exposed to their parents' cancer diagnosis and debilitating side effects 24/7," says Katherine Schaible, LSW, Program Director at CSCCNJ.
The virtual aspect of the conference provided an opportunity to reach even more attendees than previous years. There were 92 attendees tuning in virtually from the comfort of their homes, offices, and classrooms from across the United States and internationally.
Strengthening Our Schools is the centerpiece of CSCCNJ's efforts to address the significant unmet needs for adolescents and teens facing a cancer diagnosis or the diagnosis/death of a family member. Since 2013, this conference has provided tools and resources to professionals in these communities and made them aware of the services available to their schools.
Tara Geraghty, BA, REBT, presented a keynote speech on "Finding the Fun: Parenting in the Face of Cancer." The presentation discussed what a parent and child experience in a pediatric cancer diagnosis. Tara made a point to answer any questions from these professionals as she added in how she felt and what worked best for her situation. By the end of the virtual conference, these professionals were equipped with tools and resources to bring back to their communities to better serve the children and families impacted by a cancer diagnosis.
"Before and during the pandemic, it has always been our mission to provide age and developmentally appropriate emotional and social support programs to children, teens, and families," says Schaible.
This conference was made possible thanks to the generosity of Clinton Sunrise Rotary, Daiichi Sankyo, Sanofi US, and The Tyler Foundation.
For more information about School Based Support, contact Jesse Guzik, CCLS, Child/Youth Program Coordinator, at 908-658-5400 x5.
About Cancer Support Community Central New Jersey:
Cancer Support Community Central New Jersey (CSCCNJ) is a registered 501(c)(3). As experts in oncology mental health, the organization provides support, education, and hope to all people with cancer and their loved ones. Backed by evidence that the best cancer care includes social and emotional support, CSCCNJ creates a caring community to help individuals live with, through and beyond cancer. At no charge to people with cancer, family members, and caregivers, the organization delivers essential programs and services including individual and group support; educational, nutrition, and healthy-cooking workshops; classes to enhance health and wellness; and activities that build social connections. CSCCNJ has temporarily moved its program of support to a virtual platform since the start of stay-at-home orders, and will continue to provide both virtual and in-person support in the future. For more information, visit their website at cancersupportcnj.org or call (908) 658-5400.



START your own Wordpress site, business or personal website, or online store at www.siteground.com